0001731122-23-000408.txt : 20230317 0001731122-23-000408.hdr.sgml : 20230317 20230317080050 ACCESSION NUMBER: 0001731122-23-000408 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kaival Brands Innovations Group, Inc. CENTRAL INDEX KEY: 0001762239 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-NONSTORE RETAILERS [5960] IRS NUMBER: 833492907 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40641 FILM NUMBER: 23740712 BUSINESS ADDRESS: STREET 1: 4460 OLD DIXIE HIGHWAY CITY: GRANT STATE: FL ZIP: 32949 BUSINESS PHONE: (833) 452-4825 MAIL ADDRESS: STREET 1: 4460 OLD DIXIE HIGHWAY CITY: GRANT STATE: FL ZIP: 32949 FORMER COMPANY: FORMER CONFORMED NAME: Quick Start Holdings, Inc. DATE OF NAME CHANGE: 20181218 10-Q 1 e4478_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ____________

Commission file number 000-56016

KAIVAL BRANDS INNOVATIONS GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware		83-3492907
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

4460 Old Dixie Highway

Grant-Valkaria, Florida 32949

(Address of principal executive offices, including zip code)

(833) 452-4825

(Registrant’s telephone number, including area code)

N/A

(Former name, former address, and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		KAVL		The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒

As of March 17, 2023, there were 56,169,090 shares of common stock, $0.001 par value, outstanding.

KAIVAL BRANDS INNOVATIONS GROUP, INC.

FORM 10-Q

TABLE OF CONTENTS

Item		Page

Cautionary Note Concerning Forward-Looking Statements		ii

PART I	Financial Information

Item 1.	Financial Statements
	Unaudited Consolidated Balance Sheets	F-1
	Unaudited Consolidated Statements of Operations	F-2
	Unaudited Consolidated Statements of Changes in Stockholders’ Equity	F-3
	Unaudited Consolidated Statements of Cash Flows	F-5
	Notes to Unaudited Consolidated Financial Statements	F-6
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1
	Liquidity and Capital Resources	6
	Results of Operations	7
	Emerging Growth Company	8
Item 3	Quantitative and Qualitative Disclosures about Market Risk	8
Item 4	Controls and Procedures	9

PART II	Other Information	10

Item 1.	Legal Proceedings	10
Item 1A.	Risk Factors	10
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	10
Item 3	Defaults Upon Senior Securities	10
Item 4	Mine Safety Disclosures	10
Item 5	Other Information	10
Item 6	Exhibits	11

Signatures		12

-i-

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements and information included in this Quarterly Report on Form 10-Q for the quarter ended January 31, 2023 (this “Report”) contain or may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995.

We generally use the words “may,” “should,” “believe,” “expect,” “intend,” “plan,” “anticipate,” “likely,” “estimate,” “potential,” “continue,” “will,” and similar expressions to identify forward-looking statements. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results, including, without limitation, statements related to:

●

our substantial reliance on, and efforts to diversify our business from, that of our affiliate Bidi Vapor, LLC (“Bidi”);

●

our ability to obtain the products we distribute from Bidi;

●

the impact of the August 2022 11^thCircuit Court of Appeals decision overturning the U.S. Food and Drug Administration’s (“FDA”) previous denial of Bidi’s Premarket Tobacco Product Application (“PMTA”) for its non-tobacco flavored BIDI® Stick electronic nicotine delivery system (“ENDS”), which we are permitted to distribute in the U.S. subject to FDA enforcement and maintenance of all state licenses and permits;

●

our substantial reliance on QuikfillRx, LLC (now known as Kaival Marketing Services) to provide key sales, marketing and other support services to us;

●

our relationships with, and reliance on, third parties to broker and distribute our products;

●

the scope of future FDA enforcement of regulations in the ENDS products generally;

●

the market perception of the products we distribute and related impacts on our reputation;

●

the FDA’s approach to the regulation and enforcement of synthetic nicotine and our competitors’ use of the substance in their products to avoid the PMTA requirements;

●

the impact of black-market goods on our business;

●

the demand for the products we distribute;

●

anticipated product performance, and our market and industry expectations;

●

our relationships with key third party commercial collaborators such as Phillip Morris International;

●

our ability or plans to diversify our product offerings;

●

changes in government regulation or laws that affect our business; and

●

circumstances or developments that may make us unable to implement or realize the anticipated benefits, or that may increase the costs of, our current and planned business initiatives, including matters over which we have little or no control such as the COVID-19 pandemic.

Forward-looking statements, including those concerning our expectations, involve significant risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance, or achievements, or industry results to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. See the “Management’s Discussion and Analysis of Financial Condition and Results of Operation” section contained in this Report and the section “Risk Factors” in our Annual Report on Form 10-K for the year ended October 31, 2022 for a listing of some of the factors that could cause the results anticipated by our forward-looking statements to differ from actual future results. Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Report.

-ii-

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

Kaival Brands Innovations Group, Inc.

Consolidated Balance Sheets

(Unaudited)


	January 31, 2023			October 31, 2022
ASSETS
CURRENT ASSETS:
Cash	$	3,773,628		$	3,685,893
Accounts receivable, net		518,291			574,606
Other receivable – related party – short term		2,026,245			1,539,486
Inventories		3,761,491			1,239,725
Prepaid expenses		316,621			426,407
Income tax receivable		—			1,607,302
Total current assets		10,396,276			9,073,419
Fixed assets, net		3,364			—
Other receivable – related party – net of current portion		1,483,297			2,164,646
Right of use asset- operating lease		1,152,020			1,198,969
TOTAL ASSETS	$	13,034,957		$	12,437,034

LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	81,265		$	40,023
Accounts payable- related party		2,350,787			—
Accrued expenses		675,453			1,099,157
Customer deposits		12,098			44,973
Customer refund due		366,956			—
Deferred revenue		129,702			235,274
Operating lease obligation – short term		170,603			166,051
Total current liabilities		3,786,864			1,585,478

LONG TERM LIABILITIES
Operating lease obligation, net of current portion		1,006,435			1,050,776

TOTAL LIABILITIES		4,793,299			2,636,254

STOCKHOLDERS’ EQUITY:

Preferred stock; 5,000,000 shares authorized: Series A Convertible Preferred stock ($0.001 par value, 3,000,000 shares authorized, none issued and outstanding as of January 31, 2023 and October 31, 2022, respectively)		—			—

Common stock ($0.001 par value, 1,000,000,000 shares authorized, 56,169,090 and 56,169,090 issued and outstanding as of January 31, 2023 and October 31, 2022, respectively)		56,169			56,169

Additional paid-in capital		30,811,574			29,375,787

Accumulated deficit		(22,626,085	)		(19,631,176	)
Total Stockholders’ Equity		8,241,658			9,800,780
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	$	13,034,957		$	12,437,034

The accompanying notes are an integral part of these unaudited consolidated financial statements.

F-1

Kaival Brands Innovations Group, Inc.

Consolidated Statements of Operations

(Unaudited)


	For the Three Months Ended January 31,
	2023			2022
Revenues
Revenues, net	$	2,435,835		$	2,841,990
Revenues - related parties		3,085			23,765
Royalty revenue		105,572			—
Excise tax on products		(18,574	)		(23,872	)
Total revenues, net		2,525,918			2,841,883

Cost of revenue
Cost of revenue - related party		1,985,800			3,484,620
Cost of revenue – other		—			48,172
Total cost of revenue		1,985,800			3,532,792

Gross profit (loss)		540,118			(690,909	)

Operating expenses
Advertising and promotions		588,910			592,501
General and administrative expenses		2,958,069			1,498,554
Total operating expenses		3,546,979			2,091,055

Other income
Interest income		11,952			—
Total Other income		11,952			—

Loss before income taxes provision		(2,994,909	)		(2,781,964	)

Provision for income taxes		—			—

Net loss	$	(2,994,909	)	$	(2,781,964	)

Net loss per common share - basic and diluted	$	(0.05	)	$	(0.09	)

Weighted average number of common shares outstanding - basic and diluted		56,169,090			30,234,477

The accompanying notes are an integral part of these unaudited consolidated financial statements.

F-2

Kaival Brands Innovations Group, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

For the Three Months Ended January 31, 2023

(Unaudited)


	Convertible Preferred Shares (Series A)		Par Value Convertible Preferred Shares (Series A)		Common Shares		Par Value Common Shares		Additional Paid-in Capital		Accumulated Deficit			Total

Balances, October 31, 2022		—	$	—		56,169,090	$	56,169	$	29,375,787	$	(19,631,176	)	$	9,800,780

Stock option expense		—		—		—		—		1,435,787		—			1,435,787
Net loss		—		—		—		—		—		(2,994,909	)		(2,994,909	)

Balances, January 31, 2023		—	$	—		56,169,090	$	56,169	$	30,811,574	$	(22,626,085	)	$	8,241,658

The accompanying notes are an integral part of these unaudited consolidated financial statements.

F-3

Kaival Brands Innovations Group, Inc.

Consolidated Statement of Changes in Stockholders’ Equity

For the Three Months Ended January 31, 2022

(Unaudited)

	Convertible Preferred Shares (Series A)		Par Value Convertible Preferred Shares (Series A)		Common Shares			Par Value Common Shares			Additional Paid-in Capital			Accumulated Deficit			Total

Balances, October 31, 2021		3,000,000	$	3,000		30,195,312		$	30,195		$	21,551,959		$	(5,260,841	)	$	16,324,313

Stock issued for services – RSU		—		—		61,250			61			110,189			—			110,250
Common stock settled and cancelled		—		—		(19,866	)		(20	)		(35,739	)		—			(35,759	)
Stock option expense		—		—		—			—			309,700			—			309,700
Net loss		—		—		—			—			—			(2,781,964	)		(2,781,964	)
Balances, January 31, 2022		3,000,000	$	3,000		30,236,696		$	30,236		$	21,936,109		$	(8,042,805	)	$	13,926,540

The accompanying notes are an integral part of these unaudited consolidated financial statements.

F-4

Kaival Brands Innovations Group, Inc.

Consolidated Statements of Cash Flows

(Unaudited)


	For the Three Months Ended January 31, 2023			For the Three Months Ended January 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(2,994,909	)	$	(2,781,964	)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities:
Stock based compensation		—			110,250
Depreciation		116			—
Stock option expense		1,435,787			309,700
ROU operating lease expense		46,949			3,649
Changes in current assets and liabilities:
Accounts receivable		56,315			688,982
Other receivable – related party		194,590			—
Prepaid expenses		109,786			29,543
Inventory		(2,521,766	)		3,484,620
Income tax receivable		1,607,302			—
Accounts payable		41,242			(62,812	)
Accounts payable – related party		2,350,787			(3,538,010	)
Accrued expenses		(423,704	)		(205,192	)
Deferred revenue		(105,572	)		—
Customer deposits		(32,875	)		—
Customer refund due		366,956			(169,110	)
Right of use liabilities – operating lease		(39,789	)		(3,170	)
Net cash provided by (used in) operating activities		91,215			(2,133,514	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for equipment		(3,480	)		—
Net cash used in investing activities		(3,480	)		—

CASH FLOWS FROM FINANCING ACTIVITIES:

Settled RSU shares with cash		—			(35,759	)
Net cash used in financing activities		—			(35,759	)

Net change in cash and restricted cash		87,735			(2,169,273	)
Beginning cash and restricted cash balance		3,685,893			7,825,235
Ending cash and restricted cash balance	$	3,773,628		$	5,655,962

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Interest paid	$	—		$	—
Income taxes paid	$	—		$	106,385

The accompanying notes are an integral part of these unaudited consolidated financial statements.

F-5

KAIVAL BRANDS INNOVATIONS GROUP, INC.

Notes to Unaudited Consolidated Financial Statements

Note 1 – Organization and Description of Business

Kaival Brands Innovations Group, Inc. (the “Company,” the “Registrant,” “we,” “us,” or “our”), formerly known as Quick Start Holdings, Inc., was incorporated on September 4, 2018, in the State of Delaware.

Description of Business

In March 2020, the Company commenced business operations as a result of becoming the exclusive distributor of certain electronic nicotine delivery system (“ENDS”) and related components (the “Products”) manufactured by Bidi Vapor, LLC (“Bidi”), a related party company that is owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company.

On March 9, 2020, the Company entered into an exclusive distribution agreement (the “Distribution Agreement”) with Bidi, which was amended and restated on May 21, 2020, and again on April 20, 2021 (collectively, the “A&R Distribution Agreement”). Pursuant to the A&R Distribution Agreement, Bidi granted the Company an exclusive worldwide right to distribute the Products for sale and resale to both retail level customers and non-retail level customers. Currently, the Products consist entirely of the “BIDI^® Stick.” The Company ceased all direct-to-consumer sales in February 2021. On June 10, 2022, and again on November 17, 2022 the Company and Bidi entered into a third amended and restated exclusive distribution agreement (the “Third A&R Distribution Agreement”) which memorializes the Company’s current business relationship with Bidi.

On August 31, 2020, the Company formed Kaival Labs, Inc., a Delaware corporation (herein referred to as “Kaival Labs”), as a wholly owned subsidiary of the Company, for the purpose of developing Company-branded and white-label products and services. The Company has not yet launched any Kaival-branded product, nor has it begun to provide white label wholesale solutions for other product manufacturers. The Company may also utilize Kaival Labs to acquire or license complimentary businesses or assets. On March 11, 2022, the Company formed Kaival Brands International, LLC, a Delaware limited liability company (herein referred to as “KBI”), as a wholly owned subsidiary of the Company, for the purpose of entering into an international licensing agreement with Philip Morris Products S.A. (“PMPSA”), a wholly owned affiliate of Philip Morris International Inc. (“PMI”).

Current Product Offerings

Pursuant to the A&R Distribution Agreement, The Company sells and resells electronic nicotine delivery systems, which it may refer to herein as “ENDS Products”, or “e-cigarettes”, to non-retail level customers. The sole Product the Company resells is the “BIDI® Stick,” a disposable, tamper-resistant ENDS product that comes in a variety of flavor options for adult cigarette smokers. The Company does not manufacture any of the Products it resells. The BIDI® Stick is manufactured by Bidi. Pursuant to the terms of the A&R Distribution Agreement, Bidi provides the Company with all branding, logos, and marketing materials to be utilized by the Company in connection with its marketing and promotion of the Products.

F-6

COVID-19 Impact

In January 2020, the World Health Organization (the “WHO”) announced a global health emergency because of a new strain of coronavirus (“COVID-19”) originating in Wuhan, China and the risks to the international community as the virus spread globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in global exposure.

During the Company’s fiscal year 2021 and early part of fiscal 2022, the Company was indirectly impacted by supply chain issues and regulatory oversight arising out of COVID-19. The Company believes that many retailers and distributers relaxed their ENDS compliance standards as an indirect result of COVID-19 for two reasons: (i) government enforcement of regulations was very limited due to imposed social restrictions, resulting in less in-person monitor enforcement by government officials and (ii) retail stores experienced light foot traffic from customers due to COVID-19 restrictions and fears, which resulted in relaxed compliance in an effort to generate additional revenue. While the impact of COVID-19 decreased during the Company’s fiscal 2022 year and the first quarter of its fiscal 2023 year, outbreaks of COVID-19 or its variants, either locally, nationally or globally, as well as related supply chain issues, could adversely impact the Company’s business.

Impact of the FDA PMTA Decision and Subsequent Court Actions

Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored ENDS products. With respect to Bidi, the MDO covered all non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick. As a result, beginning in September 2021, Bidi pursued multiple avenues to challenge the MDO. First, on September 21, 2021, separate from the judicial appeal of the MDO in its entirety, Bidi filed a 21 C.F.R. § 10.75 internal FDA supervisory review request specifically of the decision to include the Arctic (menthol) BIDI® Stick in the MDO. In May 2022, the FDA issued a determination that it views the Arctic BIDI® Stick as a non-tobacco flavored ENDS product, and not strictly a menthol flavored product.

On September 29, 2021, Bidi petitioned the U.S. Court of Appeals for the Eleventh Circuit (the “11th Circuit”) to review the FDA’s denial of the comprehensive PMTAs for its non-tobacco flavored BIDI® Stick ENDS, arguing that it was arbitrary and capricious under the Administrative Procedure Act (“APA”), as well as ultra vires, for the FDA not to conduct any scientific review of Bidi’s comprehensive applications, as required by the Tobacco Control Act (“TCA”), to determine whether the BIDI® Sticks are “appropriate for the protection of the public health”. Bidi further argued that the FDA violated due process and the APA by failing to provide fair notice of the FDA’s new requirement for ENDS companies to conduct long-term comparative smoking cessation studies for their flavored products, and that the FDA should have gone through the notice and comment rulemaking process for this requirement.

On October 14, 2021, Bidi requested that the FDA re-review the MDO and reconsider its position that Bidi did not include certain scientific data in its applications sufficient to allow the PMTAs to proceed to scientific review. In light of this request, on October 22, 2021, pursuant to 21 C.F.R. § 10.35(a), the FDA issued an administrative stay of Bidi’s MDO pending its re-review, permitting the Company to continue sales. Subsequently, the FDA decided not to rescind the MDO and lifted its administrative stay on December 17, 2021. Following the lifting of the FDA’s administrative stay, Bidi filed a renewed motion to stay the MDO with the 11th Circuit. On February 1, 2022, the appellate court granted Bidi’s motion to stay (i.e., put on hold) the MDO, again allowing the Company to continue sales pending the litigation on the merits. Oral arguments in the merits-based proceeding were held on May 17, 2022.

On August 23, 2022, the U.S. Court of Appeals for the Eleventh Circuit set aside the MDO issued to the non-tobacco flavored BIDI® Sticks and remanded Bidi’s back to the FDA for further review. Specifically, the Court held that the MDO was “arbitrary and capricious” in violation of the Administrative Procedure Act (“APA”) because FDA failed to consider the relevant evidence before it, specifically Bidi’s aggressive and comprehensive marketing and sales-access-restrictions plans designed to prevent youth appeal and access.

F-7

The 11th Circuit’s opinion further found indicated that the FDA did not properly review the data and evidence that it has long made clear are critical to the appropriate for the protection of the public health (“APPH”) standard for PMTAs set forth in the Tobacco Control Act including, in Bidi’s case, “product information, scientific safety testing, literature reviews, consumer insight surveys, and details about the company’s youth access prevention measures, distribution channels, and adult-focused marketing practices,” which “target only existing adult vapor product users, including current adult smokers,” as well as our retailer monitoring program and state-of-the-art anti-counterfeit authentication system. Because a MDO must be based on a consideration of the relevant factors, such as the marketing and sales-access-restrictions plans, the denial order was deemed arbitrary and capricious, and vacated by the FDA.

The FDA did not appeal to the 11th Circuit’s decision. The FDA had until October 7, 2022 (45 days from the August 23, 2022 decision) to either request a panel rehearing or a rehearing “en banc” (a review by the entire 11th Circuit, not just the 3-judge panel that issued the decision), and until November 21, 2022 (90 days after the decision) to seek review of the decision by the U.S. Supreme Court. No request for a rehearing was filed, and no petition for a writ of certiorari was made to the Supreme Court. In the meantime, the Company anticipates continued ability to market and sell the non-tobacco flavored BIDI® Sticks, subject to the FDA’s enforcement discretion, for the duration of the PMTA scientific review.

Separately, on or about May 13, 2022, FDA placed the tobacco-flavored Classic BIDI® Stick into the final Phase III scientific review, and in September 2022 completed a remote regulatory assessment of Bidi and its contract manufacturer in China, SMISS Technology Co. LTD, in relation to the pending PMTA for the Classic BIDI® Stick.

Risks and Uncertainties

FDA has indicated that it is prioritizing enforcement of unauthorized ENDS against companies (1) that never submitted PMTAs, (2) whose PMTAs have been refused acceptance or filing by the FDA, (3) whose PMTAs remain subject to MDOs, and (4) that are continuing to market unauthorized synthetic nicotine products after the July 13, 2022, cutoff. Subject to FDA’s enforcement discretion, until the scientific review process is complete on each of Bidi’s PMTAs, the Company views the risk of FDA enforcement against Bidi as low. The Company anticipates FDA will move forward with a review of Bidi’s PMTA on remand, as directed by the Court; however, the Company cannot provide any assurances as to the timing or outcome.

Accordingly, the Company anticipates FDA will move forward with a review of Bidi’s PMTA on remand, as directed by the Court.

Moreover, the Company believes that Bidi’s application is particularly comprehensive, and now includes, among other things, a randomized, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® Stick, several behavioral, perception and intention studies, as well as a nationally-representative population prevalence study. A complete scientific review of the PMTA would require FDA to review all this information before making an APPH determination, and while FDA could narrowly interpret the Court’s ruling as an order to review only Bidi’s marketing and sales-access restrictions plans, the 11^th Circuit’s opinion, in the Company’s view, makes clear that all “relevant evidence” in an application must be considered. For applications that are in scientific review, FDA typically issues a deficiency letter identifying its questions before making a marketing authorization decision and gives the applicant at least 90 days to respond. This further solidifies the Company’s belief that the scientific review of Bidi’s non-tobacco flavored applications could take 1-2 years or longer. However, the Company cannot provide any assurances as to the timing or outcome.

Note 2 – Basis of Presentation and Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiaries, Kaival Labs and KBI. Intercompany transactions are eliminated.

F-8

Basis of Presentation

The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s most recent audited financial statements contained within the Company’s Annual Report on Form 10-K, filed with the SEC on January 30, 2023 (the “2022 Annual Report”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full fiscal year. Notes to the consolidated financial statements, which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period as reported in the 2022 Annual Report, have been omitted.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents and restricted cash as of January 31, 2023 and October 31, 2022. Cash as of January 31, 2023 and October 31, 2022 was $3,773,628 and $3,685,893, respectively.

The Federal Deposit Insurance Corporation (“FDIC”) insures deposits according to the ownership category in which the funds are insured and how the accounts are titled. The standard deposit insurance coverage limit is $250,000 per depositor, per FDIC-insured bank, per ownership category. The Company had uninsured cash and cash equivalents of $3,250,651 and $2,912,793 at January 31, 2023, and October 31, 2022, respectively.

Advertising and Promotion

All advertising, promotion and marketing expenses, including commissions, are expensed when incurred.

F-9

Accounts Receivable and Allowance for Doubtful Accounts

Receivables are stated at cost, net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of accounts receivable. A considerable amount of judgment is required in assessing the amount of the allowance and the Company considers the historical level of credit losses and collection history and applies percentages to aged receivable categories. The Company makes judgments about the creditworthiness of debtors based on ongoing credit evaluations and monitors current economic trends that might impact the level of credit losses in the future. If the financial condition of the debtors were to deteriorate, resulting in their inability to make payments, a larger allowance may be required. As of January 31, 2023 and October 31, 2022, based upon management’s assessment of the accounts receivable aging and the customers’ payment history, the Company has determined that no allowance for doubtful accounts is required.

Inventories

All product inventory is purchased from a related party, Bidi. Inventories are stated at the lower of cost and net realizable value. Cost includes all costs of purchase and other costs incurred in bringing the inventories to their present location and condition. The Company determines cost based on the first-in, first-out (“FIFO”) method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. As of January 31, 2023 and October 31, 2022, the inventories only consisted of finished goods and were located in three locations: the Company’s main warehouse located in Florida and two customer warehouses whose service agreements are on a consignment basis with the Company. Based upon fiscal year 2022 inventory management procedures, as well as those inventory management procedures performed during the first fiscal quarter ended January 31, 2023 and their results for both periods of time, the Company has determined that no allowance for inventory was required as of January 31, 2023 and October 31, 2022.

Revenue Recognition

The Company adopted ASC 606, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), in the second quarter of fiscal year 2020, as this was the first quarter that the Company generated revenues. Under ASC 606, the Company recognizes revenue when a customer obtains control of promised goods, in an amount that reflects the consideration that the Company expects to receive in exchange for the goods. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (1) identify the contracts with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to the customer. Under ASC 606, disaggregated revenue from contracts with customers depicts the nature, amount, timing, and uncertainty of revenue and cash flows affected by economic factors.

Deferred Revenue

The Company accepts partial payments for orders from wholesale customers, which it holds as deposits or deferred revenue, until the Company has received full payment and orders are shipped to the customer. Revenue for these orders is recognized at the time of shipment to the customer. As of January 31, 2023, and October 31, 2022, the Company has $12,098 and $44,973 in deposits from customers, respectively, which is included with the Company’s current liabilities. As of January 31, 2023, and October 31, 2022, the Company has $129,701 and $235,274 in deferred income from PMI guaranteed royalty revenue prepayments, respectively, which is included with the Company’s current liabilities.

Customer Refunds

The Company infrequently has a need to adjust the size of an order after it has been shipped, received and paid for, due to the customer oversizing the order for more product that it can realistically sell at that time. If and when this occurs, the Company will ask the customer to return the over allotted product. Once received and inspected, the Company will issue a refund for the product return. As of January 31, 2023, and October 31, 2022, the Company had customer refunds due in the amounts equal to $366,956 and $0, respectively.

F-10

Products Revenue

The Company generates products revenue from the sale of the Products (as defined above) to non-retail customers. The Company recognizes revenue at a point in time based on management’s evaluation of when performance obligations under the terms of a contract with the customer are satisfied and control of the Products has been transferred to the customer. In most situations, transfer of control is considered complete when the products have been shipped to the customer. The Company determined that a customer obtains control of the Product upon shipment when title of such product and risk of loss transfer to the customer. However, when the Company enters a consignment agreement with a new customer, once it ships and delivers the requested amount of ordered Products to its distribution center for its retail sales locations, the Company retains ownership of the delivered Products until they are delivered to the actual retail stores (as opposed to the Company’s consignment customer). The Company’s shipping and handling costs are fulfillment costs, and such amounts are classified as part of cost of sales. The Company offers credit sales arrangements to non-retail (or wholesale) customers and monitors the collectability of each credit sale routinely.

Revenue is measured by the transaction price, which is defined as the amount of consideration expected to be received in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes refunds and returns as well as incentive offers and promotional discounts on current orders. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce revenue in the period of the sale. Variable consideration related to incentive offers and promotional programs are recorded as a reduction to revenue based on amounts the Company expects to collect. Estimates are regularly updated, and the impact of any adjustments are recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established at the time an order is placed and incentives have very short-term durations.

Amounts billed and due from customers are short term in nature and are classified as receivable since payments are unconditional and only the passage of time related to credit terms is required before payments are due. The Company does not grant payment financing terms greater than one year. Payments received in advance of revenue recognition are recorded as deferred revenue, as noted above.

Royalty Revenue

The initial term of the PMI License Agreement is five (5) years and automatically renews for an additional five-year period unless PMPSA has failed to meet the agreed upon minimum key performance indicators set forth in the PMI License Agreement, in which case the PMI License Agreement will automatically terminate at the end of the initial license term.

In consideration for the grant of the licensed rights, PMPSA agreed to pay to KBI a royalty equal to a percentage of the base price of the first sale of each unit of Product manufactured. In addition, before the launch of the first product in a market and each anniversary of such launch, PMPSA agrees to pre-pay to KBI a guaranteed minimum royalty based on the estimated royalties payable by PMPSA to KBI in relation to all markets in the twelve (12)-month period following the first launch or each successive anniversary of the first launch, subject to an aggregate maximum guaranteed royalty payment for all markets for each applicable twelve (12)-month period. PMPSA may require modification of certain products to be sold under the PMI Licensing Agreement to be modified for a PMI Market. Pursuant to the PMI Licensing Agreement, PMPSA has absolute discretion over sales, marketing, product branding and packaging pertaining to sales in the PMI Markets, as well as the right to select the specific PMI Markets in which to launch commercialization and determine what product types are to be promoted in each market, subject to sales and marketing plans and annual business plans set by PMPSA and certain expansion criteria agreed between PMPSA and KBI. Royalty revenue earned from the PMI License Agreement is recognized in the period the sales of the Product manufactured occurs.

F-11

The PMI License Agreement contains customary representations, warranties, covenants, and indemnification provisions; however, KBI’s liability under the PMI License Agreement is capped at the greater of: (i) Ten Million Dollars ($10,000,000); or (ii) an amount equal to the total of the royalties due to KBI (but not yet paid) plus the royalties (including the guaranteed royalty payment) paid to KBI pursuant to the PMI License Agreement during the immediately preceding twelve (12) consecutive months, provided that such amount shall not exceed Thirty Million Dollars ($30,000,000). These royalties may be initially offset on a limited basis by jointly agreed upon costs such as development costs incurred for entry to specific international markets.

The KBI License agreement provides that KBI shall pay Bidi license fees equivalent to 50% of the adjusted earned royalty payments, after any offsets due to jointly agreed costs such development costs incurred for entry to specific international markets. Consequently, the Company has determined that no license fees are owed to Bidi as of January 31, 2023.

Concentration of Revenues and Accounts Receivable

For the three months ended January 31, 2023, (i) 25% or $599,201 of the revenue from the sale of Products, solely consisting of the BIDI^®Stick, was generated from GPM Investments, LLC, (“GPM”), (ii) 18% or $432,000 of the revenue from the sale of the Products was generated from FAVS Business, (“FAVS”), and (iii) approximately 15% or $372,518 of the revenue from the sale of Products, solely consisting of the BIDI Stick, was generated from H.T. Hackney Co.

For the three months ended January 31, 2022, 45%, or $1,287,180, of the revenue from the sale of Products was generated from FAVS, 12%, or $352,554, of the revenue from the sale of Products was generated from Lakshmi Distributor Inc., doing business as C Store Master (“C Store Master”), and 12%, or $332,595, of the revenue from the sale of Products was generated from H.T. Hackney Company.

FAVS, with an outstanding balance of $201,600, GPM, with an outstanding balance of $126,158, and Stewart Distribution with an outstanding balance of $59,404, accounted for 39%, 24%, and 11% of the total accounts receivable from customers, respectively, as of January 31, 2023. FAVS and C Store Master had outstanding balances of $374,400 and $282,414, respectively, which accounted for 29% and 22%, respectively, of the total accounts receivable from customers as of January 31, 2022.

F-12

Share-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments (share-based payments, referred to herein as “SBP”) based on the grant-date fair value of the award. That cost is recognized over the period during which a recipient is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to performance conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model.

The fair value of each option granted during the fiscal three-month period ended January 31, 2023, and January 31, 2022, was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table:


	As of January			As of January
	31, 2023			31, 2022
Expected dividend yield		0	%		0	%
Expected option term (years)		10			10
Expected volatility		275.68	%		294.57%- 301.53	%
Risk-free interest rate		4.12	%		1.19-1.63%

The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company’s common stock. The assumed discount rate was the default risk-free ten-year interest rate for U.S. Treasury bills. The Company’s stock option expense for the fiscal three months ended January 31, 2023, and ended January 31, 2022 were $1,435,787 and $309,700, respectively.

Fair Value of Financial Instruments

The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

●	Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

●

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

●	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of January 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, accounts receivable, inventory, accounts payable and accrued expenses . As of January 31, 2023 and October 31, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on a recurring basis.

F-13

Recent Accounting Pronouncements

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Note 3 – Going Concern

The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. As shown in the accompanying consolidated financial statements, the Company has incurred significant recurring losses, which raises substantial doubt about the Company’s ability to continue as a going concern.

In response to the above, the Company assessed its management’s plans to alleviate that doubt. The Company has positive working capital as of January 31, 2023, of $6,503,841. The Company considered that its losses were due to various factors such as: (i) uncertainty surrounding the PMTA process with FDA and (ii) the MDO that was issued to Bidi Vapor on its non-tobacco flavored ENDS products. However, the MDO was set aside and vacated by the 11^th Circuit in August 2022, and the ability to appeal such decision has passed, thereby facilitating the continued sales of the non-tobacco flavored BIDI® Sticks for sale in the United States (pending FDA’s review of the pending PMTAs and subject to FDA enforcement). Concurrently, the PMTA for the tobacco-flavored (Classic) BIDI® Sticks for sale in the United States continues to move through the PMTA scientific review phase. Management’s assessment included the preparation of cash flow forecasts which considered increases in revenues considering the favorable ruling obtained on the MDO as disclosed above.

The Company believes that its available cash and the cash to be provided by future operating activities should enable the Company to meet its estimated liquidity needs for the next 12 months after the date that the financial statements are issued. Because of the above factors, the Company believes that this alleviates the substantial doubt in connection with the Company’s ability to continue as a going concern.

However, there is no assurance that the Company’s plans will be able to generate expected or greater amounts of revenues or ever achieve profitability, due to the current economic climate in the United States and globally, the regulation and public perception of ENDS products and the various other risks faced by the Company. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these or other risks or uncertainties.

Note 4 – Leases

The Company capitalizes all leased assets pursuant to ASU 2016-02, Leases (Topic 842) (“Topic 842”), which requires lessees to recognize right-of-use (“ROU”) assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. The Company does not have financing leases and only one operating lease for office space and inventory storage space with Just Pick, LLC (“Just Pick”), a related party owned and controlled by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company, as of January 31, 2023, and October 31, 2022. Certain of the Company’s leases, have and may in the future, include renewal options, which have been and might be in the future, included in the calculation of the lease liabilities and right of use assets when the Company is reasonably certain to exercise the option.

F-14

Office and Storage Space

On November 1, 2021, the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022.

On November 11, 2021, the Company entered into a month- to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022.

On June 10, 2022, the Company entered into a Lease Agreement (the “2022 Lease”) with Just Pick for approximately 21,332 rentable square feet combined in the office building and warehouse located at 4460 Old Dixie Highway, Grant-Valkaria, Florida 32949 (the “Premises”), together with all improvements thereon. The Company must pay Just Pick base rent equal to $17,776.67 per month during the first year of the Lease Term with a five-year lease renewal option. Thereafter, the monthly base rent will be increased annually with a monthly base rent of $18,665.50 in the second year, $19,554.33 in the third year, $20,443.17 in the fourth year, $22,220.83 in the fifth year, $23,998.50 in the sixth year, and one twelfth (1/12th) of the market annual rent for the seventh through eleventh years, if applicable. In addition to the base rent, the Company must pay one hundred percent (100%) of operating expenses, insurance costs, and taxes for each calendar year during the Lease term. For both the ROU asset and ROU liability, the lease renewal option was considered in the calculation with an incremental borrowing rate of 4.5%. The Company had $46,949 and $3,649 in operating lease expense for the three months ended January 31, 2023, and January 31, 2022, respectively.

Cash flow information related to leases was as follows:


	January 31, 2023			January 31, 2022
Other Lease Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(46,949	)	$	(3,649	)

The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets as of January 31, 2023, and October 31, 2022:

Schedule Of Condensed Balance Sheet
Lease Position	January 31, 2023		October 31, 2022
Operating Leases
Operating lease right-of-use assets	$	1,152,020	$	1,198,969
Right of use liability operating lease current portion	$	170,603	$	166,051
Right of use liability operating lease long term		1,006,435		1,050,776
Total operating lease liabilities	$	1,177,038	$	1,216,827

The following table provides the maturities of lease liabilities at January 31, 2023:


	Operating Leases
Maturity of Lease Liabilities on January 31, 2023
2023	$	164,139
2024		228,134
2025		238,800
2026		253,614
2027 and thereafter		450,934
Total future undiscounted lease payments	$	1,335,621
Less: Interest		(158,583	)
Present value of lease liabilities	$	1,177,038

F-15

At January 31, 2023, the Company had no additional leases which had not yet commenced.

Note 5 – Stockholders’ Equity

Common Stock

During the three months ended January 31, 2023:

No shares of Common Stock were issued during the three months ended January 31, 2023.

Preferred Stock Converted

The authorized preferred stock of the Company consists of 5,000,000 shares with a par value of $ 0.001 per share, of which 3,000,000 shares were designated as Series A Convertible Preferred Stock (the “Series A Preferred Stock”). Each share of the Series A Preferred Stock was initially convertible into 100 shares of Common Stock; however, as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock. On June 24, 2022, all 3,000,000 shares of Series A Preferred Stock were converted into shares of Common Stock by Kaival Holdings, LLC, a related party and the Company’s majority shareholder. The conversion of 3,000,000 shares of Series A Preferred Stock, at a conversion rate of 8.33, equaled 25,000,000 shares of Common Stock. As a result, the authorized, preferred stock of the Company consists of 5,000,000 shares with a par value of $0.001 per share, with 0 shares of preferred stock issued or outstanding as of October 31, 2022.

Stock Options

Summary of stock options information is as follows:

Schedule of stock options
							Weighted
	Aggregate		Aggregate		Exercise Price		Average
	Number		Exercise Price		Range		Exercise Price
Outstanding, October 31, 2022		3,202,265		8,921,419		1.03-28.68		2.79
Granted		3,250,000		3,207,425		0.99		0.99
Exercised		—		—		—		—
Cancelled, forfeited, or expired		—		—		—		—
Outstanding, January 31, 2023		6,452,265	$	12,128,844	$	0.99-28.69	$	1.88
Exercisable, January 31, 2023		2,151,217	$	6,085,555	$	0.99-28.69	$	2.83

On November 9, 2022, non-qualified stock options exercisable for up to 250,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vested on the issue date. The fair value of the options on the grant date was $246,747 using a Black-Scholes option pricing model with the following assumptions: stock price $0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of 275.68%, expected term of 10 years, and a risk-free interest rate of 4.12%.

F-16

On November 9, 2022, non-qualified stock options exercisable for up to 3,000,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vesting based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years. The fair value of the options on the grant date was $2,960,968 using a Black-Scholes option pricing model with the following assumptions: stock price $0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of 275.68%, expected term of 10 years, and a risk-free interest rate of 4.12%.

Warrants

Warrant information as of the periods indicated is as follows:


							Weighted
	Aggregate		Aggregate		Exercise Price		Average
	Number		Exercise Price		Range		Exercise Price
Outstanding, October 31, 2022		2,318,317		4,404,802		1.90		1.90
Granted		—		—		—		—
Exercised		—		—		—		—
Cancelled, forfeited, or expired		—		—		—		—
Outstanding, January 31, 2023		2,318,317	$	4,404,802	$	1.90	$	1.90
Exercisable, January 31, 2023		2,318,317	$	4,404,802	$	1.90	$	1.90

The weighted average remaining contractual life is approximately 3.66 years for Common Stock warrants outstanding as of January 31, 2023. As of January 31, 2023, there was no intrinsic value of outstanding stock warrants.

F-17

Note 6 – Related-Party Transactions

In March 2020, the Company commenced business operations as a result of becoming the exclusive distributor of certain ENDS and related components (the “Products”) manufactured by Bidi, a related party company that is also owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company.

Other Receivable

On August 1, 2022, the Company and Bidi agreed to a price credit for short-coded or expiring inventory against the related-party accounts payable balance due to Bidi. A credit of $2,924,655 was applied on August 1, 2022, resulting in a related-party accounts receivable balance due from Bidi of $2,134,413, to be applied on future orders of Product. On October 31, 2022, the Company and Bidi agreed to a return for short-coded or expiring inventory. An additional credit of $1,543,545 and $108,841 for recycling cost was applied on October 31, 2022, to the related-party receivable balance due from Bidi.

As of January 31, 2023 and October 31, 2022, the Company has a related-party receivable balance due from Bidi of $3,509,542 and $3,704,132, respectively. The receivable balance will be realized though Bidi applying 5% credits on all future orders of product purchased until the entire balance is extinguished.

Revenue and Accounts Receivable

During the three months ended January 31, 2023, the Company recognized revenue of $3,085 from one company owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company, and/or his wife. There was no accounts receivable balance for these transactions as of January 31, 2023.

During the three months ended January 31, 2022, the Company recognized revenue of $23,765 from four companies owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company, and/or his wife. As of January 31, 2022, the Company had accounts receivable from this related party in the amount of $245.

Concentration Purchases and Accounts Payable

During the three months ended January 31, 2023, 100% of the inventories of Products, consisting solely of the BIDI® Stick, were purchased from Bidi, a related party controlled by Nirajkumar Patel, in the amount of $3,697,210. As of January 31, 2023, the Company had accounts payable to Bidi of $2,350,787 and Products valued at $3,761,491 were held in inventory. In addition, as of January 31, 2023, the Company had accrued freight in expense of $347,760. As of October 31, 2022, the Company did not have an accounts payable balance to Bidi.

During the three months ended January 31, 2022, the Company did not purchase Products from Bidi, a related party company that is owned by Nirajkumar Patel. As of January 31, 2022, the Company had accounts payable to Bidi of $9,129,759 and Products valued at $11,841,750 were held in inventory.

Leased Office Space and Storage Space

The Company capitalizes all leased assets pursuant to ASU 2016-02, Leases (Topic 842) (“Topic 842”), which requires lessees to recognize right-of-use (“ROU”) assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. On June 10, 2022, the Company entered into the 2022 Lease with Just Pick for approximately 21,332 rentable square feet combined in the office building and warehouse located at the Premises, together with all improvements thereon. Just Pick is considered a related party to the Company because the Company’s Chief Science and Regulatory Officer and director, Mr. Nirajkumar Patel, owns and controls Just Pick.

F-18

Note 7 – Commitments and Contingencies

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. There were no commitments or contingencies as of January 31, 2023, and October 31, 2022, other than the below:

QuikfillRx Service Agreement Amendment

Effective as of November 9, 2022, the Company entered into its latest amendment to the Service Agreement with QuikfillRx (collectively with prior amendments, the “Amended Service Agreement”). The November 9, 2022 amendment to the Service Agreement was captioned as the “Fourth Amendment” although it was the fifth amendment to the Service Agreement. Pursuant to the Amended Service Agreement:

(a) the term of the Amended Service Agreement was extended (unless earlier terminated pursuant to the terms of the Amended Service Agreement) from November 1, 2022 (the “Effective Date”) until October 31, 2025, following which the term shall automatically renew for successive one (1) year periods beginning November 1, 2025;

(b) QuikfillRx agreed to change its “doing business as” name to “Kaival Marketing Services” within thirty (30) days following the Effective Date;

(c) it was provided that either party may terminate the Amended Service Agreement without cause upon not less than ninety (90) days prior written notice to the other party;

(d) QuikfillRx was granted a one-time, fully vested, ten-year non-qualified option award to purchase up to 250,000 shares of Company common stock with an exercise price of $0.9869 per share (the closing price of the Company’s common stock on November 9, 2022)”)., which option grant was memorialized pursuant to a Nonqualified Option Agreement, dated November 9, 2022, between the Company and QuikfillRx; and

(e) the parties agreed to revise the compensation for services as follows: (i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years.

The Company accrued $28,318 for a quarterly bonus payable to QuikfillRx, based on the Applicable Gross Quarterly Sales results of the three months ended January 31, 2023. The Company accrued 33,871 for a quarterly bonus payable to QuikfillRx, based on the Applicable Gross Quarterly Sales results for the three months ended October 31, 2022.

F-19

Note 8 – Subsequent Events

On February 1, 2023, the Company entered into an agreement to cancel the 75,000 stock options that were previously issued to a third-party management consultant and agreed to pay such consultant monthly retainer of $16,750, and an incentive compensation bonus of $75,000.

On February 6, 2023, non-qualified stock options exercisable for up to 375,000 shares of common stock were awarded to the three independent board members of the Company. These stock options have a ten-year term from the grant date, with 375,000 fully vest on the earlier of February 6, 2024, or a change in control.

On February 6, 2023, non-qualified stock options exercisable for up to 1,000,000 shares of common stock were awarded to two senior executives of the Company. These stock options have a ten-year term from the grant date, with 500,000 vest on date of issuance and 500,000 vest on the earlier of February 6, 2024, or a change in control.

On February 6, 2023, non-qualified stock options exercisable for up to 150,000 shares of common stock were awarded to five employees of the Company. These stock options have a ten-year term from the grant date, with 150,000 fully vest on the earlier of February 6, 2024 or a change in control.

On February 6, 2023, non-qualified stock options exercisable for up to 200,000 shares of common stock were awarded to one consultant acting as a sales broker for the Company. These stock options have a ten-year term from the grant date, with 200,000 shall vest based on achievement of certain net sales targets up to $100,000,000. The term of the agreement is one year from the effective date with an automatic renewal of one year if net sales defined in the agreement are met.

On March 3, 2023, the Company approved amending the Consulting Agreement for Mark Thoenes, the Company’s Interim Chief Financial Officer and extend it through June 30, 2023. In order to extend its term, on March 3, 2023, the Company also approved the grant of a stock option award to Mr. Thoenes to acquire up to 50,000 shares of common stock under the Company’s Amended 2020 Stock and Incentive Compensation Plan. All of the option shares fully vest on the earlier of June 30, 2023, or upon meeting certain terms and conditions.

F-20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations is designed to provide a reader of the financial statements with a narrative report on our financial condition, results of operations, and liquidity. This discussion and analysis should be read in conjunction with the unaudited financial statements and notes thereto for the three months ended January 31, 2023 included under Item 1 – Financial Statements in this Report and our audited financial statements and notes thereto for the year ended October 31, 2022 contained in the 2022 Annual Report. The following discussion contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations, and intentions. Our actual results could differ materially from those discussed in the forward-looking statements. Please also see the cautionary language at the beginning of this Report regarding forward-looking statements.

Capitalized terms used but not defined in this discussion have the meanings ascribed to them in the notes to the accompanying unaudited financial statements.

Overview

We are focused on growing and incubating innovative and profitable products into mature, dominant brands, with a current focus on the distribution of electronic nicotine delivery systems (“ENDS”), also known as “e-cigarettes”. Our business plan is to seek to diversify into distributing other nicotine and non-nicotine delivery system products (including those related to hemp-derived cannabidiol (known as CBD) products.

Pursuant to the A&R Distribution Agreement, Bidi granted us an exclusive worldwide right to distribute Bidi’s ENDS as well as non-electronic nicotine delivery systems and related components (as more particularly set forth in the A&R Distribution Agreement, the “Products”) for sale and resale to both retail level customers and non-retail level customers. Currently, the Products consist solely of the “BIDI^® Stick”, Bidi’s disposable, tamper resistant ENDS product made with medical-grade components, a UL-certified battery and technology designed to deliver a consistent vaping experience for adult smokers 21 and over. We presently distribute Products to wholesalers and retailers of ENDS products, having ceased all direct-to-consumer sales in February 2021. Nirajkumar Patel, our Chief Science and Regulatory Officer and director and an indirect controlling shareholder of our company, owns Bidi.

BIDI^® Stick comes in a variety of flavor options for adult cigarette smokers. We do not manufacture any of the Products we resell. The BIDI® Stick is manufactured by Bidi. Pursuant to the terms of the A&R Distribution Agreement, Bidi provides us with all branding, logos, and marketing materials to use with our commercial partners use in connection with our marketing and promotion of the Products.

We process all sales made only to non-retail customers, with all sales to non-retail customers made through Bidi’s age-restricted website, www.wholesale.bidivapor.com. We ceased all direct-to-consumer sales in February 2021 in order to better ensure youth access prevention and to comply with the Prevent All Cigarette Trafficking (“PACT”) Act. We provide all customer service and support at our own expense. We set the minimum prices for all sales made by us. We maintain adequate inventory levels of the Products in order to meet the demands of our non-retail customers, and deliver the Products sold to these customers.

A key third party collaborator of ours is QuikfillRx, LLC, (“QuikfillRx”) a Florida limited liability company which recently began doing business as “Kaival Marketing Services” to better reflect its contributions to our company. QuikfillRx provides us with certain services and support relating to sales management, website development and design, graphics, content, public communication, social media, management and analytics, and market and other research. QuikfillRx provides these services to us pursuant to a Services Agreement, most recently amended on November 9, 2022, which has a current term ending on October 31, 2025 (subject to potential one-year extensions) and pursuant to which QuikfillRx receives monthly cash compensation and was granted certain equity compensation in the form of options.

We have also entered into key international licensing agreements with Philip Morris Products S.A. (“PMPSA”), a wholly owned affiliate of Philip Morris International Inc. (“PMI”).

On August 31, 2020, we formed Kaival Labs, Inc., a Delaware corporation (herein referred to as “Kaival Labs”), as a wholly owned subsidiary for the purpose of developing our own branded and white-label products and services, of which none has commenced as of the date of this Report. On March 11, 2022, we formed Kaival Brands International, LLC, a Delaware limited liability company (herein referred to as “KBI”), as a wholly owned subsidiary for the purpose of entering into an international licensing agreement with PMPSA.

FDA PMTA Determinations, 11^th Circuit Decision and Impact on Our Business

In September 2021, in connection with the Bidi’s Premarket Tobacco Product Application (“PMTA”) process for BIDI^® Stick, the U.S. Food and Drug Administration’s (“FDA”) effectively “banned” non-tobacco flavored ENDS by denying nearly all then-pending PMTAs for such products (including Bidi’s). Following the issuance of by the FDA of a related Marketing Denial Order (“MDO”) regarding these ENDS products, manufacturers were required to stop selling non-tobacco flavored ENDS products. Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored ENDS products. With respect to Bidi, the MDO covered all non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick. As a result, beginning in September 2021, Bidi pursued multiple avenues to challenge the MDO. First, on September 21, 2021, separate from the judicial appeal of the MDO in its entirety, Bidi filed a 21 C.F.R. §10.75 internal FDA supervisory review request specifically of the decision to include the Arctic (menthol) BIDI® Stick in the MDO. In May 2022, the FDA issued a determination that it views the Arctic BIDI® Stick as a non-tobacco flavored ENDS product, and not strictly a menthol flavored product.

On September 29, 2021, Bidi petitioned the U.S. Court of Appeals for the Eleventh Circuit (the “11th Circuit”) to review the FDA’s denial of the PMTAs for its non-tobacco flavored BIDI® Stick ENDS (including the Arctic BIDI® Stick), arguing that it was arbitrary and capricious under the Administrative Procedure Act (“APA”), as well as ultra vires, for the FDA not to conduct any scientific review of Bidi’s comprehensive applications, as required by the Tobacco Control Act (“TCA”), to determine whether the BIDI® Sticks are “appropriate for the protection of the public health”. Bidi further argued that the FDA violated due process and the APA by failing to provide fair notice of the FDA’s new requirement for ENDS companies to conduct long-term comparative smoking cessation studies for their non-tobacco flavored products compared to tobacco-flavored ENDS products, and that the FDA should have gone through the notice and comment rulemaking process for this requirement.

On August 23, 2022, the 11^th Circuit set aside (i.e., vacated) the MDO issued to the non-tobacco flavored BIDI® Sticks and remanded Bidi’s PMTA back to the FDA for further review. Specifically, the 11^th Circuit held that the MDO was “arbitrary and capricious” in violation of the APA because the FDA failed to consider the relevant evidence before it, specifically Bidi’s aggressive and comprehensive marketing and sales-access-restrictions plans designed to prevent youth appeal and access.

The 11^th Circuit’s opinion further indicated that the FDA did not properly review the data and evidence that it has long made clear are critical to the appropriate for the protection of the public health (“APPH”) standard for PMTAs set forth in the Tobacco Control Act including, in Bidi’s case, “product information, scientific safety testing, literature reviews, consumer insight surveys, and details about the company’s youth access prevention measures, distribution channels, and adult-focused marketing practices,” which “target only existing adult vapor product users, including current adult smokers,” as well as our retailer monitoring program and state-of-the-art anti-counterfeit authentication system. Because a MDO must be based on a consideration of the relevant factors, such as the marketing and sales-access-restrictions plans, the denial order was deemed arbitrary and capricious, and vacated by the FDA.

In light of the 11th Circuit decision, we anticipate having the continued ability to market and sell the non-tobacco flavored BIDI® Sticks, subject to FDA’s enforcement discretion, for the duration of the PMTA scientific review. The FDA has indicated that it is prioritizing enforcement of unauthorized ENDS against companies (1) that never submitted PMTAs, (2) whose PMTAs have been refused acceptance or filing by the FDA, (3) whose PMTAs remain subject to MDOs, and (4) that are continuing to market unauthorized synthetic nicotine products after the July 13, 2022 cutoff. As none of these scenarios apply to Bidi, we believe the current risk of FDA enforcement is low.

Since the PMTA was remanded, Bidi has continued to update its application with the results of new studies, including a nationwide population prevalence study on the BIDI® Stick that is currently undergoing peer review for publication.

Material Items, Trends and Risks Impacting Our Business

We believe that the following items and trends may be useful in better understanding our results of operations.

Dependence on Bidi and Nirajkumar Patel

We are wholly dependent on Bidi to supply the BIDI® Sticks to us for distribution. Accordingly, any supply or other issues that impact Bidi, indirectly impact us and our ability to operate our business. Moreover, and while we are seeking to diversify our product offerings, the loss of our relationship with Bidi would substantially harm the viability of our business.

Bidi is controlled by Nirajkumar Patel, our Chief Science and Regulatory Officer and a director of the Company. Moreover, Kaival Holdings, an entity controlled by Mr. Patel, is our majority shareholder. In addition, our corporate headquarters is leased to us by an affiliate of Mr. Patel. Therefore, Mr. Patel has the power and ability to control or influence our business.

Dependence on QuikfillRx, LLC and Distributors

We are substantially dependent on QuikfillRx, LLC (d/b/a Kaival Marketing Services, or KMS) to provide key marketing, sales and other support services to us. In addition, we rely on third-party brokers and distributors to introduce and place our products into our historic foundation of convenience-stores and more recently into new retail channels, including dollar, grocery and mass-merchandisers. The loss of one or more of these key relationships would have a material adverse effect on our business.

Nature of our Products and Regulation

Competition in the market for e-cigarettes from illicit sources may have an adverse effect on our overall sales volume, restricting our ability to increase selling prices and damaging our brand equity and reputation. Illicit trade and tobacco trafficking in the form of counterfeit products, smuggled genuine products, and locally manufactured products on which applicable taxes or regulatory requirements are evaded, represent a significant and growing threat to the legitimate tobacco industry, including the products we sell.

Although we combat counterfeiting of our Products by engaging in certain tactics, such as requiring all sales force personnel to randomly collect our Products from retailers in order to be tested by our quality control team, maintaining a quality control group that is responsible for identifying counterfeit products and surveillance of retailers we suspect are selling counterfeit Products through our own secret shopper force, no assurance can be given that we will be able to detect or stop sales of all counterfeit products. In addition, while we may bring suits against retailers and distributors that sell certain counterfeit products, no assurance can be given that we will be successful in any such suits or that such suits will be successful in stopping other retailers or distributors from selling counterfeit products.

Our Products are regulated by the FDA, which has broad regulatory powers. The market for ENDS products is subject to a great deal of uncertainty and is still evolving. ENDS products, having recently been introduced to market over the past 10 to 15 years, are at a relatively early stage of development, and represent core components of a market that is evolving rapidly, highly regulated, and characterized by a number of market participants. Rapid growth in the use of, and interest in, ENDS products is recent, and may not continue on a lasting basis. The demand and market acceptance for these products is subject to a high level of uncertainty. Therefore, we are subject to all the business risks associated with a new enterprise in an evolving market.

Some of our Product offerings through Bidi are subject to developing and unpredictable regulation. Our Products are sold through our distribution network and may be subject to uncertain and evolving federal, state, and local regulations, including hemp, non-THC cannabidiol (CBD) and other non-tobacco consumable products. Enforcement initiatives by those authorities are therefore unpredictable and impossible to anticipate. We anticipate that all levels of government, which have not already done so, are likely to seek in some way to regulate these products, but the type, timing, and impact of such regulations remains uncertain. With respect to CBD in particular, on January 26, 2023, FDA announced that it would not initiate rulemaking to regulate CBD as a dietary food ingredient. Rather, after careful review, the FDA has concluded that a new regulatory pathway for CBD is needed and has further indicated that it is prepared to work with Congress to create a new regulatory pathway for CBD through legislation.

In addition to the de facto FDA flavor ban that has resulted from the denial of nearly all PMTAs for flavored ENDS, ENDS products that are non-tobacco flavored continue to face the threat of prohibition at the local level, as many state and local authorities and attorneys general push for bans or request the FDA to deny PMTAs for flavored ENDS. In addition, a number of states and localities have banned the sale of non-tobacco flavored tobacco products. Recently, for example, California passed Proposition 31, which prohibits the sale of non-tobacco flavored tobacco products, including e-cigarettes, in retail locations. Thus, the non-tobacco flavored BIDI® Sticks are not permitted to be sold in California retail locations. We anticipate more states and localities will take this approach. Several other states have banned flavored ENDS, including New York, New Jersey, Rhode Island, and Massachusetts, with several more considering similar bans (e.g., Maryland, and Connecticut).

Inflation

Consumer purchases of tobacco products are historically affected by economic conditions, such as changes in employment, salary and wage levels, the availability of consumer credit, inflation, interest rates, fuel prices, sales taxes, and the level of consumer confidence in prevailing and future economic conditions. The U.S. has been experiencing an environment of material inflation in recent quarters, and this condition may impact discretionary consumer purchases, such as the BIDI® Stick. Demand for our Products may also decline during recessionary periods or at other times when disposable income is lower, and taxes may be higher.

Supply Chain

The spread of COVID-19 throughout the world as well as increasing tensions with China over the past several years has created global economic uncertainty, which may cause partners, suppliers, and potential customers to closely monitor their costs and reduce activities. Any of the foregoing could materially adversely affect the supply chain for Bidi and our Products, and any supply chain distribution for the Products could have a material adverse effect on our results of operations.

Corporate History

We were incorporated on September 4, 2018, in the State of Delaware. Effective July 12, 2019, we changed our corporate name from Quick Start Holdings, Inc. to Kaival Brands Innovations Group, Inc. The name change was effected through a parent/subsidiary short-form merger of Kaival Brands Innovations Group, Inc., our wholly-owned Delaware subsidiary formed solely for the purpose of the name change, with and into us. We were the surviving entity.

Change of Control

On February 6, 2019, we entered into a Share Purchase Agreement (the “Share Purchase Agreement”), by and among us, GMRZ Holdings LLC, a Nevada limited liability company (“GMRZ”), our then-controlling stockholder, and Kaival Holdings, LLC, a Delaware limited liability company (“KH”), pursuant to which, on February 20, 2019, GMRZ sold 504,000,000 shares of our restricted common stock, representing approximately 88.06% of our then issued and outstanding shares of common stock, to KH, and KH paid GMRZ consideration in the amount set forth in the Share Purchase Agreement. The consummation of the transactions contemplated by the Share Purchase Agreement resulted in a change in control, with KH becoming our largest controlling stockholder. Nirajkumar Patel and Eric Mosser are the sole voting members of KH.

Current Product Offerings

Other Potential Product Offerings

In addition to the BIDI® Stick, we anticipated launching distribution of the “BIDI® Pouch,” initially outside of the United States. The initial planned February 2021 roll-out of the BIDI® Pouch was delayed due to COVID-19 based manufacturing and supply chain constraints. Due to these complications, and in an effort to prevent future bottlenecks, Bidi decided to move manufacturing in-house. In 2021, Bidi modified the planned formulation of the BIDI® Pouch. The original BIDI® Pouch formulation (which never came to market) intended to utilize a tobacco-free (synthetic) nicotine formulation, along with natural fibers and a chew-base filler in six different flavors. However, production of the BIDI® Pouch was placed on hold domestically due to concerns about the safety of synthetic nicotine and the likelihood of the FDA enforcement of synthetic nicotine products either as unapproved drugs or unauthorized tobacco products. Subsequently, the Consolidated Appropriations Act of 2022, signed by President Biden on March 15, 2022, amended the definition of a “tobacco product” in the Food, Drug and Cosmetic Act and gave the FDA authority to regulate products containing nicotine from any source, including synthetic nicotine. The legislation also gave manufacturers of synthetic nicotine products 60 days to prepare and submit PMTAs by May 14, 2022. Synthetic nicotine products subject to timely submitted PMTAs were allowed to remain on the market without the threat of enforcement for another 60 days, until July 13, 2022. After July 13, 2022, all synthetic nicotine products, regardless of PMTA status, are illegal and subject to FDA enforcement (unless the product has actually been authorized and is subject to a PMTA Marketing Grant Order).

Also, on July 14, 2021, we announced plans to launch its first Kaival-branded product, a hemp CBD vaping product. In addition to our branded formulation, we anticipate that we will also provide white label, wholesale solutions for other product manufacturers through its subsidiary, Kaival Labs. We have not yet launched any branded product, nor has have begun to provide white label wholesale solutions for other product manufacturers, but the diversification of the types of products we distribute is an important part of our growth strategy.

Assuming we launch a hemp CBD product, of which there can be no assurances, we intend that all CBD products will be produced and distributed strictly in compliance under the Agriculture Improvement Act of 2018 (known as the 2018 Farm Bill), which defines hemp as the plant cannabis sativa and any part of the plant with a delta-9 THC concentration of not more than 0.3 percent by dry weight. According to the 2018 Farm Bill, hemp-derived products can be offered for retail sale in many forms: smoke, pouch, tinctures, topicals, capsules, vape oil and gummies/edibles. We plan to utilize Bidi’s patented BIDI® Stick delivery mechanism in order to provide a similar, premium experience in the initial CBD product line. We expect our industrial-grade hemp CBD formula to provide greater bioavailability than many market peers, resulting in a better consumer experience in less usage. On January 26, 2023, FDA announced that it would not initiate rulemaking to regulate CBD as a dietary food ingredient. Rather, after careful review, the FDA has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks. FDA further indicated that it is prepared to work with Congress on this matter.

PMI Licensing Agreement and International Distribution

On June 13, 2022, we, through our wholly owned subsidiary, KBI, entered into the PMI License Agreement with PMPSA, a wholly owned affiliate of PMI, for the development and distribution of ENDS products in certain markets outside of the United States, subject to market (or regulatory assessment). The PMI License Agreement grants to PMPSA a license of certain intellectual property rights relating to Bidi’s ENDS device, known as the BIDI® Stick in the United States, as well as potentially newly developed devices, to permit PMPSA to manufacture, promote, sell, and distribute such ENDS device and newly developed devices, in international markets, outside of the United States.

On July 25, 2022, we announced the launch of PMPSA’s custom-branded self-contained e-vapor product, pursuant to the licensing agreement. The product, a self-contained e-vapor device, VEEBA, has been custom developed and is now being distributed in Canada. VEEBA was then commercially launched by PMPSA in Europe in February 2023 and we expect to generate royalty revenues pursuant to the licensing agreement beginning in our fiscal fourth quarter of 2023 (quarter ending October 31, 2023), with additional market launches planned this year.

Going Concern

Our financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. As shown in the accompanying consolidated financial statements, the Company has incurred significant recurring losses, which raises substantial doubt about the Company’s ability to continue as a going concern.

In response to the above, our management assessed our plans to alleviate that doubt. We had positive working capital as of January 31, 2023, of $6,503,841. Management considered that the Company’s losses were due to various factors such as: (i) uncertainty surrounding the PMTA process with FDA and (ii) the MDO that was issued to Bidi Vapor on its non-tobacco flavored ENDS products. However, the MDO was set aside and vacated by the 11^th Circuit in August 2022, and the ability to appeal such decision has passed, thereby facilitating the continued sales of the non-tobacco flavored BIDI® Sticks for sale in the United States (pending FDA’s review of the pending PMTAs and subject to FDA enforcement). Concurrently, the PMTA for the tobacco-flavored (Classic) BIDI® Sticks for sale in the United States continues to move through the PMTA scientific review phase (pending FDA’s review of that PMTA). Management’s assessment included the preparation of cash flow forecasts which considered increases in revenues considering the favorable ruling obtained on the MDO as disclosed above.

We believe that our available cash and the cash to be provided by future operating activities should enable the Company to meet its estimated liquidity needs for the next 12 months after the date that the financial statements included within this Report are issued. Because of the above factors, our management believe that this condition alleviates the substantial doubt in connection with our ability to continue as a going concern.

However, there is no assurance that the Company’s plans will be able to generate expected or greater amounts of revenues or ever achieve profitability, due to the current economic climate in the United States and globally, the regulation and public perception of ENDS products and the various other risks faced by the Company. The consolidated financial statements included in this Report do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these or other risks or uncertainties.

Liquidity and Capital Resources

We believe we have sufficient cash on hand as of the date of this Report to support our operations for at least 12 months. As of January 31, 2023, we had working capital of approximately $6.6 million and total cash of approximately $3.8 million.

We intend to generally rely on cash from operations and equity and debt offerings to the extent necessary and available, to satisfy our liquidity needs. There are a number of factors that could result in the need to raise additional funds, including a decline in revenue or a lack of anticipated sales growth and increased costs. Our efforts are directed toward generating positive cash flow and, ultimately, profitability. If these efforts are not successful, we may need to raise additional capital. Should capital not be available to us at reasonable terms, other actions may become necessary in addition to cost control measures and continued efforts to increase sales. These actions may include exploring strategic options for the sale of the Company, the creation of joint ventures or strategic alliances under which we will pursue business opportunities, or other alternatives. We believe we have the financial resources to weather any short-term impacts of the FDA’s PMTA process and Bidi’s receipt of a MDO from the FDA, which has now been set aside and remanded by the 11th Circuit. At this time, we do not foresee the need for further strategic financing for the next twelve months, given the financing we completed in September 2021, as indicated below, and our continual sales efforts and results.

Cash Flows:

Cash flow provided by operations was approximately $0.1 million for the first three months of fiscal year 2023, compared to $2.1 million used in operations for the first three months of fiscal year 2022. The increase in cash flow provided by operations for the first three months of fiscal year 2023 compared to the first three months of fiscal 2022 was primarily due to changes in related party accounts payable, and income tax receivable.

The Company had cash flow used in investing activities of approximately $3,400 for the first three months of fiscal year 2023, compared to no cash flow used in investing activities for the first three months of fiscal year 2022. The cash used in investing activities for the first three months of fiscal year 2023 consisted of cash used for the purchase of warehouse equipment.

The Company had no net cash flow from financing activities for the first three months of fiscal year 2023, compared to cash flow used in financing activities of approximately $35,000 for the first three months of fiscal year 2022. The cash used in financing activities for the first three months of fiscal year of 2022 consisted of cash used for the settlement of RSUs issued to employees.

Results of Operations

Three months ended January 31, 2023, compared to three months ended January 31, 2022

Revenues:

Revenues for the first quarter of fiscal year 2023 were approximately $2.5 million, compared to approximately $2.8 million in the same period of the prior fiscal year. Revenues decreased in the first quarter of 2023, primarily due to credits/discounts/rebates issued to customers. We do not anticipate this trend to continue as renewed distribution ramps up and sales of non-tobacco flavored BIDI^® Sticks increase, and even more so now that the MDO has been vacated, which allows us to continue marketing and selling the Products, subject to the FDA’s enforcement discretion.

Cost of Revenue, Net and Gross Profit (Loss):

Gross profit in the first quarter of fiscal year 2023 was approximately $0.5 million, or approximately 21.4% of revenues, net, compared to approximately ($0.7) million gross loss or approximately (24.3%), of revenues, net, for the first quarter of fiscal year 2022. Total cost of revenue, net was approximately $2.0 million, or approximately 78.6% of revenue, net for the first quarter of fiscal year 2023, compared to approximately $3.5 million, or approximately 124.3% of revenue, net for the first quarter of fiscal year 2022. The increase in gross profit is primarily driven by the improvement in overall unit pricing, being offset by the credits/discounts/rebates issued to customers, totaling approximately $0.7 million, during the first quarter of fiscal year 2023.

Operating Expenses:

Total operating expenses were approximately $3.5 million for the first quarter of fiscal year 2023, compared to approximately $2.1 million for the first quarter of fiscal year 2022. For the first quarter of fiscal year 2023, operating expenses consisted primarily of advertising and promotion fees of approximately $0.6 million, stock option expense of approximately $1.4 million, professional fees of approximately $0.6 million, and all other general and administrative expenses of approximately $0.9 million. General and administrative expenses in the first quarter of fiscal year 2023 consisted primarily of salaries and wages, stock option expense, insurance, lease expense, project expenses, banking fees, business fees and state and franchise taxes. For the first quarter of fiscal year 2022, operating expenses were approximately $2.1 million, consisting primarily of advertising and promotion fees of approximately $0.6 million, stock option expense of 0.3 million, professional fees totaling approximately $0.5 million, and all other general and administrative expenses of approximately $0.7 million. General and administrative expenses consisted primarily of salaries and wages, insurance, banking fees, business fees, and other service fees. We expect future operating expenses to increase while we increase the footprint of our business and generate increased sales growth.

Income Taxes:

During the first quarter of fiscal year 2023, we did not accrue a tax provision for income taxes, due to the pre-tax loss of approximately ($3.1) million, similarly we did not accrue a tax provision for income taxes, due to the pre-tax loss of approximately ($2.8) million for the first quarter of fiscal year 2022.

Net Loss:

As a result of the items noted above, the net loss for the first quarter of fiscal year 2023 was approximately $3.0 million, or $0.05 basic and diluted net loss per share, compared to a net loss of approximately $2.8 million, or $0.09 basic and diluted net loss per share, for the first quarter of fiscal year 2022. The increase in the net loss for the first quarter of fiscal year 2023, as compared to the first quarter of fiscal year 2022, is primarily attributable to the decrease revenues and increase in customer credits/discounts/rebates, as noted above.

Critical Accounting Policies and Estimates

Other than the policy changes disclosed in Note 2, Basis of Presentation and Significant Accounting Policies, to the unaudited Consolidated Financial Statements in Item 1 of Part I of this Quarterly Report, there have been no material changes to our critical accounting policies and estimates during the three months ended January 31, 2023 from those disclosed in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our 2022 Annual Report for the year ended October 31, 2022.

Emerging Growth Company

We are an “emerging growth company,” that is exempt from certain financial disclosure and governance requirements for up to five years as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The JOBS Act eases restrictions on the sale of securities and increases the number of stockholders a company must have before becoming subject to the SEC’s reporting and disclosure rules. We have not elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(2) of the JOBS Act, that allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitations, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our President and Chief Operating Officer and Interim Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of January 31, 2023, the end of the period covered by this Quarterly Report. Based on that evaluation, the President and Chief Operating Officer and Interim Chief Financial Officer concluded that because of material weaknesses in our internal control over financial reporting, our disclosure controls and procedures were not effective as of January 31, 2023. Some of those internal controls include multiple levels of review of the accounting and reporting procedures and processes, lack of proper segregation of duties, lack of sufficient and consistent real time remote communications, as well as certain accounting and reporting issues.

Remediation of Material Weaknesses

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that all material weaknesses are remediated as soon as possible. Management will continue to work to improve its disclosure controls and procedures during fiscal 2023 with the goal of improvement in the effectiveness of its systems in our internal controls during the next 12 months. We intend to hire additional staff and to take such other actions as may be necessary to address its material weaknesses. The Company did add additional financial and accounting personnel during its fiscal year ended October 31, 2022, and as such, we believe we have made progress in the implementation of certain internal controls, such as multiple levels of review and analysis of the accounting and reporting procedures and processes, and of journal entries and general ledger account reconciliations.

Changes in Internal Control over Financial Reporting

Due to the identification of certain material weaknesses, we continue to work on strengthening our internal control structure. We made no other changes in internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during the quarter ended January 31, 2023 that have materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

Item 1. Legal Proceedings.

There are no material pending legal proceedings as defined by Item 103 of Regulation S-K, to which we are a party or of which any of our property is the subject, other than ordinary routine litigation incidental to the Company’s business.

Item 1A. Risk Factors.

Our business, operations, and financial condition are subject to various risks and uncertainties. The risk factors described in Part I, “Item 1A. Risk Factors” in the 2022 Annual Report, for the year ended October 31, 2022, should be carefully considered, together with the other information contained or incorporated by reference in this Quarterly Report and in our other filings with the SEC in connection with evaluating us, our business, and the forward-looking statements contained in this Quarterly Report. During the quarter ended January 31, 2023, there have been no material changes from the risk factors previously disclosed under Part I, “Item 1A. Risk Factors” in the 2022 Annual Report, for the year ended October 31, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

The following exhibits are filed herewith as a part of this Quarterly Report.

Exhibit Number		Description

31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934*

31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934*

32.1		Chief Executive Officer pursuant to 18 U.S.C. Section 1350 of Chapter 63 of Title 18 of the United States Code*

32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 of Chapter 63 of Title 18 of the United States Code*

33.1		Amendment to Interim Chief Financial Officer Services Agreement

101.INS		Inline XBRL Instance Document*

101.SCH		Inline XBRL Taxonomy Extension Schema Document*

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document*

101.PRE		Inline XBRL Taxonomy Presentation Linkbase Document*

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

(1)

Schedules and Exhibits omitted pursuant to Item 601(b) (10) (iv) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any Schedule or Exhibit so furnished

*filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	KAIVAL BRANDS INNOVATIONS GROUP, INC.

Date: March 17, 2023	A	/s/ Eric Mosser
		Eric Mosser
		President and Chief Operating Officer

Date: March 17, 2023	By:	/s/ Mark Thoenes
		Mark Thoenes
		Interim Chief Financial Officer

EX-31.1 2 e4478_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

I, Eric Mosser, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Kaival Brands Innovations Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 17, 2023	By:	/s/ Eric Mosser
		Eric Mosser
		President, and Chief Operating Officer

EX-31.2 3 e4478_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934

I, Mark Thoenes, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Kaival Brands Innovations Group, Inc.;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 17, 2023	By:	/s/ Mark Thoenes
		Mark Thoenes
		Interim Chief Financial Officer

EX-32.1 4 e4478_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

Certification of Chief Executive Officer

Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

Pursuant to U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned Chief Executive Officer of Kaival Brands Innovations Group, Inc. (the “Company”) does hereby certify, to the best of such officer’s knowledge, that:

The Quarterly Report on Form 10-Q of the Company for the quarterly period ended January 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 17, 2023	By:	/s/ Eric Mosser
		Eric Mosser
		President and Chief Operating Officer

The certifications set forth above are being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Kaival Brands Innovations Group, Inc. and will be retained by Kaival Brands Innovations Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 e4478_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

Certification of Chief Financial Officer

Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

Pursuant to U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned Chief Financial Officer of Kaival Brands Innovations Group, Inc. (the “Company”) does hereby certify, to the best of such officer’s knowledge, that:

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 17, 2023	By:	/s/ Mark Thoenes
		Mark Thoenes
		Interim Chief Financial Officer

The certifications set forth above are being furnished as an exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

EX-33.1 6 e4478_ex33-1.htm EXHIBIT 33.1

EXHIBIT 1

AMENDMENT TO

CONSULTING AGREEMENT

This Amendment to Consulting Agreement (“Amendment”) is entered into as of March 3, 2023 (“Effective Date”) and is between Kaival Brands Innovations Group, Inc., a Delaware corporation (the “Company”) and Mark L. Thoenes/MLT Consulting Services, LLC (the “Consultant”) (the Company and Consultant are each a “Party” and collectively the “Parties”).

R E C I T A L S

WHEREAS, the Company and Consultant are parties to that certain Consulting Agreement dated June 14, 2021 (the “Original Agreement”); and

WHEREAS, the Parties desire to amend the Original Agreement as set forth in this Amendment.

Now, Therefore, in consideration of the promises and the mutual covenants contained herein, and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, and with the intent to be legally bound hereby, the Company and Consultant agree as follows:

1. Defined Terms. Unless otherwise defined herein, all capitalized terms used in this Amendment have the meanings assigned to such terms in the Original Agreement, as amended hereby.

2. Amendment to Section 1(c). Section 1(c) of the Original Agreement is hereby deleted in its entirety and replaced with the following:

“The term of the consulting relationship under this Agreement shall commence on the Effective Date and continue through June 30, 2023, unless the consulting relationship is sooner terminated in accordance with Section 9(b) below.”

3. Hourly Compensation. The Parties agree that the hourly compensation shall remain at $150.00 per hour.

4. Additional Non-Qualified Stock Options. The Parties agree that a new Section 3.1(e) shall be added to Exhibit A as follows:

“3.1(e) The Company shall grant to the Consultant Fifty Thousand (50,000) non- qualified stock options (the “Additional NQSOs”) in the Company’s common stock as of the Effective Date (the “Amendment Effective Date”) pursuant to a Notice of Grant which shall be issued as of the Amendment Effective Date. The Parties further agree that the Additional NQSOs shall vest upon the earlier of: (a) June 30, 2023; (b) one (1) day after the Company files its 10-Q3; (c) if terminated by the Company for any reason other than a material breach by Consultant that remains uncured for five (5) business days after Company notifies Consultant of such breach; or (d) if Company undergoes a Change of Control.

For purposes of this Agreement, a Change of Control shall mean any of the following: (i) any sale, lease or other disposition of all or substantially all of the Company’s assets or (ii) any merger, consolidation, equity exchange, reorganization, or other similar transaction or series of transactions of the Company in which Eric Mosser, Nirajkumar Patel, the family members of Nirajkumar Patel, the family members of Eric Mosser, trusts established for the primary benefit of Nirajkumar Patel, Eric Mosser, or their family members, or closely held business organizations organized, formed, or incorporated and that are owned by Nirajkumar Patel, Eric Mosser, the family members of Nirajkumar Patel, the family members of Eric Mosser, trusts established for the primary benefit of Nirajkumar Patel, Eric Mosser, or their family members (collectively, the “Founders”) collectively own fifty percent (50%) or less of the voting power in the resulting entity immediately after such event, or (iii) any purchase or purchases by any person or persons of equity interests of the Company directly from one or more of the Founders, the effect of which is, following such purchase or purchasers, that the Founders collectively own fifty percent (50%) or less of the voting power in the Company. For the avoidance of doubt, a Change of Control shall not occur under clause (iii) above if the purchase of the equity interests arises out of or relate to a securities offering by the Company pursuant to which new capital is raised by the Company.”

5. Effect of this Amendment. Except as expressly amended hereby, the Original Agreement, as amended, remains in full force and effect. In the event of a conflict or inconsistency between the Original Agreement and this Amendment, the terms of this Amendment shall control.

6. Execution in Counterparts. This Amendment may be executed in counterparts, including electronically by DocuSign, each of which when so executed and delivered shall be deemed to be an original and all of which taken together shall constitute one and the same instrument.

(SIGNATURES ON FOLLOWING PAGE)

IN WITNESS WHEREOF, the Company and the Consultant have executed this Amendment as of the Effective Date written above.

Kaival Brands Innovations Group, Inc.		Mark L. Thoenes/MLT Consulting Services, LLC
(Company)		(Consultant)

/s/ Eric Mosser		/s/ Mark Thoenes
Eric Mosser, President & COO		Mark Thoenes, President

EX-101.SCH 7 kavl-20230131.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Leases (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Leases (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stockholder Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 kavl-20230131_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 kavl-20230131_def.xml XBRL DEFINITION FILE EX-101.LAB 10 kavl-20230131_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Transaction Type [Axis] P M I License Agreement [Member] Related Party [Axis] G P M [Member] Lakshmi Distributor Inc [Member] Hackney [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Related Party Transaction [Axis] Favs [Member] Stewart [Member] C Store Master [Member] Share Based Compensation [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Lease Contractual Term [Axis] Year One [Member] Year Two [Member] Year Three [Member] Year Four [Member] Year Five [Member] Year Six [Member] Office And Storage Space [Member] Award Type [Axis] Kaival Holdings L L C [Member] Financial Instrument [Axis] Bond Option [Member] Two Consultants [Member] One Consultants [Member] Stock Warrants [Member] Warrant [Member] Other Receivable [Member] Nirajkumar Patel [Member] Bidi Vapor [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Three Board [Member] Two Board [Member] Five Employees [Member] Plan Name [Axis] Incentive Compensation Plan [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS CURRENT ASSETS: Cash Accounts receivable, net Other receivable – related party – short term Inventories Prepaid expenses Income tax receivable Total current assets Fixed assets, net Other receivable – related party – net of current portion Right of use asset- operating lease TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable Accounts payable- related party Accrued expenses Customer deposits Customer refund due Deferred revenue Operating lease obligation – short term Total current liabilities LONG TERM LIABILITIES Operating lease obligation, net of current portion TOTAL LIABILITIES STOCKHOLDERS’ EQUITY: Preferred Stock, Value Common stock ($0.001 par value, 1,000,000,000 shares authorized, 56,169,090 and 56,169,090 issued and outstanding as of January 31, 2023 and October 31, 2022, respectively) Additional paid-in capital Accumulated deficit Total Stockholders’ Equity TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Revenues, net Revenues - related parties Royalty revenue Excise tax on products Total revenues, net Cost of revenue Cost of revenue - related party Cost of revenue – other Total cost of revenue Gross profit (loss) Operating expenses Advertising and promotions General and administrative expenses Total operating expenses Other income Interest income Total Other income Loss before income taxes provision Provision for income taxes Net loss Net loss per common share - basic and diluted Weighted average number of common shares outstanding - basic and diluted Beginning balance, value Balance at beginning (in shares) Stock issued for services – RSU Stock issued for services - RSUs, (in shares) Common stock settled and cancelled Common shares settled and cancelled (in shares) Stock option expense Net loss Ending balance, value Balance at end (in shares) Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustment to reconcile net loss to net cash provided by (used in) operating activities: Stock based compensation Depreciation Stock option expense EX-101.PRE 11 kavl-20230131_pre.xml XBRL PRESENTATION FILE GRAPHIC 12 image_001.gif GRAPHIC begin 644 image_001.gif M1TE&.#EAR@"4 '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y M! $ + #* )0 AP ,P 9@ F0 S _P S S,P S M9@ SF0 SS S_P!F !F,P!F9@!FF0!FS !F_P"9 "9,P"99@"9F0"9S "9 M_P#, #,,P#,9@#,F0#,S #,_P#_ #_,P#_9@#_F0#_S #__S, #, ,S, M9C, F3, S#, _S,S #,S,S,S9C,SF3,SS#,S_S-F #-F,S-F9C-FF3-FS#-F M_S.9 #.9,S.99C.9F3.9S#.9_S/, #/,,S/,9C/,F3/,S#/,_S/_ #/_,S/_ M9C/_F3/_S#/__V8 &8 ,V8 9F8 F68 S&8 _V8S &8S,V8S9F8SF68SS&8S M_V9F &9F,V9F9F9FF69FS&9F_V:9 &:9,V:99F:9F6:9S&:9_V;, &;,,V;, M9F;,F6;,S&;,_V;_ &;_,V;_9F;_F6;_S&;__YD )D ,YD 9ID F9D S)D M_YDS )DS,YDS9IDSF9DSS)DS_YEF )EF,YEF9IEFF9EFS)EF_YF9 )F9,YF9 M9IF9F9F9S)F9_YG, )G,,YG,9IG,F9G,S)G,_YG_ )G_,YG_9IG_F9G_S)G_ M_\P ,P ,\P 9LP F

/($.*'$FRI,F3*%.J7,FRIO8,.*'4NV MK-FS:-.J7//J9=EJ;T$ @ ,+'DRXL.'#B!,3;L58 ML>/'D"-+GDRYLN7+AEL)TLP9L^?/H$.+'IV8L>G3K4BK7LVZ-6G&V#;+-NVZ MMNW;N .GIHVZ<>[?P(-;YIT: &?&@H0K7\Y<,.W%IYM+GYX;VV'.R:EKWS[: M=V;OW,.+_X]C3>WZNOKU[Q\C?RY\/O3S]^^[CX]^OGCW__]M%IUPI M>@2B!X$&E@(@ *4 0N"#@.17'BO"!6(@((!<&"& >F"H82 ;XH:-??#YQDH@ MRA6H8H(+(KCB@;GY9UYYI@1BBG 8=MAAAC?^QTJ.@.B8H8BRE>@=*S *YR*" M"P)0XX$J/FA;;T8"QDJ#@9"86R (1JCE?D+N"&)MR&&'6&RP!29E9V/P;I9XA@XE69B%@%G(9:BF?XIF8GGH"T":J@3X:F8V@%O_&):@6DEIK MJ;,>)J:8G79'J)EV9NPZBQB]07;Z9+OL]INK M8'W6*^ZOA1KG'9?%6H9DMPPK*VFW[S(8992)6NCPI(DAO&3%#3]\,<.]1CKQ MN=V-NYMW-6IXV8_X[NIAAAFR&W/$+6,XF,LZVDO8AX"^*?.',-<<>>,F-UZ/!JPNGVO1S")'A/X M],=@)^;QHXWO7+FNDIXKML.23YQ@HB)W&S=H=-[LHNPB$&] MK/%CZ\SUZ!*/K7G85'OM?.2 J2VNC W^^;;=1Y-F2OJ$P\LO[ SR:V_-!6)V M)?Y^,ATXW6QCS\->)['&D0\S!NR8T[KGL/LID&1-V]AC,@]T?_I2QCB(NMD)365ADYFNU.6A1Z5,8(9YG\5 "*2A"6EH&7J4T6QC M-<.,#WJ.N9&R_[)7K?%U:GN'L=[50/6U;QFQB$0T4#34A,36@.B&L*K;W!(G MF \:+519))RQ_G? O;$P$&TBT+IT-D.9>2A/@;IBN_S7+BYB!G))5.#G%&.* M"L*(%5IJW![*YSF,6:Z0QL+C(1_8K,4@DGRA2]AHK$.\H2%&=I5$G@]IB+;J MR9%V8:ODMW!X(5#1L'<[XV3/,E9"XW'2CI(YV\3$1T12.=%[7-QN5T-P)0BRN4E8-#=(T\R10 /Z,G(4!7K6J-DS(#'%9 M-*OE_8BE-F$!IHJ=BR*4JC>^6RZ+F%^C7SIK:*%W@5-,KW)FKP['3ST5J(W: M/"B_ $HX36J+?P6*T.[(R$R>YNMVOLR>OQ[(,[5=HUH=L4Y>IJR*3(J)&4QV/K M0]D)PL*LE$$/<*(I25M)[+W<2(][WC_:YVPIO>Z[27--_=PQ4 <(7]\E>\]\&AG#-S O/O"*QUL<%/\7Q9H1+XX]#)CW M9IB\*9XQC?';W_B>M[\:!DR32USD(L>8O#V&LK 27)SO^E,F40;&"C5QD)2-8_\Q"WG%UL<%C*2M8,!C'L8?'V M=\B#QO. !5W>.K>9Q7T>S9X7H^,_*_K.X9O24!^Q?\4:,U"/.,8R+;&@G-]LSSR;UL"F]YSPG>S Z M1O2%Q>WB.!OD67]9<+S?+6^"P-O>]1[(O?6=;X'LV]_]MD[ _RUP>D]$W@0G M.$("7O!Y.QS?!V&X7R9.\8I;_.(8S[C&-\[QCGO\XR /N<*0SW>E-5WK4GRYUJ%N]ZEBGNM:GSO6K;]WK7WUSWN=Y^[W?>.=[[KO>^ _[O@\TYXOQ<^\(<7?$ " #L! end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.4

Cover - shares
3 Months Ended

Jan. 31, 2023

Mar. 17, 2023

Cover [Abstract]

Document Type 10-Q

Amendment Flag false

Document Quarterly Report true

Document Transition Report false

Document Period End Date Jan. 31, 2023

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2023

Current Fiscal Year End Date --10-31

Entity File Number 000-56016

Entity Registrant Name KAIVAL BRANDS INNOVATIONS GROUP, INC.

Entity Central Index Key 0001762239

Entity Tax Identification Number 83-3492907

Entity Incorporation, State or Country Code DE

Entity Address, Address Line One 4460 Old Dixie Highway

Entity Address, City or Town Grant-Valkaria

Entity Address, State or Province FL

Entity Address, Postal Zip Code 32949

City Area Code (833)

Local Phone Number 452-4825

Title of 12(b) Security Common Stock, par value $0.001 per share

Trading Symbol KAVL

Security Exchange Name NASDAQ

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Non-accelerated Filer

Entity Small Business true

Entity Emerging Growth Company true

Elected Not To Use the Extended Transition Period false

Entity Shell Company false

Entity Common Stock, Shares Outstanding 56,169,090

XML 14 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) - USD ($)	Jan. 31, 2023	Oct. 31, 2022
CURRENT ASSETS:
Cash	$ 3,773,628	$ 3,685,893
Accounts receivable, net	518,291	574,606
Other receivable – related party – short term	2,026,245	1,539,486
Inventories	3,761,491	1,239,725
Prepaid expenses	316,621	426,407
Income tax receivable		1,607,302
Total current assets	10,396,276	9,073,419
Fixed assets, net	3,364
Other receivable – related party – net of current portion	1,483,297	2,164,646
Right of use asset- operating lease	1,152,020	1,198,969
TOTAL ASSETS	13,034,957	12,437,034
CURRENT LIABILITIES:
Accounts payable	81,265	40,023
Accounts payable- related party	2,350,787
Accrued expenses	675,453	1,099,157
Customer deposits	12,098	44,973
Customer refund due	366,956	0
Deferred revenue	129,702	235,274
Operating lease obligation – short term	170,603	166,051
Total current liabilities	3,786,864	1,585,478
LONG TERM LIABILITIES
Operating lease obligation, net of current portion	1,006,435	1,050,776
TOTAL LIABILITIES	4,793,299	2,636,254
STOCKHOLDERS’ EQUITY:
Common stock ($0.001 par value, 1,000,000,000 shares authorized, 56,169,090 and 56,169,090 issued and outstanding as of January 31, 2023 and October 31, 2022, respectively)	56,169	56,169
Additional paid-in capital	30,811,574	29,375,787
Accumulated deficit	(22,626,085)	(19,631,176)
Total Stockholders’ Equity	8,241,658	9,800,780
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	13,034,957	12,437,034
Series A Preferred Stock [Member]
STOCKHOLDERS’ EQUITY:
Preferred Stock, Value

XML 15 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jan. 31, 2023	Oct. 31, 2022
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	56,169,090	56,169,090
Common stock, shares outstanding	56,169,090	56,169,090
Series A Preferred Stock [Member]
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

XML 16 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Revenues
Revenues, net	$ 2,435,835	$ 2,841,990
Revenues - related parties	3,085	23,765
Royalty revenue	105,572
Excise tax on products	(18,574)	(23,872)
Total revenues, net	2,525,918	2,841,883
Cost of revenue
Cost of revenue - related party	1,985,800	3,484,620
Cost of revenue – other		48,172
Total cost of revenue	1,985,800	3,532,792
Gross profit (loss)	540,118	(690,909)
Operating expenses
Advertising and promotions	588,910	592,501
General and administrative expenses	2,958,069	1,498,554
Total operating expenses	3,546,979	2,091,055
Other income
Interest income	11,952
Total Other income	11,952
Loss before income taxes provision	(2,994,909)	(2,781,964)
Provision for income taxes
Net loss	$ (2,994,909)	$ (2,781,964)
Net loss per common share - basic and diluted	$ (0.05)	$ (0.09)
Weighted average number of common shares outstanding - basic and diluted	56,169,090	30,234,477

XML 17 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Oct. 31, 2021	$ 3,000	$ 30,195	$ 21,551,959	$ (5,260,841)	$ 16,324,313
Balance at beginning (in shares) at Oct. 31, 2021	3,000,000	30,195,312
Stock issued for services – RSU		$ 61	110,189		110,250
Stock issued for services - RSUs, (in shares)		61,250
Common stock settled and cancelled		$ (20)	(35,739)		(35,759)
Common shares settled and cancelled (in shares)		(19,866)
Stock option expense			309,700		309,700
Net loss				(2,781,964)	(2,781,964)
Ending balance, value at Jan. 31, 2022	$ 3,000	$ 30,236	21,936,109	(8,042,805)	13,926,540
Balance at end (in shares) at Jan. 31, 2022	3,000,000	30,236,696
Beginning balance, value at Oct. 31, 2022		$ 56,169	29,375,787	(19,631,176)	9,800,780
Balance at beginning (in shares) at Oct. 31, 2022		56,169,090
Stock option expense			1,435,787		1,435,787
Net loss				(2,994,909)	(2,994,909)
Ending balance, value at Jan. 31, 2023		$ 56,169	$ 30,811,574	$ (22,626,085)	$ 8,241,658
Balance at end (in shares) at Jan. 31, 2023		56,169,090

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 18 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,994,909)	$ (2,781,964)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities:
Stock based compensation		110,250
Depreciation	116
Stock option expense	1,435,787	309,700
ROU operating lease expense	46,949	3,649
Changes in current assets and liabilities:
Accounts receivable	56,315	688,982
Other receivable – related party	194,590
Prepaid expenses	109,786	29,543
Inventory	(2,521,766)	3,484,620
Income tax receivable	1,607,302
Accounts payable	41,242	(62,812)
Accounts payable – related party	2,350,787	(3,538,010)
Accrued expenses	(423,704)	(205,192)
Deferred revenue	(105,572)
Customer deposits	(32,875)
Customer refund due	366,956	(169,110)
Right of use liabilities – operating lease	(39,789)	(3,170)
Net cash provided by (used in) operating activities	91,215	(2,133,514)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for equipment	(3,480)
Net cash used in investing activities	(3,480)
CASH FLOWS FROM FINANCING ACTIVITIES:
Settled RSU shares with cash		(35,759)
Net cash used in financing activities		(35,759)
Net change in cash and restricted cash	87,735	(2,169,273)
Beginning cash and restricted cash balance	3,685,893	7,825,235
Ending cash and restricted cash balance	3,773,628	5,655,962
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes paid		$ 106,385

XML 19 R7.htm IDEA: XBRL DOCUMENT

Organization and Description of Business

3 Months Ended

Jan. 31, 2023

Accounting Policies [Abstract]

Organization and Description of Business

Note 1 – Organization and Description of Business

Description of Business

Current Product Offerings

COVID-19 Impact

Impact of the FDA PMTA Decision and Subsequent Court Actions

As of January 31, 2022, the FDA announced that it has taken action on over 99% of applications and issued Marketing Denial Orders (“MDOs”) for more than 1,167,000 non-tobacco flavored ENDS products, while issuing zero marketing authorizations for such products.

Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored ENDS products. With respect to Bidi, the MDO covered all non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick. As a result, beginning in September 2021, Bidi pursued multiple avenues to challenge the MDO. First, on September 21, 2021, separate from the judicial appeal of the MDO in its entirety, Bidi filed a 21 C.F.R. § 10.75 internal FDA supervisory review request specifically of the decision to include the Arctic (menthol) BIDI® Stick in the MDO. In May 2022, the FDA issued a determination that it views the Arctic BIDI® Stick as a non-tobacco flavored ENDS product, and not strictly a menthol flavored product.

On September 29, 2021, Bidi petitioned the U.S. Court of Appeals for the Eleventh Circuit (the “11th Circuit”) to review the FDA’s denial of the comprehensive PMTAs for its non-tobacco flavored BIDI® Stick ENDS, arguing that it was arbitrary and capricious under the Administrative Procedure Act (“APA”), as well as ultra vires, for the FDA not to conduct any scientific review of Bidi’s comprehensive applications, as required by the Tobacco Control Act (“TCA”), to determine whether the BIDI® Sticks are “appropriate for the protection of the public health”. Bidi further argued that the FDA violated due process and the APA by failing to provide fair notice of the FDA’s new requirement for ENDS companies to conduct long-term comparative smoking cessation studies for their flavored products, and that the FDA should have gone through the notice and comment rulemaking process for this requirement.

On October 14, 2021, Bidi requested that the FDA re-review the MDO and reconsider its position that Bidi did not include certain scientific data in its applications sufficient to allow the PMTAs to proceed to scientific review. In light of this request, on October 22, 2021, pursuant to 21 C.F.R. § 10.35(a), the FDA issued an administrative stay of Bidi’s MDO pending its re-review, permitting the Company to continue sales. Subsequently, the FDA decided not to rescind the MDO and lifted its administrative stay on December 17, 2021. Following the lifting of the FDA’s administrative stay, Bidi filed a renewed motion to stay the MDO with the 11th Circuit. On February 1, 2022, the appellate court granted Bidi’s motion to stay (i.e., put on hold) the MDO, again allowing the Company to continue sales pending the litigation on the merits. Oral arguments in the merits-based proceeding were held on May 17, 2022.

On August 23, 2022, the U.S. Court of Appeals for the Eleventh Circuit set aside the MDO issued to the non-tobacco flavored BIDI® Sticks and remanded Bidi’s back to the FDA for further review. Specifically, the Court held that the MDO was “arbitrary and capricious” in violation of the Administrative Procedure Act (“APA”) because FDA failed to consider the relevant evidence before it, specifically Bidi’s aggressive and comprehensive marketing and sales-access-restrictions plans designed to prevent youth appeal and access.

The 11th Circuit’s opinion further found indicated that the FDA did not properly review the data and evidence that it has long made clear are critical to the appropriate for the protection of the public health (“APPH”) standard for PMTAs set forth in the Tobacco Control Act including, in Bidi’s case, “product information, scientific safety testing, literature reviews, consumer insight surveys, and details about the company’s youth access prevention measures, distribution channels, and adult-focused marketing practices,” which “target only existing adult vapor product users, including current adult smokers,” as well as our retailer monitoring program and state-of-the-art anti-counterfeit authentication system. Because a MDO must be based on a consideration of the relevant factors, such as the marketing and sales-access-restrictions plans, the denial order was deemed arbitrary and capricious, and vacated by the FDA.

The FDA did not appeal to the 11th Circuit’s decision. The FDA had until October 7, 2022 (45 days from the August 23, 2022 decision) to either request a panel rehearing or a rehearing “en banc” (a review by the entire 11th Circuit, not just the 3-judge panel that issued the decision), and until November 21, 2022 (90 days after the decision) to seek review of the decision by the U.S. Supreme Court. No request for a rehearing was filed, and no petition for a writ of certiorari was made to the Supreme Court. In the meantime, the Company anticipates continued ability to market and sell the non-tobacco flavored BIDI® Sticks, subject to the FDA’s enforcement discretion, for the duration of the PMTA scientific review.



Separately, on or about May 13, 2022, FDA placed the tobacco-flavored Classic BIDI® Stick into the final Phase III scientific review, and in September 2022 completed a remote regulatory assessment of Bidi and its contract manufacturer in China, SMISS Technology Co. LTD, in relation to the pending PMTA for the Classic BIDI® Stick.

Risks and Uncertainties

FDA has indicated that it is prioritizing enforcement of unauthorized ENDS against companies (1) that never submitted PMTAs, (2) whose PMTAs have been refused acceptance or filing by the FDA, (3) whose PMTAs remain subject to MDOs, and (4) that are continuing to market unauthorized synthetic nicotine products after the July 13, 2022, cutoff. Subject to FDA’s enforcement discretion, until the scientific review process is complete on each of Bidi’s PMTAs, the Company views the risk of FDA enforcement against Bidi as low. The Company anticipates FDA will move forward with a review of Bidi’s PMTA on remand, as directed by the Court; however, the Company cannot provide any assurances as to the timing or outcome.

Accordingly, the Company anticipates FDA will move forward with a review of Bidi’s PMTA on remand, as directed by the Court.

Moreover, the Company believes that Bidi’s application is particularly comprehensive, and now includes, among other things, a randomized, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® Stick, several behavioral, perception and intention studies, as well as a nationally-representative population prevalence study. A complete scientific review of the PMTA would require FDA to review all this information before making an APPH determination, and while FDA could narrowly interpret the Court’s ruling as an order to review only Bidi’s marketing and sales-access restrictions plans, the 11^th Circuit’s opinion, in the Company’s view, makes clear that all “relevant evidence” in an application must be considered. For applications that are in scientific review, FDA typically issues a deficiency letter identifying its questions before making a marketing authorization decision and gives the applicant at least 90 days to respond. This further solidifies the Company’s belief that the scientific review of Bidi’s non-tobacco flavored applications could take 1-2 years or longer. However, the Company cannot provide any assurances as to the timing or outcome.

XML 20 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies

3 Months Ended

Jan. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation and Significant Accounting Policies

Note 2 – Basis of Presentation and Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiaries, Kaival Labs and KBI. Intercompany transactions are eliminated.

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Advertising and Promotion

All advertising, promotion and marketing expenses, including commissions, are expensed when incurred.

Accounts Receivable and Allowance for Doubtful Accounts

Inventories

Revenue Recognition

Deferred Revenue

Customer Refunds

Products Revenue

Royalty Revenue

On June 13, 2022, KBI entered into the PMI License Agreement with PMPSA, effective as of May 13, 2022 (the “PMI Commencement Date”). Pursuant to the PMI License Agreement, KBI granted PMPSA an exclusive irrevocable license to use its technology, documentation, and intellectual property to make, distribute, and sell disposable nicotine e-cigarettes Products based on the intellectual property in certain international markets set forth in the PMI License Agreement (the “PMI Markets”). The Company has the exclusive international distribution rights to the Products and, in order to allow KBI to fulfill its obligations set forth in the PMI License Agreement, has contributed the international distribution rights for the PMI Markets to KBI as set forth in a Capital Contribution Agreement, dated June 10, 2022. The sublicense granted to PMPSA is exclusive in the PMI Markets and neither KBI nor any of its affiliates can sell, promote, use, or distribute any competing products in the PMI Markets for the duration of the term of the PMI License Agreement and any Sell-Out Period (as defined in the PMI License Agreement). PMSPA will be responsible for any regulatory filings necessary to sell the Products in the PMI Markets. Both KBI and PMPSA agree to work together in the registration and maintenance of the Intellectual Property, but KBI will bear all cost and expense to implement the registration strategy. Finally, PMPSA has agreed to potential future development services with KBI in the PMI Markets and has been granted certain rights with respect to potential future products.

The initial term of the PMI License Agreement is five (5) years and automatically renews for an additional five-year period unless PMPSA has failed to meet the agreed upon minimum key performance indicators set forth in the PMI License Agreement, in which case the PMI License Agreement will automatically terminate at the end of the initial license term.

In consideration for the grant of the licensed rights, PMPSA agreed to pay to KBI a royalty equal to a percentage of the base price of the first sale of each unit of Product manufactured. In addition, before the launch of the first product in a market and each anniversary of such launch, PMPSA agrees to pre-pay to KBI a guaranteed minimum royalty based on the estimated royalties payable by PMPSA to KBI in relation to all markets in the twelve (12)-month period following the first launch or each successive anniversary of the first launch, subject to an aggregate maximum guaranteed royalty payment for all markets for each applicable twelve (12)-month period. PMPSA may require modification of certain products to be sold under the PMI Licensing Agreement to be modified for a PMI Market. Pursuant to the PMI Licensing Agreement, PMPSA has absolute discretion over sales, marketing, product branding and packaging pertaining to sales in the PMI Markets, as well as the right to select the specific PMI Markets in which to launch commercialization and determine what product types are to be promoted in each market, subject to sales and marketing plans and annual business plans set by PMPSA and certain expansion criteria agreed between PMPSA and KBI. Royalty revenue earned from the PMI License Agreement is recognized in the period the sales of the Product manufactured occurs.

The PMI License Agreement contains customary representations, warranties, covenants, and indemnification provisions; however, KBI’s liability under the PMI License Agreement is capped at the greater of: (i) Ten Million Dollars ($10,000,000); or (ii) an amount equal to the total of the royalties due to KBI (but not yet paid) plus the royalties (including the guaranteed royalty payment) paid to KBI pursuant to the PMI License Agreement during the immediately preceding twelve (12) consecutive months, provided that such amount shall not exceed Thirty Million Dollars ($30,000,000). These royalties may be initially offset on a limited basis by jointly agreed upon costs such as development costs incurred for entry to specific international markets.



The KBI License agreement provides that KBI shall pay Bidi license fees equivalent to 50% of the adjusted earned royalty payments, after any offsets due to jointly agreed costs such development costs incurred for entry to specific international markets. Consequently, the Company has determined that no license fees are owed to Bidi as of January 31, 2023.

Concentration of Revenues and Accounts Receivable

For the three months ended January 31, 2023, (i) 25% or $599,201 of the revenue from the sale of Products, solely consisting of the BIDI^®Stick, was generated from GPM Investments, LLC, (“GPM”), (ii) 18% or $432,000 of the revenue from the sale of the Products was generated from FAVS Business, (“FAVS”), and (iii) approximately 15% or $372,518 of the revenue from the sale of Products, solely consisting of the BIDI Stick, was generated from H.T. Hackney Co.

For the three months ended January 31, 2022, 45%, or $1,287,180, of the revenue from the sale of Products was generated from FAVS, 12%, or $352,554, of the revenue from the sale of Products was generated from Lakshmi Distributor Inc., doing business as C Store Master (“C Store Master”), and 12%, or $332,595, of the revenue from the sale of Products was generated from H.T. Hackney Company.

FAVS, with an outstanding balance of $201,600, GPM, with an outstanding balance of $126,158, and Stewart Distribution with an outstanding balance of $59,404, accounted for 39%, 24%, and 11% of the total accounts receivable from customers, respectively, as of January 31, 2023. FAVS and C Store Master had outstanding balances of $374,400 and $282,414, respectively, which accounted for 29% and 22%, respectively, of the total accounts receivable from customers as of January 31, 2022.

Share-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments (share-based payments, referred to herein as “SBP”) based on the grant-date fair value of the award. That cost is recognized over the period during which a recipient is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to performance conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model.

The fair value of each option granted during the fiscal three-month period ended January 31, 2023, and January 31, 2022, was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table:

As of January As of January

31, 2023 31, 2022

Expected dividend yield 0 % 0 %

Expected option term (years) 10 10

Expected volatility 275.68 % 294.57%-
301.53 %

Risk-free interest rate 4.12 % 1.19-1.63%

The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company’s common stock. The assumed discount rate was the default risk-free ten-year interest rate for U.S. Treasury bills. The Company’s stock option expense for the fiscal three months ended January 31, 2023, and ended January 31, 2022 were $1,435,787 and $309,700, respectively.

Fair Value of Financial Instruments

The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of January 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, accounts receivable, inventory, accounts payable and accrued expenses  . As of January 31, 2023 and October 31, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on a recurring basis.

Recent Accounting Pronouncements

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

XML 21 R9.htm IDEA: XBRL DOCUMENT

Going Concern

3 Months Ended

Jan. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

Note 3 – Going Concern

XML 22 R10.htm IDEA: XBRL DOCUMENT

Leases

3 Months Ended

Jan. 31, 2023

Leases

Leases

Note 4 – Leases

Office and Storage Space

Cash flow information related to leases was as follows:

January 31, 2023 January 31, 2022

Other Lease Information

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases $ (46,949 ) $ (3,649 )

The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets as of January 31, 2023, and October 31, 2022:

Schedule Of Condensed Balance Sheet

Lease Position January 31, 2023 October 31, 2022

Operating Leases

Operating lease right-of-use assets $ 1,152,020 $ 1,198,969

Right of use liability operating lease current portion $ 170,603 $ 166,051

Right of use liability operating lease long term 1,006,435 1,050,776

Total operating lease liabilities $ 1,177,038 $ 1,216,827

The following table provides the maturities of lease liabilities at January 31, 2023:


	Operating Leases
Maturity of Lease Liabilities on January 31, 2023
2023	$	164,139
2024		228,134
2025		238,800
2026		253,614
2027 and thereafter		450,934
Total future undiscounted lease payments	$	1,335,621
Less: Interest		(158,583	)
Present value of lease liabilities	$	1,177,038

At January 31, 2023, the Company had no additional leases which had not yet commenced.

XML 23 R11.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity

3 Months Ended

Jan. 31, 2023

Equity [Abstract]

Stockholders’ Equity

Note 5 – Stockholders’ Equity

Common Stock

During the three months ended January 31, 2023:

No shares of Common Stock were issued during the three months ended January 31, 2023.

Preferred Stock Converted

Stock Options

Summary of stock options information is as follows:

Schedule of stock options

Weighted

Aggregate Aggregate Exercise Price Average

Number Exercise Price Range Exercise Price

Outstanding, October 31, 2022 3,202,265 8,921,419 1.03-28.68 2.79

Granted 3,250,000 3,207,425 0.99 0.99

Exercised — — — —

Cancelled, forfeited, or expired — — — —

Outstanding, January 31, 2023 6,452,265 $ 12,128,844 $ 0.99-28.69 $ 1.88

Exercisable, January 31, 2023 2,151,217 $ 6,085,555 $ 0.99-28.69 $ 2.83

During the three months ended January 31, 2023, and 2022, the Company recognized $1,435,787 and $309,700, respectively of stock option expense related to outstanding stock options. On January 31, 2023, the Company had $3,488,735 of unrecognized expenses related to options. The weighted average remaining contractual life is approximately 9.38 years for stock options outstanding on January 31, 2023. The aggregate intrinsic value of these outstanding options as of January 31, 2023, was $0. Compensation expense related to performance-based options is recognized on a straight-line basis over the requisite service period, provided that it is probable that performance conditions will be achieved, with probability assessed on a quarterly basis and any changes in expectations recognized as an adjustment to earnings in the period of the change. Compensation cost is not recognized for service- and performance-based awards that do not vest because service or performance conditions are not satisfied, and any previously recognized compensation cost is reversed. If vesting occurs prior to the end of the requisite service period, expense is accelerated and fully recognized through the vesting date.

On November 9, 2022, non-qualified stock options exercisable for up to 250,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vested on the issue date. The fair value of the options on the grant date was $246,747 using a Black-Scholes option pricing model with the following assumptions: stock price $0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of 275.68%, expected term of 10 years, and a risk-free interest rate of 4.12%.

On November 9, 2022, non-qualified stock options exercisable for up to 3,000,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vesting based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years. The fair value of the options on the grant date was $2,960,968 using a Black-Scholes option pricing model with the following assumptions: stock price $0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of 275.68%, expected term of 10 years, and a risk-free interest rate of 4.12%.

Warrants

Warrant information as of the periods indicated is as follows:

Weighted

Aggregate Aggregate Exercise Price Average

Number Exercise Price Range Exercise Price

Outstanding, October 31, 2022 2,318,317 4,404,802 1.90 1.90

Granted — — — —

Exercised — — — —

Cancelled, forfeited, or expired — — — —

Outstanding, January 31, 2023 2,318,317 $ 4,404,802 $ 1.90 $ 1.90

Exercisable, January 31, 2023 2,318,317 $ 4,404,802 $ 1.90 $ 1.90

The weighted average remaining contractual life is approximately 3.66 years for Common Stock warrants outstanding as of January 31, 2023. As of January 31, 2023, there was no intrinsic value of outstanding stock warrants.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

XML 24 R12.htm IDEA: XBRL DOCUMENT

Related-Party Transactions

3 Months Ended

Jan. 31, 2023

Related-Party Transactions

Note 6 – Related-Party Transactions

Other Receivable

Revenue and Accounts Receivable

Concentration Purchases and Accounts Payable

During the three months ended January 31, 2023, 100% of the inventories of Products, consisting solely of the BIDI® Stick, were purchased from Bidi, a related party controlled by Nirajkumar Patel, in the amount of $3,697,210. As of January 31, 2023, the Company had accounts payable to Bidi of $2,350,787 and Products valued at $3,761,491 were held in inventory. In addition, as of January 31, 2023, the Company had accrued freight in expense of $347,760. As of October 31, 2022, the Company did not have an accounts payable balance to Bidi.

During the three months ended January 31, 2022, the Company did not purchase Products from Bidi, a related party company that is owned by Nirajkumar Patel. As of January 31, 2022, the Company had accounts payable to Bidi of $9,129,759 and Products valued at $11,841,750 were held in inventory.

The KBI License agreement provides that KBI shall pay Bidi license fees equivalent to 50% of the adjusted earned royalty payments, after any offsets due to jointly agreed costs such development costs incurred for entry to specific international markets. Consequently, the Company has determined that no license fees are owed to Bidi as of January 31, 2023 and October 31, 2022.



Leased Office Space and Storage Space

The Company capitalizes all leased assets pursuant to ASU 2016-02, Leases (Topic 842) (“Topic 842”), which requires lessees to recognize right-of-use (“ROU”) assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. On June 10, 2022, the Company entered into the 2022 Lease with Just Pick for approximately 21,332 rentable square feet combined in the office building and warehouse located at the Premises, together with all improvements thereon. Just Pick is considered a related party to the Company because the Company’s Chief Science and Regulatory Officer and director, Mr. Nirajkumar Patel, owns and controls Just Pick.

XML 25 R13.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Jan. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 7 – Commitments and Contingencies

QuikfillRx Service Agreement Amendment

(b) QuikfillRx agreed to change its “doing business as” name to “Kaival Marketing Services” within thirty (30) days following the Effective Date;

(c) it was provided that either party may terminate the Amended Service Agreement without cause upon not less than ninety (90) days prior written notice to the other party;

XML 26 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Jan. 31, 2023

Subsequent Events [Abstract]

Subsequent Events

Note 8 – Subsequent Events

XML 27 R15.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Policies)

3 Months Ended

Jan. 31, 2023

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiaries, Kaival Labs and KBI. Intercompany transactions are eliminated.

Basis of Presentation

Basis of Presentation

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Advertising and Promotion

Advertising and Promotion

All advertising, promotion and marketing expenses, including commissions, are expensed when incurred.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

Inventories

Inventories

Revenue Recognition

Revenue Recognition

Deferred Revenue

Customer Refunds

Products Revenue

Royalty Revenue

Share-Based Compensation

Share-Based Compensation


	As of January			As of January
	31, 2023			31, 2022
Expected dividend yield		0	%		0	%
Expected option term (years)		10			10
Expected volatility		275.68	%		294.57%- 301.53	%
Risk-free interest rate		4.12	%		1.19-1.63%

Fair Value of Financial Instruments

Fair Value of Financial Instruments

● Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

●

●	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

XML 28 R16.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Tables)

3 Months Ended

Jan. 31, 2023

Accounting Policies [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions


	As of January			As of January
	31, 2023			31, 2022
Expected dividend yield		0	%		0	%
Expected option term (years)		10			10
Expected volatility		275.68	%		294.57%- 301.53	%
Risk-free interest rate		4.12	%		1.19-1.63%

XML 29 R17.htm IDEA: XBRL DOCUMENT

Leases (Tables)

3 Months Ended

Jan. 31, 2023

Leases

Schedule of cash flow information related to leases


	January 31, 2023			January 31, 2022
Other Lease Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(46,949	)	$	(3,649	)

Schedule Of Condensed Balance Sheet

Schedule Of Condensed Balance Sheet
Lease Position	January 31, 2023		October 31, 2022
Operating Leases
Operating lease right-of-use assets	$	1,152,020	$	1,198,969
Right of use liability operating lease current portion	$	170,603	$	166,051
Right of use liability operating lease long term		1,006,435		1,050,776
Total operating lease liabilities	$	1,177,038	$	1,216,827

Schedule of Lessee Operating Lease Liability Maturity


	Operating Leases
Maturity of Lease Liabilities on January 31, 2023
2023	$	164,139
2024		228,134
2025		238,800
2026		253,614
2027 and thereafter		450,934
Total future undiscounted lease payments	$	1,335,621
Less: Interest		(158,583	)
Present value of lease liabilities	$	1,177,038

XML 30 R18.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity (Tables)

3 Months Ended

Jan. 31, 2023

Equity [Abstract]

Share-based Payment Arrangement, Option, Activity

Schedule of stock options
							Weighted
	Aggregate		Aggregate		Exercise Price		Average
	Number		Exercise Price		Range		Exercise Price
Outstanding, October 31, 2022		3,202,265		8,921,419		1.03-28.68		2.79
Granted		3,250,000		3,207,425		0.99		0.99
Exercised		—		—		—		—
Cancelled, forfeited, or expired		—		—		—		—
Outstanding, January 31, 2023		6,452,265	$	12,128,844	$	0.99-28.69	$	1.88
Exercisable, January 31, 2023		2,151,217	$	6,085,555	$	0.99-28.69	$	2.83

During the three months ended January 31, 2023, and 2022, the Company recognized $1,435,787 and $309,700, respectively of stock option expense related to outstanding stock options. On January 31, 2023, the Company had $3,488,735 of unrecognized expenses related to options. The weighted average remaining contractual life is approximately 9.38 years for stock options outstanding on January 31, 2023. The aggregate intrinsic value of these outstanding options as of January 31, 2023, was $0. Compensation expense related to performance-based options is recognized on a straight-line basis over the requisite service period, provided that it is probable that performance conditions will be achieved, with probability assessed on a quarterly basis and any changes in expectations recognized as an adjustment to earnings in the period of the change. Compensation cost is not recognized for service- and performance-based awards that do not vest because service or performance conditions are not satisfied, and any previously recognized compensation cost is reversed. If vesting occurs prior to the end of the requisite service period, expense is accelerated and fully recognized through the vesting date.

On November 9, 2022, non-qualified stock options exercisable for up to 250,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vested on the issue date. The fair value of the options on the grant date was $246,747 using a Black-Scholes option pricing model with the following assumptions: stock price $0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of 275.68%, expected term of 10 years, and a risk-free interest rate of 4.12%.

On November 9, 2022, non-qualified stock options exercisable for up to 3,000,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vesting based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years. The fair value of the options on the grant date was $2,960,968 using a Black-Scholes option pricing model with the following assumptions: stock price $0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of 275.68%, expected term of 10 years, and a risk-free interest rate of 4.12%.

Warrants

Warrant information as of the periods indicated is as follows:

Weighted

Aggregate Aggregate Exercise Price Average

Number Exercise Price Range Exercise Price

Outstanding, October 31, 2022 2,318,317 4,404,802 1.90 1.90

Granted — — — —

Exercised — — — —

Cancelled, forfeited, or expired — — — —

Outstanding, January 31, 2023 2,318,317 $ 4,404,802 $ 1.90 $ 1.90

Exercisable, January 31, 2023 2,318,317 $ 4,404,802 $ 1.90 $ 1.90

Share-based Payment Arrangement, Option, Activity


							Weighted
	Aggregate		Aggregate		Exercise Price		Average
	Number		Exercise Price		Range		Exercise Price
Outstanding, October 31, 2022		2,318,317		4,404,802		1.90		1.90
Granted		—		—		—		—
Exercised		—		—		—		—
Cancelled, forfeited, or expired		—		—		—		—
Outstanding, January 31, 2023		2,318,317	$	4,404,802	$	1.90	$	1.90
Exercisable, January 31, 2023		2,318,317	$	4,404,802	$	1.90	$	1.90

XML 31 R19.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)	3 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Expected dividend yield	0.00%	0.00%
Expected option term (years)	10 years	10 years
Expected volatility	275.68%
Risk-free interest rate	4.12%
Minimum [Member]
Property, Plant and Equipment [Line Items]
Expected volatility		294.57%
Risk-free interest rate		1.19%
Maximum [Member]
Property, Plant and Equipment [Line Items]
Expected volatility		301.53%
Risk-free interest rate		1.63%

XML 32 R20.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Oct. 31, 2022
Product Information [Line Items]
Cash equivalents	$ 0		$ 0
Cash and cash equivalents	3,773,628		3,685,893
Cash, FDIC Insured Amount	250,000
Cash, Uninsured Amount	3,250,651		2,912,793
Allowance for doubtful accounts	0		0
Deposits from customers	12,098		44,973
Deferred income	129,701		235,274
Customer Refund Liability, Current	366,956		$ 0
Revenue Not from Contract with Customer, Other		$ 1,287,180
Revenue from sale	432,000
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)	1,435,787	309,700
Share Based Compensation [Member]
Product Information [Line Items]
Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)	1,435,787	309,700
Accounts Receivable [Member] \| G P M [Member]
Product Information [Line Items]
Outstanding balance	201,600
Accounts Receivable [Member] \| Favs [Member]
Product Information [Line Items]
Outstanding balance	126,158
Accounts Receivable [Member] \| Stewart [Member]
Product Information [Line Items]
Outstanding balance	59,404
G P M [Member]
Product Information [Line Items]
Revenue Not from Contract with Customer, Other	599,201
Lakshmi Distributor Inc [Member]
Product Information [Line Items]
Revenue Not from Contract with Customer, Other		352,554
Hackney [Member]
Product Information [Line Items]
Revenue Not from Contract with Customer, Other		332,595
Favs [Member]
Product Information [Line Items]
Revenue Not from Contract with Customer, Other		374,400
C Store Master [Member]
Product Information [Line Items]
Revenue Not from Contract with Customer, Other		$ 282,414
P M I License Agreement [Member]
Product Information [Line Items]
Liabilities	10,000,000
Royalty payment	$ 30,000,000

XML 33 R21.htm IDEA: XBRL DOCUMENT

Going Concern (Details Narrative)	Jan. 31, 2023 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital	$ 6,503,841

XML 34 R22.htm IDEA: XBRL DOCUMENT

Leases (Details) - USD ($)	3 Months Ended
Leases (Details) - USD ($)	Jan. 31, 2023	Jan. 31, 2022
Leases
Operating cash flows from operating leases	$ (46,949)	$ (3,649)

XML 35 R23.htm IDEA: XBRL DOCUMENT

Leases (Details 1) - USD ($)	Jan. 31, 2023	Oct. 31, 2022
Operating Leases
Operating lease right-of-use assets	$ 1,152,020	$ 1,198,969
Right of use liability operating lease current portion	170,603	166,051
Right of use liability operating lease long term	1,006,435	1,050,776
Total operating lease liabilities	$ 1,177,038	$ 1,216,827

XML 36 R24.htm IDEA: XBRL DOCUMENT

Leases (Details 2) - USD ($)	Jan. 31, 2023	Oct. 31, 2022
Leases
2023	$ 164,139
2024	228,134
2025	238,800
2026	253,614
2027 and thereafter	450,934
Total future undiscounted lease payments	1,335,621
Less: Interest	(158,583)
Present value of lease liabilities	$ 1,177,038	$ 1,216,827

XML 37 R25.htm IDEA: XBRL DOCUMENT

Leases (Details Narrative) - USD ($)			3 Months Ended
Leases (Details Narrative) - USD ($)	Nov. 11, 2021	Nov. 02, 2021	Jan. 31, 2023	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Leases, description	the Company entered into a month- to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022.	the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022.
Lessee, Operating Lease, Discount Rate			4.50%
Increase (Decrease) in Operating Lease Liability			$ (39,789)	$ (3,170)
Additional leases			0
Office And Storage Space [Member]
Lessee, Lease, Description [Line Items]
Increase (Decrease) in Operating Lease Liability			46,949	$ 3,649
Year One [Member]
Lessee, Lease, Description [Line Items]
Payments for Rent			17,776
Year Two [Member]
Lessee, Lease, Description [Line Items]
Payments for Rent			18,665
Year Three [Member]
Lessee, Lease, Description [Line Items]
Payments for Rent			19,554
Year Four [Member]
Lessee, Lease, Description [Line Items]
Payments for Rent			20,443
Year Five [Member]
Lessee, Lease, Description [Line Items]
Payments for Rent			22,220
Year Six [Member]
Lessee, Lease, Description [Line Items]
Payments for Rent			$ 23,998

XML 38 R26.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Details) - USD ($)	3 Months Ended
Stockholders' Equity (Details) - USD ($)	Jan. 31, 2023	Oct. 31, 2022
Number of shares outstanding, ending	6,452,265	3,202,265
Aggregate exercise price outstanding, ending	$ 12,128,844	$ 8,921,419
Weighted average exercise price outstanding, ending	$ 1.88	$ 2.79
Granted	3,250,000
Aggregate exercise price, granted	$ 3,207,425
Exercise price range, granted	$ 0.99
Weighted average exercise price, granted	$ 0.99
Exercised
Aggregate exercise price, exercised
Exercise price range, exercised
Weighted average exercise price, exercised
Cancelled forfeited or expired
Aggregate exercise price, cancelled forfeited or expired
Exercise price range, cancelled forfeited or expired
Weighted average exercise price, cancelled forfeited or expired
Maximum [Member]
Exercise price range outstanding, ending	0.99	1.03
Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price	28.69
Minimum [Member]
Exercise price range outstanding, ending	28.69	$ 28.68
Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price	$ 0.99

XML 39 R27.htm IDEA: XBRL DOCUMENT

Stockholder Equity (Details 1) - USD ($)	3 Months Ended
Stockholder Equity (Details 1) - USD ($)	Jan. 31, 2023	Oct. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares outstanding, ending	6,452,265	3,202,265
Aggregate exercise price outstanding, ending	$ 12,128,844	$ 8,921,419
Weighted average exercise price outstanding, ending	$ 1.88	$ 2.79
Granted	3,250,000
Aggregate exercise price, granted	$ 3,207,425
Exercise price range, granted	$ 0.99
Weighted average exercise price, granted	$ 0.99
Exercised
Aggregate exercise price, exercised
Exercise price range, exercised
Weighted average exercise price, exercised
Cancelled forfeited or expired
Aggregate exercise price, cancelled forfeited or expired
Exercise price range, cancelled forfeited or expired
Weighted average exercise price, cancelled forfeited or expired
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares outstanding, ending	2,318,317	2,318,317
Aggregate exercise price outstanding, ending	$ 4,404,802	$ 4,404,802
Exercise price range outstanding, ending	$ 1.90	$ 1.90
Weighted average exercise price outstanding, ending	$ 1.90	$ 1.90
Granted
Aggregate exercise price, granted
Exercise price range, granted
Weighted average exercise price, granted
Exercised
Aggregate exercise price, exercised
Exercise price range, exercised
Weighted average exercise price, exercised
Cancelled forfeited or expired
Aggregate exercise price, cancelled forfeited or expired
Exercise price range, cancelled forfeited or expired
Weighted average exercise price, cancelled forfeited or expired
Exercisable	2,318,317
Aggregate exercise price, exercisable	$ 4,404,802
Exercise price range, exercisable	$ 1.90
Weighted average exercise price, exercisable	$ 1.90

XML 40 R28.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
Stockholders’ Equity (Details Narrative) - USD ($)	Nov. 09, 2022	Jun. 24, 2022	Jan. 31, 2023	Jan. 31, 2022	Oct. 31, 2022	Apr. 22, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares, issued			0
Preferred stock, shares authorized			5,000,000		5,000,000
Reverse stock split description			as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock.
Number of shares converted			3,000,000
Recognized expense			$ 1,435,787	$ 309,700
Unrecognized expenses related to options			$ 3,488,735
Weighted average remaining contractual life			9 years 4 months 17 days
Aggregate intrinsic value			$ 0
Volatility rate			275.68%
Interest rate			4.12%
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Recognized expense
Bond Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Recognized expense			$ 1,435,787	$ 309,700
Two Consultants [Member] \| Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options exercisable	250,000
Fire value granted	$ 246,747
Share price	$ 0.9869
Volatility rate	275.68%
Expected term	10 years
Interest rate	4.12%
One Consultants [Member] \| Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock options exercisable						3,000,000
Fire value granted	$ 2,960,968
Share price	$ 0.9869
Volatility rate	275.68%
Expected term	10 years
Interest rate	4.12%
Total net revenues	$ 180,000,000
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized			3,000,000
Conversion price			$ 8.33
Preferred stock, shares issued			0
Series A Preferred Stock [Member] \| Kaival Holdings L L C [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares converted		3,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares converted		25,000,000
Stock Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Weighted average remaining life			3 years 7 months 28 days

XML 41 R29.htm IDEA: XBRL DOCUMENT

Related-Party Transactions (Details Narrative) - USD ($)		3 Months Ended
	Aug. 01, 2022	Jan. 31, 2023	Jan. 31, 2022
Related Party Transaction [Line Items]
Recognized revenue		$ 3,085	$ 23,765
Inventory quality control expenses		3,697,210
Accrued freight		347,760
Other Receivable [Member]
Related Party Transaction [Line Items]
Accounts payable	$ 2,924,655
Accounts receivable	2,134,413
Additional amount	1,543,545
Related-party receivable balance	$ 108,841	3,509,542	3,704,132
Nirajkumar Patel [Member]
Related Party Transaction [Line Items]
Recognized revenue		3,085	23,765
Bidi Vapor [Member]
Related Party Transaction [Line Items]
Accounts payable		2,350,787	9,129,759
Sale of Products		$ 3,761,491	$ 11,841,750

XML 42 R30.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative) - USD ($)		3 Months Ended
	Feb. 01, 2023	Jan. 31, 2023	Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Service Agreement description	(i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years
Sale of Products		$ 28,318	$ 33,871

XML 43 R31.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - USD ($)			3 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Mar. 03, 2023	Feb. 01, 2023	Jan. 31, 2023	Feb. 06, 2023
Subsequent Event [Line Items]
Option granted			3,250,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Stock options		75,000
Retainer amount		$ 16,750
Stock based compensation		$ 75,000
Subsequent Event [Member] \| Incentive Compensation Plan [Member]
Subsequent Event [Line Items]
Option granted	50,000
Subsequent Event [Member] \| Three Board [Member]
Subsequent Event [Line Items]
Stock options				375,000
Stock Vest				375,000
Subsequent Event [Member] \| Two Board [Member]
Subsequent Event [Line Items]
Stock options				1,000,000
Stock Vest				500,000
Subsequent Event [Member] \| Five Employees [Member]
Subsequent Event [Line Items]
Stock options				150,000
Stock Vest				150,000
Subsequent Event [Member] \| One Consultants [Member]
Subsequent Event [Line Items]
Stock options				200,000
Stock Vest				200,000

XML 44 e4478_10q_htm.xml IDEA: XBRL DOCUMENT 0001762239 2022-11-01 2023-01-31 0001762239 2023-03-17 0001762239 2023-01-31 0001762239 2022-10-31 0001762239 us-gaap:SeriesAPreferredStockMember 2023-01-31 0001762239 us-gaap:SeriesAPreferredStockMember 2022-10-31 0001762239 2021-11-01 2022-01-31 0001762239 us-gaap:PreferredStockMember 2022-10-31 0001762239 us-gaap:CommonStockMember 2022-10-31 0001762239 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001762239 us-gaap:RetainedEarningsMember 2022-10-31 0001762239 us-gaap:PreferredStockMember 2021-10-31 0001762239 us-gaap:CommonStockMember 2021-10-31 0001762239 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001762239 us-gaap:RetainedEarningsMember 2021-10-31 0001762239 2021-10-31 0001762239 us-gaap:PreferredStockMember 2022-11-01 2023-01-31 0001762239 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001762239 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001762239 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001762239 us-gaap:PreferredStockMember 2021-11-01 2022-01-31 0001762239 us-gaap:CommonStockMember 2021-11-01 2022-01-31 0001762239 us-gaap:AdditionalPaidInCapitalMember 2021-11-01 2022-01-31 0001762239 us-gaap:RetainedEarningsMember 2021-11-01 2022-01-31 0001762239 us-gaap:PreferredStockMember 2023-01-31 0001762239 us-gaap:CommonStockMember 2023-01-31 0001762239 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001762239 us-gaap:RetainedEarningsMember 2023-01-31 0001762239 us-gaap:PreferredStockMember 2022-01-31 0001762239 us-gaap:CommonStockMember 2022-01-31 0001762239 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0001762239 us-gaap:RetainedEarningsMember 2022-01-31 0001762239 2022-01-31 0001762239 kavl:PMILicenseAgreementMember 2023-01-31 0001762239 kavl:PMILicenseAgreementMember 2022-11-01 2023-01-31 0001762239 kavl:GPMMember 2022-11-01 2023-01-31 0001762239 kavl:LakshmiDistributorIncMember 2021-11-01 2022-01-31 0001762239 kavl:HackneyMember 2021-11-01 2022-01-31 0001762239 us-gaap:AccountsReceivableMember kavl:GPMMember 2022-11-01 2023-01-31 0001762239 us-gaap:AccountsReceivableMember kavl:FavsMember 2022-11-01 2023-01-31 0001762239 us-gaap:AccountsReceivableMember kavl:StewartMember 2022-11-01 2023-01-31 0001762239 kavl:FavsMember 2021-11-01 2022-01-31 0001762239 kavl:CStoreMasterMember 2021-11-01 2022-01-31 0001762239 kavl:ShareBasedCompensationMember 2022-11-01 2023-01-31 0001762239 kavl:ShareBasedCompensationMember 2021-11-01 2022-01-31 0001762239 srt:MinimumMember 2021-11-01 2022-01-31 0001762239 srt:MaximumMember 2021-11-01 2022-01-31 0001762239 2021-10-28 2021-11-02 0001762239 2021-10-28 2021-11-11 0001762239 kavl:YearOneMember 2022-11-01 2023-01-31 0001762239 kavl:YearTwoMember 2022-11-01 2023-01-31 0001762239 kavl:YearThreeMember 2022-11-01 2023-01-31 0001762239 kavl:YearFourMember 2022-11-01 2023-01-31 0001762239 kavl:YearFiveMember 2022-11-01 2023-01-31 0001762239 kavl:YearSixMember 2022-11-01 2023-01-31 0001762239 kavl:OfficeAndStorageSpaceMember 2022-11-01 2023-01-31 0001762239 kavl:OfficeAndStorageSpaceMember 2021-11-01 2022-01-31 0001762239 us-gaap:SeriesAPreferredStockMember 2023-01-31 0001762239 us-gaap:SeriesAPreferredStockMember kavl:KaivalHoldingsLLCMember 2022-06-01 2022-06-24 0001762239 us-gaap:CommonStockMember 2022-06-01 2022-06-24 0001762239 us-gaap:BondOptionMember 2022-11-01 2023-01-31 0001762239 us-gaap:BondOptionMember 2021-11-01 2022-01-31 0001762239 kavl:TwoConsultantsMember us-gaap:CommonStockMember 2022-11-09 0001762239 kavl:TwoConsultantsMember us-gaap:CommonStockMember 2022-11-01 2022-11-09 0001762239 kavl:OneConsultantsMember us-gaap:CommonStockMember 2022-04-22 0001762239 kavl:OneConsultantsMember us-gaap:CommonStockMember 2022-11-01 2022-11-09 0001762239 kavl:OneConsultantsMember us-gaap:CommonStockMember 2022-11-09 0001762239 kavl:StockWarrantsMember 2022-11-01 2023-01-31 0001762239 srt:MaximumMember 2022-10-31 0001762239 srt:MinimumMember 2022-10-31 0001762239 srt:MaximumMember 2023-01-31 0001762239 srt:MinimumMember 2023-01-31 0001762239 us-gaap:WarrantMember 2022-10-31 0001762239 us-gaap:WarrantMember 2022-11-01 2023-01-31 0001762239 us-gaap:WarrantMember 2023-01-31 0001762239 kavl:OtherReceivableMember 2022-07-25 2022-08-01 0001762239 kavl:OtherReceivableMember 2022-08-01 0001762239 kavl:OtherReceivableMember 2023-01-31 0001762239 kavl:OtherReceivableMember 2022-01-31 0001762239 kavl:NirajkumarPatelMember 2022-11-01 2023-01-31 0001762239 kavl:NirajkumarPatelMember 2021-11-01 2022-01-31 0001762239 kavl:BidiVaporMember 2023-01-31 0001762239 kavl:BidiVaporMember 2022-11-01 2023-01-31 0001762239 kavl:BidiVaporMember 2022-01-31 0001762239 kavl:BidiVaporMember 2021-11-01 2022-01-31 0001762239 2023-01-25 2023-02-01 0001762239 us-gaap:SubsequentEventMember 2023-01-25 2023-02-01 0001762239 kavl:ThreeBoardMember us-gaap:SubsequentEventMember 2023-02-06 0001762239 kavl:TwoBoardMember us-gaap:SubsequentEventMember 2023-02-06 0001762239 kavl:FiveBoardMember us-gaap:SubsequentEventMember 2023-02-06 0001762239 kavl:OneConsultantsMember us-gaap:SubsequentEventMember 2023-02-06 0001762239 kavl:IncentiveCompensationPlanMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-03 iso4217:USD shares iso4217:USD shares pure 0001762239 false --10-31 2023 Q1 Yes Yes

10-Q true 2023-01-31 false 000-56016 KAIVAL BRANDS INNOVATIONS GROUP, INC. DE 83-3492907 4460 Old Dixie Highway Grant-Valkaria FL 32949 (833) 452-4825 Common Stock, par value $0.001 per share KAVL NASDAQ Non-accelerated Filer true true false false 56169090

3773628

3685893

518291

574606

2026245

1539486

3761491

1239725

316621

426407

1607302

10396276

9073419

3364

1483297

2164646

1152020

1198969

13034957

12437034

81265

40023

2350787

675453

1099157

12098

44973

366956

129702

235274

170603

166051

3786864

1585478

1006435

1050776

4793299

2636254

5000000

0.001

3000000

0.001

1000000000

56169090

56169

30811574

29375787

-22626085

-19631176

8241658

9800780

13034957

12437034

2435835 2841990

3085

23765

105572 18574 23872

2525918

2841883

1985800 3484620

48172

1985800

3532792

540118

-690909

588910

592501

2958069

1498554

3546979

2091055

11952

-2994909

-2781964

-2994909

-2781964

-0.05 -0.09 56169090 30234477

56169090

56169

29375787

-19631176

9800780

1435787

-2994909

56169090

56169

30811574

-22626085

8241658

3000000

3000

30195312

30195

21551959

-5260841

16324313

61250

110189

110250

-19866 -20 -35739 -35759

309700

-2781964

3000000

3000

30236696

30236

21936109

-8042805

13926540

-2994909

-2781964

110250

116

1435787 309700 46949 3649

-56315

-688982

-194590

-109786

-29543

2521766

-3484620

-1607302

41242

-62812

2350787

-3538010

-423704

-205192

-105572

-32875 -366956 169110

-39789

-3170

91215

-2133514

3480

-3480

35759

-35759

87735

-2169273

3685893

7825235

3773628

5655962

106385

Note 1 – Organization and Description of Business Kaival Brands Innovations Group, Inc. (the “Company,” the “Registrant,” “we,” “us,” or “our”), formerly known as Quick Start Holdings, Inc., was incorporated on September 4, 2018, in the State of Delaware. Description of Business In March 2020, the Company commenced business operations as a result of becoming the exclusive distributor of certain electronic nicotine delivery system (“ENDS”) and related components (the “Products”) manufactured by Bidi Vapor, LLC (“Bidi”), a related party company that is owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company. On March 9, 2020, the Company entered into an exclusive distribution agreement (the “Distribution Agreement”) with Bidi, which was amended and restated on May 21, 2020, and again on April 20, 2021 (collectively, the “A&R Distribution Agreement”). Pursuant to the A&R Distribution Agreement, Bidi granted the Company an exclusive worldwide right to distribute the Products for sale and resale to both retail level customers and non-retail level customers. Currently, the Products consist entirely of the “BIDI® Stick.” The Company ceased all direct-to-consumer sales in February 2021. On June 10, 2022, and again on November 17, 2022 the Company and Bidi entered into a third amended and restated exclusive distribution agreement (the “Third A&R Distribution Agreement”) which memorializes the Company’s current business relationship with Bidi. On August 31, 2020, the Company formed Kaival Labs, Inc., a Delaware corporation (herein referred to as “Kaival Labs”), as a wholly owned subsidiary of the Company, for the purpose of developing Company-branded and white-label products and services. The Company has not yet launched any Kaival-branded product, nor has it begun to provide white label wholesale solutions for other product manufacturers. The Company may also utilize Kaival Labs to acquire or license complimentary businesses or assets. On March 11, 2022, the Company formed Kaival Brands International, LLC, a Delaware limited liability company (herein referred to as “KBI”), as a wholly owned subsidiary of the Company, for the purpose of entering into an international licensing agreement with Philip Morris Products S.A. (“PMPSA”), a wholly owned affiliate of Philip Morris International Inc. (“PMI”). Current Product Offerings Pursuant to the A&R Distribution Agreement, The Company sells and resells electronic nicotine delivery systems, which it may refer to herein as “ENDS Products”, or “e-cigarettes”, to non-retail level customers. The sole Product the Company resells is the “BIDI® Stick,” a disposable, tamper-resistant ENDS product that comes in a variety of flavor options for adult cigarette smokers. The Company does not manufacture any of the Products it resells. The BIDI® Stick is manufactured by Bidi. Pursuant to the terms of the A&R Distribution Agreement, Bidi provides the Company with all branding, logos, and marketing materials to be utilized by the Company in connection with its marketing and promotion of the Products. COVID-19 Impact In January 2020, the World Health Organization (the “WHO”) announced a global health emergency because of a new strain of coronavirus (“COVID-19”) originating in Wuhan, China and the risks to the international community as the virus spread globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in global exposure. During the Company’s fiscal year 2021 and early part of fiscal 2022, the Company was indirectly impacted by supply chain issues and regulatory oversight arising out of COVID-19. The Company believes that many retailers and distributers relaxed their ENDS compliance standards as an indirect result of COVID-19 for two reasons: (i) government enforcement of regulations was very limited due to imposed social restrictions, resulting in less in-person monitor enforcement by government officials and (ii) retail stores experienced light foot traffic from customers due to COVID-19 restrictions and fears, which resulted in relaxed compliance in an effort to generate additional revenue. While the impact of COVID-19 decreased during the Company’s fiscal 2022 year and the first quarter of its fiscal 2023 year, outbreaks of COVID-19 or its variants, either locally, nationally or globally, as well as related supply chain issues, could adversely impact the Company’s business. Impact of the FDA PMTA Decision and Subsequent Court Actions As of January 31, 2022, the FDA announced that it has taken action on over 99% of applications and issued Marketing Denial Orders (“MDOs”) for more than 1,167,000 non-tobacco flavored ENDS products, while issuing zero marketing authorizations for such products. Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored ENDS products. With respect to Bidi, the MDO covered all non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick. As a result, beginning in September 2021, Bidi pursued multiple avenues to challenge the MDO. First, on September 21, 2021, separate from the judicial appeal of the MDO in its entirety, Bidi filed a 21 C.F.R. § 10.75 internal FDA supervisory review request specifically of the decision to include the Arctic (menthol) BIDI® Stick in the MDO. In May 2022, the FDA issued a determination that it views the Arctic BIDI® Stick as a non-tobacco flavored ENDS product, and not strictly a menthol flavored product. On September 29, 2021, Bidi petitioned the U.S. Court of Appeals for the Eleventh Circuit (the “11th Circuit”) to review the FDA’s denial of the comprehensive PMTAs for its non-tobacco flavored BIDI® Stick ENDS, arguing that it was arbitrary and capricious under the Administrative Procedure Act (“APA”), as well as ultra vires, for the FDA not to conduct any scientific review of Bidi’s comprehensive applications, as required by the Tobacco Control Act (“TCA”), to determine whether the BIDI® Sticks are “appropriate for the protection of the public health”. Bidi further argued that the FDA violated due process and the APA by failing to provide fair notice of the FDA’s new requirement for ENDS companies to conduct long-term comparative smoking cessation studies for their flavored products, and that the FDA should have gone through the notice and comment rulemaking process for this requirement. On October 14, 2021, Bidi requested that the FDA re-review the MDO and reconsider its position that Bidi did not include certain scientific data in its applications sufficient to allow the PMTAs to proceed to scientific review. In light of this request, on October 22, 2021, pursuant to 21 C.F.R. § 10.35(a), the FDA issued an administrative stay of Bidi’s MDO pending its re-review, permitting the Company to continue sales. Subsequently, the FDA decided not to rescind the MDO and lifted its administrative stay on December 17, 2021. Following the lifting of the FDA’s administrative stay, Bidi filed a renewed motion to stay the MDO with the 11th Circuit. On February 1, 2022, the appellate court granted Bidi’s motion to stay (i.e., put on hold) the MDO, again allowing the Company to continue sales pending the litigation on the merits. Oral arguments in the merits-based proceeding were held on May 17, 2022. On August 23, 2022, the U.S. Court of Appeals for the Eleventh Circuit set aside the MDO issued to the non-tobacco flavored BIDI® Sticks and remanded Bidi’s back to the FDA for further review. Specifically, the Court held that the MDO was “arbitrary and capricious” in violation of the Administrative Procedure Act (“APA”) because FDA failed to consider the relevant evidence before it, specifically Bidi’s aggressive and comprehensive marketing and sales-access-restrictions plans designed to prevent youth appeal and access. The 11th Circuit’s opinion further found indicated that the FDA did not properly review the data and evidence that it has long made clear are critical to the appropriate for the protection of the public health (“APPH”) standard for PMTAs set forth in the Tobacco Control Act including, in Bidi’s case, “product information, scientific safety testing, literature reviews, consumer insight surveys, and details about the company’s youth access prevention measures, distribution channels, and adult-focused marketing practices,” which “target only existing adult vapor product users, including current adult smokers,” as well as our retailer monitoring program and state-of-the-art anti-counterfeit authentication system. Because a MDO must be based on a consideration of the relevant factors, such as the marketing and sales-access-restrictions plans, the denial order was deemed arbitrary and capricious, and vacated by the FDA. The FDA did not appeal to the 11th Circuit’s decision. The FDA had until October 7, 2022 (45 days from the August 23, 2022 decision) to either request a panel rehearing or a rehearing “en banc” (a review by the entire 11th Circuit, not just the 3-judge panel that issued the decision), and until November 21, 2022 (90 days after the decision) to seek review of the decision by the U.S. Supreme Court. No request for a rehearing was filed, and no petition for a writ of certiorari was made to the Supreme Court. In the meantime, the Company anticipates continued ability to market and sell the non-tobacco flavored BIDI® Sticks, subject to the FDA’s enforcement discretion, for the duration of the PMTA scientific review. Separately, on or about May 13, 2022, FDA placed the tobacco-flavored Classic BIDI® Stick into the final Phase III scientific review, and in September 2022 completed a remote regulatory assessment of Bidi and its contract manufacturer in China, SMISS Technology Co. LTD, in relation to the pending PMTA for the Classic BIDI® Stick. Risks and Uncertainties FDA has indicated that it is prioritizing enforcement of unauthorized ENDS against companies (1) that never submitted PMTAs, (2) whose PMTAs have been refused acceptance or filing by the FDA, (3) whose PMTAs remain subject to MDOs, and (4) that are continuing to market unauthorized synthetic nicotine products after the July 13, 2022, cutoff. Subject to FDA’s enforcement discretion, until the scientific review process is complete on each of Bidi’s PMTAs, the Company views the risk of FDA enforcement against Bidi as low. The Company anticipates FDA will move forward with a review of Bidi’s PMTA on remand, as directed by the Court; however, the Company cannot provide any assurances as to the timing or outcome. Accordingly, the Company anticipates FDA will move forward with a review of Bidi’s PMTA on remand, as directed by the Court. Moreover, the Company believes that Bidi’s application is particularly comprehensive, and now includes, among other things, a randomized, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® Stick, several behavioral, perception and intention studies, as well as a nationally-representative population prevalence study. A complete scientific review of the PMTA would require FDA to review all this information before making an APPH determination, and while FDA could narrowly interpret the Court’s ruling as an order to review only Bidi’s marketing and sales-access restrictions plans, the 11th Circuit’s opinion, in the Company’s view, makes clear that all “relevant evidence” in an application must be considered. For applications that are in scientific review, FDA typically issues a deficiency letter identifying its questions before making a marketing authorization decision and gives the applicant at least 90 days to respond. This further solidifies the Company’s belief that the scientific review of Bidi’s non-tobacco flavored applications could take 1-2 years or longer. However, the Company cannot provide any assurances as to the timing or outcome.

Note 2 – Basis of Presentation and Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiaries, Kaival Labs and KBI. Intercompany transactions are eliminated. Basis of Presentation The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s most recent audited financial statements contained within the Company’s Annual Report on Form 10-K, filed with the SEC on January 30, 2023 (the “2022 Annual Report”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full fiscal year. Notes to the consolidated financial statements, which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period as reported in the 2022 Annual Report, have been omitted. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents and restricted cash as of January 31, 2023 and October 31, 2022. Cash as of January 31, 2023 and October 31, 2022 was $3,773,628 and $3,685,893, respectively. The Federal Deposit Insurance Corporation (“FDIC”) insures deposits according to the ownership category in which the funds are insured and how the accounts are titled. The standard deposit insurance coverage limit is $250,000 per depositor, per FDIC-insured bank, per ownership category. The Company had uninsured cash and cash equivalents of $3,250,651 and $2,912,793 at January 31, 2023, and October 31, 2022, respectively. Advertising and Promotion All advertising, promotion and marketing expenses, including commissions, are expensed when incurred. Accounts Receivable and Allowance for Doubtful Accounts Receivables are stated at cost, net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of accounts receivable. A considerable amount of judgment is required in assessing the amount of the allowance and the Company considers the historical level of credit losses and collection history and applies percentages to aged receivable categories. The Company makes judgments about the creditworthiness of debtors based on ongoing credit evaluations and monitors current economic trends that might impact the level of credit losses in the future. If the financial condition of the debtors were to deteriorate, resulting in their inability to make payments, a larger allowance may be required. As of January 31, 2023 and October 31, 2022, based upon management’s assessment of the accounts receivable aging and the customers’ payment history, the Company has determined that no allowance for doubtful accounts is required. Inventories All product inventory is purchased from a related party, Bidi. Inventories are stated at the lower of cost and net realizable value. Cost includes all costs of purchase and other costs incurred in bringing the inventories to their present location and condition. The Company determines cost based on the first-in, first-out (“FIFO”) method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. As of January 31, 2023 and October 31, 2022, the inventories only consisted of finished goods and were located in three locations: the Company’s main warehouse located in Florida and two customer warehouses whose service agreements are on a consignment basis with the Company. Based upon fiscal year 2022 inventory management procedures, as well as those inventory management procedures performed during the first fiscal quarter ended January 31, 2023 and their results for both periods of time, the Company has determined that no allowance for inventory was required as of January 31, 2023 and October 31, 2022. Revenue Recognition The Company adopted ASC 606, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), in the second quarter of fiscal year 2020, as this was the first quarter that the Company generated revenues. Under ASC 606, the Company recognizes revenue when a customer obtains control of promised goods, in an amount that reflects the consideration that the Company expects to receive in exchange for the goods. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (1) identify the contracts with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to the customer. Under ASC 606, disaggregated revenue from contracts with customers depicts the nature, amount, timing, and uncertainty of revenue and cash flows affected by economic factors. Deferred Revenue The Company accepts partial payments for orders from wholesale customers, which it holds as deposits or deferred revenue, until the Company has received full payment and orders are shipped to the customer. Revenue for these orders is recognized at the time of shipment to the customer. As of January 31, 2023, and October 31, 2022, the Company has $12,098 and $44,973 in deposits from customers, respectively, which is included with the Company’s current liabilities. As of January 31, 2023, and October 31, 2022, the Company has $129,701 and $235,274 in deferred income from PMI guaranteed royalty revenue prepayments, respectively, which is included with the Company’s current liabilities. Customer Refunds The Company infrequently has a need to adjust the size of an order after it has been shipped, received and paid for, due to the customer oversizing the order for more product that it can realistically sell at that time. If and when this occurs, the Company will ask the customer to return the over allotted product. Once received and inspected, the Company will issue a refund for the product return. As of January 31, 2023, and October 31, 2022, the Company had customer refunds due in the amounts equal to $366,956 and $0, respectively. Products Revenue The Company generates products revenue from the sale of the Products (as defined above) to non-retail customers. The Company recognizes revenue at a point in time based on management’s evaluation of when performance obligations under the terms of a contract with the customer are satisfied and control of the Products has been transferred to the customer. In most situations, transfer of control is considered complete when the products have been shipped to the customer. The Company determined that a customer obtains control of the Product upon shipment when title of such product and risk of loss transfer to the customer. However, when the Company enters a consignment agreement with a new customer, once it ships and delivers the requested amount of ordered Products to its distribution center for its retail sales locations, the Company retains ownership of the delivered Products until they are delivered to the actual retail stores (as opposed to the Company’s consignment customer). The Company’s shipping and handling costs are fulfillment costs, and such amounts are classified as part of cost of sales. The Company offers credit sales arrangements to non-retail (or wholesale) customers and monitors the collectability of each credit sale routinely. Revenue is measured by the transaction price, which is defined as the amount of consideration expected to be received in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes refunds and returns as well as incentive offers and promotional discounts on current orders. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce revenue in the period of the sale. Variable consideration related to incentive offers and promotional programs are recorded as a reduction to revenue based on amounts the Company expects to collect. Estimates are regularly updated, and the impact of any adjustments are recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established at the time an order is placed and incentives have very short-term durations. Amounts billed and due from customers are short term in nature and are classified as receivable since payments are unconditional and only the passage of time related to credit terms is required before payments are due. The Company does not grant payment financing terms greater than one year. Payments received in advance of revenue recognition are recorded as deferred revenue, as noted above. Royalty Revenue On June 13, 2022, KBI entered into the PMI License Agreement with PMPSA, effective as of May 13, 2022 (the “PMI Commencement Date”). Pursuant to the PMI License Agreement, KBI granted PMPSA an exclusive irrevocable license to use its technology, documentation, and intellectual property to make, distribute, and sell disposable nicotine e-cigarettes Products based on the intellectual property in certain international markets set forth in the PMI License Agreement (the “PMI Markets”). The Company has the exclusive international distribution rights to the Products and, in order to allow KBI to fulfill its obligations set forth in the PMI License Agreement, has contributed the international distribution rights for the PMI Markets to KBI as set forth in a Capital Contribution Agreement, dated June 10, 2022. The sublicense granted to PMPSA is exclusive in the PMI Markets and neither KBI nor any of its affiliates can sell, promote, use, or distribute any competing products in the PMI Markets for the duration of the term of the PMI License Agreement and any Sell-Out Period (as defined in the PMI License Agreement). PMSPA will be responsible for any regulatory filings necessary to sell the Products in the PMI Markets. Both KBI and PMPSA agree to work together in the registration and maintenance of the Intellectual Property, but KBI will bear all cost and expense to implement the registration strategy. Finally, PMPSA has agreed to potential future development services with KBI in the PMI Markets and has been granted certain rights with respect to potential future products. The initial term of the PMI License Agreement is five (5) years and automatically renews for an additional five-year period unless PMPSA has failed to meet the agreed upon minimum key performance indicators set forth in the PMI License Agreement, in which case the PMI License Agreement will automatically terminate at the end of the initial license term. In consideration for the grant of the licensed rights, PMPSA agreed to pay to KBI a royalty equal to a percentage of the base price of the first sale of each unit of Product manufactured. In addition, before the launch of the first product in a market and each anniversary of such launch, PMPSA agrees to pre-pay to KBI a guaranteed minimum royalty based on the estimated royalties payable by PMPSA to KBI in relation to all markets in the twelve (12)-month period following the first launch or each successive anniversary of the first launch, subject to an aggregate maximum guaranteed royalty payment for all markets for each applicable twelve (12)-month period. PMPSA may require modification of certain products to be sold under the PMI Licensing Agreement to be modified for a PMI Market. Pursuant to the PMI Licensing Agreement, PMPSA has absolute discretion over sales, marketing, product branding and packaging pertaining to sales in the PMI Markets, as well as the right to select the specific PMI Markets in which to launch commercialization and determine what product types are to be promoted in each market, subject to sales and marketing plans and annual business plans set by PMPSA and certain expansion criteria agreed between PMPSA and KBI. Royalty revenue earned from the PMI License Agreement is recognized in the period the sales of the Product manufactured occurs. The PMI License Agreement contains customary representations, warranties, covenants, and indemnification provisions; however, KBI’s liability under the PMI License Agreement is capped at the greater of: (i) Ten Million Dollars ($10,000,000); or (ii) an amount equal to the total of the royalties due to KBI (but not yet paid) plus the royalties (including the guaranteed royalty payment) paid to KBI pursuant to the PMI License Agreement during the immediately preceding twelve (12) consecutive months, provided that such amount shall not exceed Thirty Million Dollars ($30,000,000). These royalties may be initially offset on a limited basis by jointly agreed upon costs such as development costs incurred for entry to specific international markets. The KBI License agreement provides that KBI shall pay Bidi license fees equivalent to 50% of the adjusted earned royalty payments, after any offsets due to jointly agreed costs such development costs incurred for entry to specific international markets. Consequently, the Company has determined that no license fees are owed to Bidi as of January 31, 2023. Concentration of Revenues and Accounts Receivable For the three months ended January 31, 2023, (i) 25% or $599,201 of the revenue from the sale of Products, solely consisting of the BIDI® Stick, was generated from GPM Investments, LLC, (“GPM”), (ii) 18% or $432,000 of the revenue from the sale of the Products was generated from FAVS Business, (“FAVS”), and (iii) approximately 15% or $372,518 of the revenue from the sale of Products, solely consisting of the BIDI Stick, was generated from H.T. Hackney Co. For the three months ended January 31, 2022, 45%, or $1,287,180, of the revenue from the sale of Products was generated from FAVS, 12%, or $<span id="xdx_908_eus-gaap--RevenueNotFromContractWithCustomerOther_pp0p0_c20211101__20220131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LakshmiDistributorIncMember_zYkekVsSaozk" title="Revenue Not from Contract with Customer, Other">352,554, of the revenue from the sale of Products was generated from Lakshmi Distributor Inc., doing business as C Store Master (“C Store Master”), and 12%, or $<span id="xdx_905_eus-gaap--RevenueNotFromContractWithCustomerOther_pp0p0_c20211101__20220131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HackneyMember_zYHlH1fEr3g8" title="Revenue Not from Contract with Customer, Other">332,595, of the revenue from the sale of Products was generated from H.T. Hackney Company. FAVS, with an outstanding balance of $<span id="xdx_908_ecustom--OutstandingBalance_pp0p0_c20221101__20230131__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--RelatedPartyTransactionAxis__custom--GPMMember_zOcxJZOrn7Sh">201,600, GPM, with an outstanding balance of $<span id="xdx_905_ecustom--OutstandingBalance_pp0p0_c20221101__20230131__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--RelatedPartyTransactionAxis__custom--FavsMember_zUBzhMdYnub2">126,158, and Stewart Distribution with an outstanding balance of $<span id="xdx_90C_ecustom--OutstandingBalance_pp0p0_c20221101__20230131__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--RelatedPartyTransactionAxis__custom--StewartMember_zTza2U8LZ6o3">59,404, accounted for 39%, 24%, and 11% of the total accounts receivable from customers, respectively, as of January 31, 2023. FAVS and C Store Master had outstanding balances of $374,400 and $282,414, respectively, which accounted for 29% and 22%, respectively, of the total accounts receivable from customers as of January 31, 2022. Share-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments (share-based payments, referred to herein as “SBP”) based on the grant-date fair value of the award. That cost is recognized over the period during which a recipient is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to performance conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model. The fair value of each option granted during the fiscal three-month period ended January 31, 2023, and January 31, 2022, was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table: <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWSnlnnaYINj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">As of January</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">As of January</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; text-indent: -10pt; padding-left: 10pt">Expected dividend yield</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected option term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20230131_z7H2cpLf0zOd" title="Expected option term (years)">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20211101__20220131_z98WferszjH5" title="Expected option term (years)">10</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">275.68</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20211101__20220131__srt--RangeAxis__srt--MinimumMember_zFCiRsnaGTga" title="Expected volatility">294.57%- <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zm178IIV3923" title="Expected volatility">301.53</td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20211101__20220131__srt--RangeAxis__srt--MinimumMember_zRGB9Y9pab5l" title="Risk-free interest rate">1.19-<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zTfwbaltecS5" title="Risk-free interest rate">1.63%</td><td style="text-align: left"> </td> </tr> </table> The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company’s common stock. The assumed discount rate was the default risk-free ten-year interest rate for U.S. Treasury bills. The Company’s stock option expense for the fiscal three months ended January 31, 2023, and ended January 31, 2022 were $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_pp0p0_c20221101__20230131__us-gaap--RelatedPartyTransactionAxis__custom--ShareBasedCompensationMember_zsxC39ntaWz9">1,435,787 and $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_pp0p0_c20211101__20220131__us-gaap--RelatedPartyTransactionAxis__custom--ShareBasedCompensationMember_ziTwzzlAKn9j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">309,700, respectively. Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: <table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-right: 0.8pt; text-align: justify; line-height: 107%">●</td> <td style="width: 97%; padding-right: 0.8pt; text-align: justify; line-height: 107%">Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-right: 0.8pt; text-align: justify; line-height: 107%">●</td> <td style="width: 97%; padding-right: 0.8pt; text-align: justify; line-height: 107%">Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-right: 0.8pt; text-align: justify; line-height: 107%">●</td> <td style="width: 97%; padding-right: 0.8pt; text-align: justify; line-height: 107%">Level 3 - Inputs that are both significant to the fair value measurement and unobservable.</td></tr> </table> Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of January 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, accounts receivable, inventory, accounts payable and accrued expenses . As of January 31, 2023 and October 31, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on a recurring basis. Recent Accounting Pronouncements The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Principles of Consolidation The consolidated financial statements include the financial statements of the Company’s wholly-owned subsidiaries, Kaival Labs and KBI. Intercompany transactions are eliminated.

Basis of Presentation The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s most recent audited financial statements contained within the Company’s Annual Report on Form 10-K, filed with the SEC on January 30, 2023 (the “2022 Annual Report”). In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full fiscal year. Notes to the consolidated financial statements, which would substantially duplicate the disclosures contained in the audited financial statements for the most recent fiscal period as reported in the 2022 Annual Report, have been omitted.

Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.

Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents and restricted cash as of January 31, 2023 and October 31, 2022. Cash as of January 31, 2023 and October 31, 2022 was $3,773,628 and $3,685,893, respectively. The Federal Deposit Insurance Corporation (“FDIC”) insures deposits according to the ownership category in which the funds are insured and how the accounts are titled. The standard deposit insurance coverage limit is $250,000 per depositor, per FDIC-insured bank, per ownership category. The Company had uninsured cash and cash equivalents of $3,250,651 and $2,912,793 at January 31, 2023, and October 31, 2022, respectively.

3773628

3685893

250000

3250651

2912793

Advertising and Promotion All advertising, promotion and marketing expenses, including commissions, are expensed when incurred.

Accounts Receivable and Allowance for Doubtful Accounts Receivables are stated at cost, net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on management’s assessment of the collectability of accounts receivable. A considerable amount of judgment is required in assessing the amount of the allowance and the Company considers the historical level of credit losses and collection history and applies percentages to aged receivable categories. The Company makes judgments about the creditworthiness of debtors based on ongoing credit evaluations and monitors current economic trends that might impact the level of credit losses in the future. If the financial condition of the debtors were to deteriorate, resulting in their inability to make payments, a larger allowance may be required. As of January 31, 2023 and October 31, 2022, based upon management’s assessment of the accounts receivable aging and the customers’ payment history, the Company has determined that no allowance for doubtful accounts is required.

Inventories All product inventory is purchased from a related party, Bidi. Inventories are stated at the lower of cost and net realizable value. Cost includes all costs of purchase and other costs incurred in bringing the inventories to their present location and condition. The Company determines cost based on the first-in, first-out (“FIFO”) method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. As of January 31, 2023 and October 31, 2022, the inventories only consisted of finished goods and were located in three locations: the Company’s main warehouse located in Florida and two customer warehouses whose service agreements are on a consignment basis with the Company. Based upon fiscal year 2022 inventory management procedures, as well as those inventory management procedures performed during the first fiscal quarter ended January 31, 2023 and their results for both periods of time, the Company has determined that no allowance for inventory was required as of January 31, 2023 and October 31, 2022.

Revenue Recognition The Company adopted ASC 606, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), in the second quarter of fiscal year 2020, as this was the first quarter that the Company generated revenues. Under ASC 606, the Company recognizes revenue when a customer obtains control of promised goods, in an amount that reflects the consideration that the Company expects to receive in exchange for the goods. To determine revenue recognition for arrangements within the scope of ASC 606, the Company performs the following five steps: (1) identify the contracts with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to the customer. Under ASC 606, disaggregated revenue from contracts with customers depicts the nature, amount, timing, and uncertainty of revenue and cash flows affected by economic factors.

Deferred Revenue The Company accepts partial payments for orders from wholesale customers, which it holds as deposits or deferred revenue, until the Company has received full payment and orders are shipped to the customer. Revenue for these orders is recognized at the time of shipment to the customer. As of January 31, 2023, and October 31, 2022, the Company has $12,098 and $44,973 in deposits from customers, respectively, which is included with the Company’s current liabilities. As of January 31, 2023, and October 31, 2022, the Company has $129,701 and $235,274 in deferred income from PMI guaranteed royalty revenue prepayments, respectively, which is included with the Company’s current liabilities.

12098

44973

129701

235274

Customer Refunds The Company infrequently has a need to adjust the size of an order after it has been shipped, received and paid for, due to the customer oversizing the order for more product that it can realistically sell at that time. If and when this occurs, the Company will ask the customer to return the over allotted product. Once received and inspected, the Company will issue a refund for the product return. As of January 31, 2023, and October 31, 2022, the Company had customer refunds due in the amounts equal to $366,956 and $0, respectively.

366956

Products Revenue The Company generates products revenue from the sale of the Products (as defined above) to non-retail customers. The Company recognizes revenue at a point in time based on management’s evaluation of when performance obligations under the terms of a contract with the customer are satisfied and control of the Products has been transferred to the customer. In most situations, transfer of control is considered complete when the products have been shipped to the customer. The Company determined that a customer obtains control of the Product upon shipment when title of such product and risk of loss transfer to the customer. However, when the Company enters a consignment agreement with a new customer, once it ships and delivers the requested amount of ordered Products to its distribution center for its retail sales locations, the Company retains ownership of the delivered Products until they are delivered to the actual retail stores (as opposed to the Company’s consignment customer). The Company’s shipping and handling costs are fulfillment costs, and such amounts are classified as part of cost of sales. The Company offers credit sales arrangements to non-retail (or wholesale) customers and monitors the collectability of each credit sale routinely. Revenue is measured by the transaction price, which is defined as the amount of consideration expected to be received in exchange for providing goods to customers. The transaction price is adjusted for estimates of known or expected variable consideration, which includes refunds and returns as well as incentive offers and promotional discounts on current orders. Estimates for sales returns are based on, among other things, an assessment of historical trends, information from customers, and anticipated returns related to current sales activity. These estimates are established in the period of sale and reduce revenue in the period of the sale. Variable consideration related to incentive offers and promotional programs are recorded as a reduction to revenue based on amounts the Company expects to collect. Estimates are regularly updated, and the impact of any adjustments are recognized in the period the adjustments are identified. In many cases, key sales terms such as pricing and quantities ordered are established at the time an order is placed and incentives have very short-term durations. Amounts billed and due from customers are short term in nature and are classified as receivable since payments are unconditional and only the passage of time related to credit terms is required before payments are due. The Company does not grant payment financing terms greater than one year. Payments received in advance of revenue recognition are recorded as deferred revenue, as noted above. Royalty Revenue On June 13, 2022, KBI entered into the PMI License Agreement with PMPSA, effective as of May 13, 2022 (the “PMI Commencement Date”). Pursuant to the PMI License Agreement, KBI granted PMPSA an exclusive irrevocable license to use its technology, documentation, and intellectual property to make, distribute, and sell disposable nicotine e-cigarettes Products based on the intellectual property in certain international markets set forth in the PMI License Agreement (the “PMI Markets”). The Company has the exclusive international distribution rights to the Products and, in order to allow KBI to fulfill its obligations set forth in the PMI License Agreement, has contributed the international distribution rights for the PMI Markets to KBI as set forth in a Capital Contribution Agreement, dated June 10, 2022. The sublicense granted to PMPSA is exclusive in the PMI Markets and neither KBI nor any of its affiliates can sell, promote, use, or distribute any competing products in the PMI Markets for the duration of the term of the PMI License Agreement and any Sell-Out Period (as defined in the PMI License Agreement). PMSPA will be responsible for any regulatory filings necessary to sell the Products in the PMI Markets. Both KBI and PMPSA agree to work together in the registration and maintenance of the Intellectual Property, but KBI will bear all cost and expense to implement the registration strategy. Finally, PMPSA has agreed to potential future development services with KBI in the PMI Markets and has been granted certain rights with respect to potential future products. The initial term of the PMI License Agreement is five (5) years and automatically renews for an additional five-year period unless PMPSA has failed to meet the agreed upon minimum key performance indicators set forth in the PMI License Agreement, in which case the PMI License Agreement will automatically terminate at the end of the initial license term. In consideration for the grant of the licensed rights, PMPSA agreed to pay to KBI a royalty equal to a percentage of the base price of the first sale of each unit of Product manufactured. In addition, before the launch of the first product in a market and each anniversary of such launch, PMPSA agrees to pre-pay to KBI a guaranteed minimum royalty based on the estimated royalties payable by PMPSA to KBI in relation to all markets in the twelve (12)-month period following the first launch or each successive anniversary of the first launch, subject to an aggregate maximum guaranteed royalty payment for all markets for each applicable twelve (12)-month period. PMPSA may require modification of certain products to be sold under the PMI Licensing Agreement to be modified for a PMI Market. Pursuant to the PMI Licensing Agreement, PMPSA has absolute discretion over sales, marketing, product branding and packaging pertaining to sales in the PMI Markets, as well as the right to select the specific PMI Markets in which to launch commercialization and determine what product types are to be promoted in each market, subject to sales and marketing plans and annual business plans set by PMPSA and certain expansion criteria agreed between PMPSA and KBI. Royalty revenue earned from the PMI License Agreement is recognized in the period the sales of the Product manufactured occurs. The PMI License Agreement contains customary representations, warranties, covenants, and indemnification provisions; however, KBI’s liability under the PMI License Agreement is capped at the greater of: (i) Ten Million Dollars ($10,000,000); or (ii) an amount equal to the total of the royalties due to KBI (but not yet paid) plus the royalties (including the guaranteed royalty payment) paid to KBI pursuant to the PMI License Agreement during the immediately preceding twelve (12) consecutive months, provided that such amount shall not exceed Thirty Million Dollars ($30,000,000). These royalties may be initially offset on a limited basis by jointly agreed upon costs such as development costs incurred for entry to specific international markets. The KBI License agreement provides that KBI shall pay Bidi license fees equivalent to 50% of the adjusted earned royalty payments, after any offsets due to jointly agreed costs such development costs incurred for entry to specific international markets. Consequently, the Company has determined that no license fees are owed to Bidi as of January 31, 2023. Concentration of Revenues and Accounts Receivable For the three months ended January 31, 2023, (i) 25% or $599,201 of the revenue from the sale of Products, solely consisting of the BIDI® Stick, was generated from GPM Investments, LLC, (“GPM”), (ii) 18% or $432,000 of the revenue from the sale of the Products was generated from FAVS Business, (“FAVS”), and (iii) approximately 15% or $372,518 of the revenue from the sale of Products, solely consisting of the BIDI Stick, was generated from H.T. Hackney Co. For the three months ended January 31, 2022, 45%, or $1,287,180, of the revenue from the sale of Products was generated from FAVS, 12%, or $<span id="xdx_908_eus-gaap--RevenueNotFromContractWithCustomerOther_pp0p0_c20211101__20220131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LakshmiDistributorIncMember_zYkekVsSaozk" title="Revenue Not from Contract with Customer, Other">352,554, of the revenue from the sale of Products was generated from Lakshmi Distributor Inc., doing business as C Store Master (“C Store Master”), and 12%, or $<span id="xdx_905_eus-gaap--RevenueNotFromContractWithCustomerOther_pp0p0_c20211101__20220131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HackneyMember_zYHlH1fEr3g8" title="Revenue Not from Contract with Customer, Other">332,595, of the revenue from the sale of Products was generated from H.T. Hackney Company. FAVS, with an outstanding balance of $<span id="xdx_908_ecustom--OutstandingBalance_pp0p0_c20221101__20230131__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--RelatedPartyTransactionAxis__custom--GPMMember_zOcxJZOrn7Sh">201,600, GPM, with an outstanding balance of $<span id="xdx_905_ecustom--OutstandingBalance_pp0p0_c20221101__20230131__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--RelatedPartyTransactionAxis__custom--FavsMember_zUBzhMdYnub2">126,158, and Stewart Distribution with an outstanding balance of $<span id="xdx_90C_ecustom--OutstandingBalance_pp0p0_c20221101__20230131__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--RelatedPartyTransactionAxis__custom--StewartMember_zTza2U8LZ6o3">59,404, accounted for 39%, 24%, and 11% of the total accounts receivable from customers, respectively, as of January 31, 2023. FAVS and C Store Master had outstanding balances of $374,400 and $282,414, respectively, which accounted for 29% and 22%, respectively, of the total accounts receivable from customers as of January 31, 2022.

10000000

30000000

599201

432000

1287180

352554

332595

201600 126158 59404

374400

282414

Share-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments (share-based payments, referred to herein as “SBP”) based on the grant-date fair value of the award. That cost is recognized over the period during which a recipient is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to performance conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model. The fair value of each option granted during the fiscal three-month period ended January 31, 2023, and January 31, 2022, was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table: <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWSnlnnaYINj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">As of January</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">As of January</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; text-indent: -10pt; padding-left: 10pt">Expected dividend yield</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected option term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20230131_z7H2cpLf0zOd" title="Expected option term (years)">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20211101__20220131_z98WferszjH5" title="Expected option term (years)">10</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">275.68</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20211101__20220131__srt--RangeAxis__srt--MinimumMember_zFCiRsnaGTga" title="Expected volatility">294.57%- <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zm178IIV3923" title="Expected volatility">301.53</td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20211101__20220131__srt--RangeAxis__srt--MinimumMember_zRGB9Y9pab5l" title="Risk-free interest rate">1.19-<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zTfwbaltecS5" title="Risk-free interest rate">1.63%</td><td style="text-align: left"> </td> </tr> </table> The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company’s common stock. The assumed discount rate was the default risk-free ten-year interest rate for U.S. Treasury bills. The Company’s stock option expense for the fiscal three months ended January 31, 2023, and ended January 31, 2022 were $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_pp0p0_c20221101__20230131__us-gaap--RelatedPartyTransactionAxis__custom--ShareBasedCompensationMember_zsxC39ntaWz9">1,435,787 and $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_pp0p0_c20211101__20220131__us-gaap--RelatedPartyTransactionAxis__custom--ShareBasedCompensationMember_ziTwzzlAKn9j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">309,700, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zWSnlnnaYINj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">As of January</td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">As of January</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%; text-align: left; text-indent: -10pt; padding-left: 10pt">Expected dividend yield</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected option term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20221101__20230131_z7H2cpLf0zOd" title="Expected option term (years)">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20211101__20220131_z98WferszjH5" title="Expected option term (years)">10</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">275.68</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20211101__20220131__srt--RangeAxis__srt--MinimumMember_zFCiRsnaGTga" title="Expected volatility">294.57%- <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zm178IIV3923" title="Expected volatility">301.53</td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.12</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20211101__20220131__srt--RangeAxis__srt--MinimumMember_zRGB9Y9pab5l" title="Risk-free interest rate">1.19-<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20211101__20220131__srt--RangeAxis__srt--MaximumMember_zTfwbaltecS5" title="Risk-free interest rate">1.63%</td><td style="text-align: left"> </td> </tr> </table>

P10Y

2.7568

2.9457

3.0153

0.0412

0.0119

0.0163

1435787

309700

Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: <table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-right: 0.8pt; text-align: justify; line-height: 107%">●</td> <td style="width: 97%; padding-right: 0.8pt; text-align: justify; line-height: 107%">Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-right: 0.8pt; text-align: justify; line-height: 107%">●</td> <td style="width: 97%; padding-right: 0.8pt; text-align: justify; line-height: 107%">Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-right: 0.8pt; text-align: justify; line-height: 107%">●</td> <td style="width: 97%; padding-right: 0.8pt; text-align: justify; line-height: 107%">Level 3 - Inputs that are both significant to the fair value measurement and unobservable.</td></tr> </table> Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of January 31, 2023. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash, accounts receivable, inventory, accounts payable and accrued expenses . As of January 31, 2023 and October 31, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on a recurring basis.

Recent Accounting Pronouncements The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.

Note 3 – Going Concern The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. As shown in the accompanying consolidated financial statements, the Company has incurred significant recurring losses, which raises substantial doubt about the Company’s ability to continue as a going concern. In response to the above, the Company assessed its management’s plans to alleviate that doubt. The Company has positive working capital as of January 31, 2023, of $6,503,841. The Company considered that its losses were due to various factors such as: (i) uncertainty surrounding the PMTA process with FDA and (ii) the MDO that was issued to Bidi Vapor on its non-tobacco flavored ENDS products. However, the MDO was set aside and vacated by the 11th Circuit in August 2022, and the ability to appeal such decision has passed, thereby facilitating the continued sales of the non-tobacco flavored BIDI® Sticks for sale in the United States (pending FDA’s review of the pending PMTAs and subject to FDA enforcement). Concurrently, the PMTA for the tobacco-flavored (Classic) BIDI® Sticks for sale in the United States continues to move through the PMTA scientific review phase. Management’s assessment included the preparation of cash flow forecasts which considered increases in revenues considering the favorable ruling obtained on the MDO as disclosed above. The Company believes that its available cash and the cash to be provided by future operating activities should enable the Company to meet its estimated liquidity needs for the next 12 months after the date that the financial statements are issued. Because of the above factors, the Company believes that this alleviates the substantial doubt in connection with the Company’s ability to continue as a going concern. However, there is no assurance that the Company’s plans will be able to generate expected or greater amounts of revenues or ever achieve profitability, due to the current economic climate in the United States and globally, the regulation and public perception of ENDS products and the various other risks faced by the Company. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these or other risks or uncertainties.

6503841

Note 4 – Leases The Company capitalizes all leased assets pursuant to ASU 2016-02, Leases (Topic 842) (“Topic 842”), which requires lessees to recognize right-of-use (“ROU”) assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. The Company does not have financing leases and only one operating lease for office space and inventory storage space with Just Pick, LLC (“Just Pick”), a related party owned and controlled by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company, as of January 31, 2023, and October 31, 2022. Certain of the Company’s leases, have and may in the future, include renewal options, which have been and might be in the future, included in the calculation of the lease liabilities and right of use assets when the Company is reasonably certain to exercise the option. Office and Storage Space On November 1, 2021, the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022. On November 11, 2021, the Company entered into a month- to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022. On June 10, 2022, the Company entered into a Lease Agreement (the “2022 Lease”) with Just Pick for approximately 21,332 rentable square feet combined in the office building and warehouse located at 4460 Old Dixie Highway, Grant-Valkaria, Florida 32949 (the “Premises”), together with all improvements thereon. The Company must pay Just Pick base rent equal to $17,776.67 per month during the first year of the Lease Term with a five-year lease renewal option. Thereafter, the monthly base rent will be increased annually with a monthly base rent of $18,665.50 in the second year, $19,554.33 in the third year, $20,443.17 in the fourth year, $22,220.83 in the fifth year, $23,998.50 in the sixth year, and one twelfth (1/12th) of the market annual rent for the seventh through eleventh years, if applicable. In addition to the base rent, the Company must pay one hundred percent (100%) of operating expenses, insurance costs, and taxes for each calendar year during the Lease term. For both the ROU asset and ROU liability, the lease renewal option was considered in the calculation with an incremental borrowing rate of 4.5%. The Company had $46,949 and $3,649 in operating lease expense for the three months ended January 31, 2023, and January 31, 2022, respectively. Cash flow information related to leases was as follows: <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zQqn9KWYSGD1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Schedule of cash flow information related to leases</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_49A_20221101__20230131_zLKxpp2o8KD2" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_494_20211101__20220131_zSqbVTFLmw76" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">January 31, 2023</td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">January 31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; font-weight: bold; text-align: left">Other Lease Information</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_i" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ProceedsFromLeasePayments_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; color: black; text-align: left">Operating cash flows from operating leases</td> <td style="width: 8%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td> <td style="width: 12%; color: black; text-align: right">(46,949</td> <td style="width: 1%; color: black; text-align: left">)</td> <td style="width: 8%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td> <td style="width: 12%; color: black; text-align: right">(3,649</td> <td style="width: 1%; color: black; text-align: left">)</td></tr> </table> The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets as of January 31, 2023, and October 31, 2022: <table cellpadding="0" cellspacing="0" id="xdx_891_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zFceIVHAnuMk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Schedule Of Condensed Balance Sheet</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_495_20230131" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_494_20221031" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left">Lease Position</td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">January 31, 2023</td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">October 31, 2022</td></tr> <tr id="xdx_40E_eus-gaap--LeasesOperatingAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Operating Leases</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; color: black; text-align: left">Operating lease right-of-use assets</td> <td style="width: 8%; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; width: 12%; color: black; text-align: right">1,152,020</td> <td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left"> </td> <td style="width: 8%; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; width: 12%; color: black; text-align: right">1,198,969</td> <td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Right of use liability operating lease current portion</td> <td style="color: black"> </td> <td style="color: black; text-align: left">$</td> <td style="color: black; text-align: right">170,603</td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left">$</td> <td style="color: black; text-align: right">166,051</td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Right of use liability operating lease long term</td> <td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: right">1,006,435</td> <td style="padding-bottom: 1pt; color: black; text-align: left"> </td> <td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: right">1,050,776</td> <td style="padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; color: black; text-align: left">Total operating lease liabilities</td> <td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: right">1,177,038</td> <td style="padding-bottom: 2.5pt; color: black; text-align: left"> </td> <td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: right">1,216,827</td> <td style="padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table> The following table provides the maturities of lease liabilities at January 31, 2023: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4ciy1dRPdti" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Schedule of Lessee Operating Lease Liability Maturity</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_49C_20230131_zsnhnT1YLQAa" style="text-align: center"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Leases</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Maturity of Lease Liabilities on January 31, 2023</td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt">2023</td> <td style="padding: 0pt 0pt 0pt 10pt; width: 1%; text-align: left; text-indent: -10pt"> </td> <td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 43%; text-align: right">164,139</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2024</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">228,134</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2025</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">238,800</td> <td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2026</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">253,614</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt">2027 and thereafter</td> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">450,934</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt">Total future undiscounted lease payments</td> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; text-align: right">1,335,621</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zJA2Vq0GMzu2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt">Less: Interest</td> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(158,583</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 10pt; text-align: left; text-indent: -10pt">Present value of lease liabilities</td> <td style="padding: 0pt 0pt 2.5pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">1,177,038</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> At January 31, 2023, the Company had no additional leases which had not yet commenced.

the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022.

the Company entered into a month- to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022.

17776

18665

19554

20443

22220

23998

0.045

46949

3649

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zQqn9KWYSGD1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Schedule of cash flow information related to leases</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_49A_20221101__20230131_zLKxpp2o8KD2" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_494_20211101__20220131_zSqbVTFLmw76" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">January 31, 2023</td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">January 31, 2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; font-weight: bold; text-align: left">Other Lease Information</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_i" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Cash paid for amounts included in the measurement of lease liabilities:</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ProceedsFromLeasePayments_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; color: black; text-align: left">Operating cash flows from operating leases</td> <td style="width: 8%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td> <td style="width: 12%; color: black; text-align: right">(46,949</td> <td style="width: 1%; color: black; text-align: left">)</td> <td style="width: 8%; color: black"> </td> <td style="width: 1%; color: black; text-align: left">$</td> <td style="width: 12%; color: black; text-align: right">(3,649</td> <td style="width: 1%; color: black; text-align: left">)</td></tr> </table>

-46949

-3649

<table cellpadding="0" cellspacing="0" id="xdx_891_esrt--ScheduleOfCondensedBalanceSheetTableTextBlock_zFceIVHAnuMk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Schedule Of Condensed Balance Sheet</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_495_20230131" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td id="xdx_494_20221031" style="color: black; text-align: center"> </td> <td style="color: black; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: left">Lease Position</td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">January 31, 2023</td> <td style="color: black; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; color: black; font-weight: bold; text-align: center">October 31, 2022</td></tr> <tr id="xdx_40E_eus-gaap--LeasesOperatingAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Operating Leases</td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left"> </td> <td style="color: black; text-align: right"> </td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; color: black; text-align: left">Operating lease right-of-use assets</td> <td style="width: 8%; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; width: 12%; color: black; text-align: right">1,152,020</td> <td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left"> </td> <td style="width: 8%; color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; color: black; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; width: 12%; color: black; text-align: right">1,198,969</td> <td style="width: 1%; padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: black; text-align: left">Right of use liability operating lease current portion</td> <td style="color: black"> </td> <td style="color: black; text-align: left">$</td> <td style="color: black; text-align: right">170,603</td> <td style="color: black; text-align: left"> </td> <td style="color: black"> </td> <td style="color: black; text-align: left">$</td> <td style="color: black; text-align: right">166,051</td> <td style="color: black; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="color: black; text-align: left">Right of use liability operating lease long term</td> <td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: right">1,006,435</td> <td style="padding-bottom: 1pt; color: black; text-align: left"> </td> <td style="color: black; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; color: black; text-align: right">1,050,776</td> <td style="padding-bottom: 1pt; color: black; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; color: black; text-align: left">Total operating lease liabilities</td> <td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: right">1,177,038</td> <td style="padding-bottom: 2.5pt; color: black; text-align: left"> </td> <td style="color: black; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; color: black; text-align: right">1,216,827</td> <td style="padding-bottom: 2.5pt; color: black; text-align: left"> </td></tr> </table>

1152020

1198969

170603

166051

1006435

1050776

1177038

1216827

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z4ciy1dRPdti" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Schedule of Lessee Operating Lease Liability Maturity</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_49C_20230131_zsnhnT1YLQAa" style="text-align: center"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Operating Leases</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Maturity of Lease Liabilities on January 31, 2023</td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt">2023</td> <td style="padding: 0pt 0pt 0pt 10pt; width: 1%; text-align: left; text-indent: -10pt"> </td> <td style="width: 10%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 43%; text-align: right">164,139</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2024</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">228,134</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2025</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">238,800</td> <td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2026</td> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">253,614</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueThereafter_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt">2027 and thereafter</td> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">450,934</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt">Total future undiscounted lease payments</td> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td> <td style="border-bottom: Black 1pt solid; text-align: right">1,335,621</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zJA2Vq0GMzu2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt">Less: Interest</td> <td style="padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(158,583</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 10pt; text-align: left; text-indent: -10pt">Present value of lease liabilities</td> <td style="padding: 0pt 0pt 2.5pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">1,177,038</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

164139

228134

238800

253614

450934

1335621

158583

1177038

Note 5 – Stockholders’ Equity Common Stock During the three months ended January 31, 2023: No shares of Common Stock were issued during the three months ended January 31, 2023. Preferred Stock Converted The authorized preferred stock of the Company consists of 5,000,000 shares with a par value of $ 0.001 per share, of which 3,000,000 shares were designated as Series A Convertible Preferred Stock (the “Series A Preferred Stock”). Each share of the Series A Preferred Stock was initially convertible into 100 shares of Common Stock; however, as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock. On June 24, 2022, all <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20220601__20220624__us-gaap--AwardTypeAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--KaivalHoldingsLLCMember_zUIG8Yj8aVKc" title="Number of shares converted">3,000,000 shares of Series A Preferred Stock were converted into shares of Common Stock by Kaival Holdings, LLC, a related party and the Company’s majority shareholder. The conversion of 3,000,000 shares of Series A Preferred Stock, at a conversion rate of 8.33, equaled 25,000,000 shares of Common Stock. As a result, the authorized, preferred stock of the Company consists of 5,000,000 shares with a par value of $0.001 per share, with 0 shares of preferred stock issued or outstanding as of October 31, 2022. Stock Options Summary of stock options information is as follows: <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zbDfEjUtBO7b" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt"> Schedule of stock options</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td style="font-size: 11pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Exercise Price</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt; font-size: 11pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 48%; font-weight: bold; text-indent: -10pt">Outstanding, October 31, 2022</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221031_pdd" style="width: 9%; text-align: right" title="Number of shares outstanding, beginning">3,202,265</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_980_ecustom--AggregateExercisePriceOutstanding_c20221031_pp0p0" style="width: 9%; text-align: right" title="Aggregate exercise price outstanding, beginning">8,921,419</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%; font-size: 11pt"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__srt--RangeAxis__srt--MaximumMember_pdd" title="Exercise price range outstanding, beginning">1.03-<span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__srt--RangeAxis__srt--MinimumMember_pdd" title="Exercise price range outstanding, beginning">28.68</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20221031_pdd" style="width: 9%; text-align: right" title="Weighted average exercise price outstanding, beginning">2.79</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20230131_pdd" style="text-align: right" title="Granted">3,250,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_ecustom--AggregateExercisePriceGranted_c20221101__20230131_pp0p0" style="text-align: right" title="Aggregate exercise price, granted">3,207,425</td> <td style="text-align: left"> </td> <td style="font-size: 11pt"> </td> <td style="text-align: left"> </td> <td id="xdx_98C_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Exercise price range, granted">0.99</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Weighted average exercise price, granted">0.99</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20230131_pdd" style="text-align: right" title="Exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_ecustom--AggregateExercisePriceExercised_c20221101__20230131_pdp0" style="text-align: right" title="Aggregate exercise price, exercised">—</td> <td style="text-align: left"> </td> <td style="font-size: 11pt"> </td> <td style="text-align: left"> </td> <td id="xdx_981_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Exercise price range, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Weighted average exercise price, exercised">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 40pt; text-align: left; text-indent: -10pt">Cancelled, forfeited, or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20221101__20230131_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_981_ecustom--AggregateExercisePriceCancelledForfeitedOrExpired_c20221101__20230131_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 11pt"> </td> <td style="text-align: left"> </td> <td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Exercise price range, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Weighted average exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 2.5pt 10pt; font-weight: bold; text-indent: -10pt">Outstanding, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230131_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, ending">6,452,265</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_983_ecustom--AggregateExercisePriceOutstanding_c20230131_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price outstanding, ending">12,128,844</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__srt--RangeAxis__srt--MaximumMember_pdd" title="Exercise price range outstanding, ending">0.99-<span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__srt--RangeAxis__srt--MinimumMember_pdd" title="Exercise price range outstanding, ending">28.69</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20230131_pdd" style="text-align: right" title="Weighted average exercise price outstanding, ending">1.88</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 40pt; text-indent: -10pt">Exercisable, January 31, 2023 </td> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: right">2,151,217</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: right">6,085,555</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="font-size: 11pt; text-align: left">$</td> <td style="font-size: 11pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20230131__srt--RangeAxis__srt--MinimumMember_pdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.99-28.69</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="font-size: 11pt; text-align: left">$</td> <td style="font-size: 11pt; text-align: right">2.83</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/></tr> </table> During the three months ended January 31, 2023, and 2022, the Company recognized $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_c20221101__20230131__us-gaap--FinancialInstrumentAxis__us-gaap--BondOptionMember_z8cW3BVwDoma" title="Recognized expense">1,435,787 and $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_c20211101__20220131__us-gaap--FinancialInstrumentAxis__us-gaap--BondOptionMember_zlKALzceY9F6" title="Recognized expense">309,700, respectively of stock option expense related to outstanding stock options. On January 31, 2023, the Company had $3,488,735 of unrecognized expenses related to options. The weighted average remaining contractual life is approximately <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20221101__20230131_zAQmSRlQlPs4" title="Weighted average remaining contractual life">9.38 years for stock options outstanding on January 31, 2023. The aggregate intrinsic value of these outstanding options as of January 31, 2023, was $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230131_z5nW2MIE2HLi" title="Aggregate intrinsic value">0. Compensation expense related to performance-based options is recognized on a straight-line basis over the requisite service period, provided that it is probable that performance conditions will be achieved, with probability assessed on a quarterly basis and any changes in expectations recognized as an adjustment to earnings in the period of the change. Compensation cost is not recognized for service- and performance-based awards that do not vest because service or performance conditions are not satisfied, and any previously recognized compensation cost is reversed. If vesting occurs prior to the end of the requisite service period, expense is accelerated and fully recognized through the vesting date. On November 9, 2022, non-qualified stock options exercisable for up to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z16fbqTbkyn" title="Stock options exercisable">250,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vested on the issue date. The fair value of the options on the grant date was $<span id="xdx_90C_ecustom--FairValuedOfOptionsGranted_pp0p0_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxhQXG4ktYk7" title="Fair valued of options granted">246,747 using a Black-Scholes option pricing model with the following assumptions: stock price $<span id="xdx_90A_eus-gaap--SharePrice_iI_pip0_uUSDPShares_c20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc7OckfJqrXh" title="Share price">0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlCNitrL7Zz2" title="Volatility rate">275.68%, expected term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pp0p0_dtY_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZWJKqiVNnf5" title="Expected term">10 years, and a risk-free interest rate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvJabKh10HGl" title="Interest rate">4.12%. On November 9, 2022, non-qualified stock options exercisable for up to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220422__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Stock options exercisable">3,000,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vesting based on achievement of certain net revenue and profit margin targets up to $<span id="xdx_909_eus-gaap--RevenuesNetOfInterestExpense_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwl1620TuPkk" title="Total net revenues">180,000,000 in total net revenues over a period of 3 years. The fair value of the options on the grant date was $<span id="xdx_90C_ecustom--FairValuedOfOptionsGranted_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzK3S3XVz2pe" title="Fire value granted">2,960,968 using a Black-Scholes option pricing model with the following assumptions: stock price $<span id="xdx_90B_eus-gaap--SharePrice_iI_pip0_uUSDPShares_c20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWEffHlyJomf" title="Share price">0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2gnKajnO4rb" title="Volatility rate">275.68%, expected term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pp0p0_dtY_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zd2mPMmxgFij" title="Expected term">10 years, and a risk-free interest rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmRCsAxhvC9l" title="Interest rate">4.12%. Warrants Warrant information as of the periods indicated is as follows: <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z0SwnjUBY9Ya" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholder Equity (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; text-align: left">Share-based Payment Arrangement, Option, Activity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Exercise Price</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; font-weight: bold; text-indent: -10pt">Outstanding, October 31, 2022</td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Number of shares outstanding, beginning">2,318,317</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_984_ecustom--AggregateExercisePriceOutstanding_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="width: 10%; text-align: right" title="Aggregate exercise price outstanding, beginning">4,404,802</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Exercise price range outstanding, beginning">1.90</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Weighted average exercise price outstanding, beginning">1.90</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_ecustom--AggregateExercisePriceGranted_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdp0" style="text-align: right" title="Aggregate exercise price, granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_ecustom--AggregateExercisePriceExercised_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="text-align: right" title="Aggregate exercise price, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, exercised">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 40pt; text-align: left; text-indent: -10pt">Cancelled, forfeited, or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_989_ecustom--AggregateExercisePriceCancelledForfeitedOrExpired_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdp0" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 2.5pt 10pt; font-weight: bold; text-indent: -10pt">Outstanding, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, ending">2,318,317</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_987_ecustom--AggregateExercisePriceOutstanding_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price outstanding, ending">4,404,802</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range outstanding, ending">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price outstanding, ending">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 40pt; text-indent: -10pt">Exercisable, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable">2,318,317</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98E_ecustom--AggregateExercisePriceExercisable_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price, exercisable">4,404,802</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, exercisable">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, exercisable">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The weighted average remaining contractual life is approximately <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_pp0p0_dtY_c20221101__20230131__us-gaap--AwardTypeAxis__custom--StockWarrantsMember_zowISjpFezO4" title="Weighted average remaining life">3.66 years for Common Stock warrants outstanding as of January 31, 2023. As of January 31, 2023, there was no intrinsic value of outstanding stock warrants.

5000000

3000000

as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock.

3000000

8.33

25000000

5000000

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_zbDfEjUtBO7b" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt"> Schedule of stock options</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td style="font-size: 11pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Exercise Price</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt; font-size: 11pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 48%; font-weight: bold; text-indent: -10pt">Outstanding, October 31, 2022</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221031_pdd" style="width: 9%; text-align: right" title="Number of shares outstanding, beginning">3,202,265</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_980_ecustom--AggregateExercisePriceOutstanding_c20221031_pp0p0" style="width: 9%; text-align: right" title="Aggregate exercise price outstanding, beginning">8,921,419</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%; font-size: 11pt"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__srt--RangeAxis__srt--MaximumMember_pdd" title="Exercise price range outstanding, beginning">1.03-<span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__srt--RangeAxis__srt--MinimumMember_pdd" title="Exercise price range outstanding, beginning">28.68</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20221031_pdd" style="width: 9%; text-align: right" title="Weighted average exercise price outstanding, beginning">2.79</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20230131_pdd" style="text-align: right" title="Granted">3,250,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_ecustom--AggregateExercisePriceGranted_c20221101__20230131_pp0p0" style="text-align: right" title="Aggregate exercise price, granted">3,207,425</td> <td style="text-align: left"> </td> <td style="font-size: 11pt"> </td> <td style="text-align: left"> </td> <td id="xdx_98C_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Exercise price range, granted">0.99</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Weighted average exercise price, granted">0.99</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20230131_pdd" style="text-align: right" title="Exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_ecustom--AggregateExercisePriceExercised_c20221101__20230131_pdp0" style="text-align: right" title="Aggregate exercise price, exercised">—</td> <td style="text-align: left"> </td> <td style="font-size: 11pt"> </td> <td style="text-align: left"> </td> <td id="xdx_981_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Exercise price range, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Weighted average exercise price, exercised">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 40pt; text-align: left; text-indent: -10pt">Cancelled, forfeited, or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20221101__20230131_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_981_ecustom--AggregateExercisePriceCancelledForfeitedOrExpired_c20221101__20230131_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-size: 11pt"> </td> <td style="text-align: left"> </td> <td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Exercise price range, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20221101__20230131_pdd" style="text-align: right" title="Weighted average exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 2.5pt 10pt; font-weight: bold; text-indent: -10pt">Outstanding, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230131_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, ending">6,452,265</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_983_ecustom--AggregateExercisePriceOutstanding_c20230131_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price outstanding, ending">12,128,844</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__srt--RangeAxis__srt--MaximumMember_pdd" title="Exercise price range outstanding, ending">0.99-<span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__srt--RangeAxis__srt--MinimumMember_pdd" title="Exercise price range outstanding, ending">28.69</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20230131_pdd" style="text-align: right" title="Weighted average exercise price outstanding, ending">1.88</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 40pt; text-indent: -10pt">Exercisable, January 31, 2023 </td> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: right">2,151,217</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 11pt; text-align: right">6,085,555</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="font-size: 11pt; text-align: left">$</td> <td style="font-size: 11pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20230131__srt--RangeAxis__srt--MinimumMember_pdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.99-28.69</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/> <td style="padding-bottom: 2.5pt; font-size: 11pt"/> <td style="font-size: 11pt; text-align: left">$</td> <td style="font-size: 11pt; text-align: right">2.83</td> <td style="padding-bottom: 2.5pt; font-size: 11pt; text-align: left"/></tr> </table> During the three months ended January 31, 2023, and 2022, the Company recognized $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_c20221101__20230131__us-gaap--FinancialInstrumentAxis__us-gaap--BondOptionMember_z8cW3BVwDoma" title="Recognized expense">1,435,787 and $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense_c20211101__20220131__us-gaap--FinancialInstrumentAxis__us-gaap--BondOptionMember_zlKALzceY9F6" title="Recognized expense">309,700, respectively of stock option expense related to outstanding stock options. On January 31, 2023, the Company had $3,488,735 of unrecognized expenses related to options. The weighted average remaining contractual life is approximately <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20221101__20230131_zAQmSRlQlPs4" title="Weighted average remaining contractual life">9.38 years for stock options outstanding on January 31, 2023. The aggregate intrinsic value of these outstanding options as of January 31, 2023, was $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20230131_z5nW2MIE2HLi" title="Aggregate intrinsic value">0. Compensation expense related to performance-based options is recognized on a straight-line basis over the requisite service period, provided that it is probable that performance conditions will be achieved, with probability assessed on a quarterly basis and any changes in expectations recognized as an adjustment to earnings in the period of the change. Compensation cost is not recognized for service- and performance-based awards that do not vest because service or performance conditions are not satisfied, and any previously recognized compensation cost is reversed. If vesting occurs prior to the end of the requisite service period, expense is accelerated and fully recognized through the vesting date. On November 9, 2022, non-qualified stock options exercisable for up to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z16fbqTbkyn" title="Stock options exercisable">250,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vested on the issue date. The fair value of the options on the grant date was $<span id="xdx_90C_ecustom--FairValuedOfOptionsGranted_pp0p0_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxhQXG4ktYk7" title="Fair valued of options granted">246,747 using a Black-Scholes option pricing model with the following assumptions: stock price $<span id="xdx_90A_eus-gaap--SharePrice_iI_pip0_uUSDPShares_c20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc7OckfJqrXh" title="Share price">0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlCNitrL7Zz2" title="Volatility rate">275.68%, expected term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pp0p0_dtY_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZWJKqiVNnf5" title="Expected term">10 years, and a risk-free interest rate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvJabKh10HGl" title="Interest rate">4.12%. On November 9, 2022, non-qualified stock options exercisable for up to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220422__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Stock options exercisable">3,000,000 shares of Common Stock were awarded to one supplier of the Company. These stock options have a ten-year term from the grant date, with the shares fully vesting based on achievement of certain net revenue and profit margin targets up to $<span id="xdx_909_eus-gaap--RevenuesNetOfInterestExpense_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwl1620TuPkk" title="Total net revenues">180,000,000 in total net revenues over a period of 3 years. The fair value of the options on the grant date was $<span id="xdx_90C_ecustom--FairValuedOfOptionsGranted_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzK3S3XVz2pe" title="Fire value granted">2,960,968 using a Black-Scholes option pricing model with the following assumptions: stock price $<span id="xdx_90B_eus-gaap--SharePrice_iI_pip0_uUSDPShares_c20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWEffHlyJomf" title="Share price">0.9869 per share (based on the quoted trading price on the date of grant), a computed volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2gnKajnO4rb" title="Volatility rate">275.68%, expected term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pp0p0_dtY_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zd2mPMmxgFij" title="Expected term">10 years, and a risk-free interest rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20221101__20221109__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OneConsultantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmRCsAxhvC9l" title="Interest rate">4.12%. Warrants Warrant information as of the periods indicated is as follows: <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z0SwnjUBY9Ya" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholder Equity (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; text-align: left">Share-based Payment Arrangement, Option, Activity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Exercise Price</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; font-weight: bold; text-indent: -10pt">Outstanding, October 31, 2022</td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Number of shares outstanding, beginning">2,318,317</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_984_ecustom--AggregateExercisePriceOutstanding_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="width: 10%; text-align: right" title="Aggregate exercise price outstanding, beginning">4,404,802</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Exercise price range outstanding, beginning">1.90</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Weighted average exercise price outstanding, beginning">1.90</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_ecustom--AggregateExercisePriceGranted_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdp0" style="text-align: right" title="Aggregate exercise price, granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_ecustom--AggregateExercisePriceExercised_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="text-align: right" title="Aggregate exercise price, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, exercised">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 40pt; text-align: left; text-indent: -10pt">Cancelled, forfeited, or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_989_ecustom--AggregateExercisePriceCancelledForfeitedOrExpired_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdp0" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 2.5pt 10pt; font-weight: bold; text-indent: -10pt">Outstanding, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, ending">2,318,317</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_987_ecustom--AggregateExercisePriceOutstanding_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price outstanding, ending">4,404,802</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range outstanding, ending">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price outstanding, ending">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 40pt; text-indent: -10pt">Exercisable, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable">2,318,317</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98E_ecustom--AggregateExercisePriceExercisable_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price, exercisable">4,404,802</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, exercisable">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, exercisable">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3202265

8921419

1.03

28.68

2.79

3250000

3207425 0.99

0.99

6452265

12128844

0.99

28.69

1.88

0.99

28.69

1435787

309700

3488735

P9Y4M17D

250000

246747

0.9869

2.7568

P10Y

0.0412

3000000

180000000

2960968

0.9869

2.7568

P10Y

0.0412

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z0SwnjUBY9Ya" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholder Equity (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; text-align: left">Share-based Payment Arrangement, Option, Activity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt; text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Aggregate</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Exercise Price</td> <td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Range</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; font-weight: bold; text-indent: -10pt">Outstanding, October 31, 2022</td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Number of shares outstanding, beginning">2,318,317</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_984_ecustom--AggregateExercisePriceOutstanding_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="width: 10%; text-align: right" title="Aggregate exercise price outstanding, beginning">4,404,802</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Exercise price range outstanding, beginning">1.90</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20221031__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="width: 10%; text-align: right" title="Weighted average exercise price outstanding, beginning">1.90</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_ecustom--AggregateExercisePriceGranted_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdp0" style="text-align: right" title="Aggregate exercise price, granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, granted">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, granted">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; text-indent: -10pt">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_ecustom--AggregateExercisePriceExercised_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="text-align: right" title="Aggregate exercise price, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, exercised">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, exercised">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 1pt 40pt; text-align: left; text-indent: -10pt">Cancelled, forfeited, or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_989_ecustom--AggregateExercisePriceCancelledForfeitedOrExpired_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdp0" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_98F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20221101__20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, cancelled forfeited or expired">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 2.5pt 10pt; font-weight: bold; text-indent: -10pt">Outstanding, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of shares outstanding, ending">2,318,317</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_987_ecustom--AggregateExercisePriceOutstanding_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price outstanding, ending">4,404,802</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range outstanding, ending">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price outstanding, ending">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 2.5pt 40pt; text-indent: -10pt">Exercisable, January 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable">2,318,317</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98E_ecustom--AggregateExercisePriceExercisable_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate exercise price, exercisable">4,404,802</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Exercise price range, exercisable">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20230131__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Weighted average exercise price, exercisable">1.90</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2318317

4404802

1.90

2318317

4404802

1.90

2318317 4404802

1.90

P3Y7M28D

Note 6 – Related-Party Transactions In March 2020, the Company commenced business operations as a result of becoming the exclusive distributor of certain ENDS and related components (the “Products”) manufactured by Bidi, a related party company that is also owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company. Other Receivable On August 1, 2022, the Company and Bidi agreed to a price credit for short-coded or expiring inventory against the related-party accounts payable balance due to Bidi. A credit of $<span id="xdx_90D_eus-gaap--IncreaseDecreaseInOtherAccountsPayable_c20220725__20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OtherReceivableMember_zYk99Yd9ods" title="Accounts payable">2,924,655 was applied on August 1, 2022, resulting in a related-party accounts receivable balance due from Bidi of $2,134,413, to be applied on future orders of Product. On October 31, 2022, the Company and Bidi agreed to a return for short-coded or expiring inventory. An additional credit of $1,543,545 and $<span id="xdx_902_eus-gaap--AccountsReceivableRelatedParties_iI_c20220801__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OtherReceivableMember_zK070lSW8A34" title="Related-party receivable balance">108,841 for recycling cost was applied on October 31, 2022, to the related-party receivable balance due from Bidi. As of January 31, 2023 and October 31, 2022, the Company has a related-party receivable balance due from Bidi of $<span id="xdx_903_eus-gaap--AccountsReceivableRelatedParties_iI_c20230131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OtherReceivableMember_z72PuQh7VjP5" title="Related-party receivable balance">3,509,542 and $<span id="xdx_90C_eus-gaap--AccountsReceivableRelatedParties_iI_c20220131__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OtherReceivableMember_z99s8UYwlHn2" title="Related-party receivable balance">3,704,132, respectively. The receivable balance will be realized though Bidi applying 5% credits on all future orders of product purchased until the entire balance is extinguished. Revenue and Accounts Receivable During the three months ended January 31, 2023, the Company recognized revenue of $3,085 from one company owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company, and/or his wife. There was no accounts receivable balance for these transactions as of January 31, 2023. During the three months ended January 31, 2022, the Company recognized revenue of $23,765 from four companies owned by Nirajkumar Patel, the Chief Science and Regulatory Officer and a director of the Company, and/or his wife. As of January 31, 2022, the Company had accounts receivable from this related party in the amount of $245. Concentration Purchases and Accounts Payable During the three months ended January 31, 2023, 100% of the inventories of Products, consisting solely of the BIDI® Stick, were purchased from Bidi, a related party controlled by Nirajkumar Patel, in the amount of $3,697,210. As of January 31, 2023, the Company had accounts payable to Bidi of $2,350,787 and Products valued at $3,761,491 were held in inventory. In addition, as of January 31, 2023, the Company had accrued freight in expense of $347,760. As of October 31, 2022, the Company did not have an accounts payable balance to Bidi. During the three months ended January 31, 2022, the Company did not purchase Products from Bidi, a related party company that is owned by Nirajkumar Patel. As of January 31, 2022, the Company had accounts payable to Bidi of $9,129,759 and Products valued at $11,841,750 were held in inventory. The KBI License agreement provides that KBI shall pay Bidi license fees equivalent to 50% of the adjusted earned royalty payments, after any offsets due to jointly agreed costs such development costs incurred for entry to specific international markets. Consequently, the Company has determined that no license fees are owed to Bidi as of January 31, 2023 and October 31, 2022. Leased Office Space and Storage Space The Company capitalizes all leased assets pursuant to ASU 2016-02, Leases (Topic 842) (“Topic 842”), which requires lessees to recognize right-of-use (“ROU”) assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. On June 10, 2022, the Company entered into the 2022 Lease with Just Pick for approximately 21,332 rentable square feet combined in the office building and warehouse located at the Premises, together with all improvements thereon. Just Pick is considered a related party to the Company because the Company’s Chief Science and Regulatory Officer and director, Mr. Nirajkumar Patel, owns and controls Just Pick.

2924655

2134413

1543545

108841

3509542

3704132

3085

23765

3697210

2350787

3761491

347760

9129759

11841750

Note 7 – Commitments and Contingencies The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. There were no commitments or contingencies as of January 31, 2023, and October 31, 2022, other than the below: QuikfillRx Service Agreement Amendment Effective as of November 9, 2022, the Company entered into its latest amendment to the Service Agreement with QuikfillRx (collectively with prior amendments, the “Amended Service Agreement”). The November 9, 2022 amendment to the Service Agreement was captioned as the “Fourth Amendment” although it was the fifth amendment to the Service Agreement. Pursuant to the Amended Service Agreement: (a) the term of the Amended Service Agreement was extended (unless earlier terminated pursuant to the terms of the Amended Service Agreement) from November 1, 2022 (the “Effective Date”) until October 31, 2025, following which the term shall automatically renew for successive one (1) year periods beginning November 1, 2025; (b) QuikfillRx agreed to change its “doing business as” name to “Kaival Marketing Services” within thirty (30) days following the Effective Date; (c) it was provided that either party may terminate the Amended Service Agreement without cause upon not less than ninety (90) days prior written notice to the other party; (d) QuikfillRx was granted a one-time, fully vested, ten-year non-qualified option award to purchase up to 250,000 shares of Company common stock with an exercise price of $0.9869 per share (the closing price of the Company’s common stock on November 9, 2022)”)., which option grant was memorialized pursuant to a Nonqualified Option Agreement, dated November 9, 2022, between the Company and QuikfillRx; and (e) the parties agreed to revise the compensation for services as follows: (i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years. The Company accrued $28,318 for a quarterly bonus payable to QuikfillRx, based on the Applicable Gross Quarterly Sales results of the three months ended January 31, 2023. The Company accrued 33,871 for a quarterly bonus payable to QuikfillRx, based on the Applicable Gross Quarterly Sales results for the three months ended October 31, 2022.

(i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years

28318

33871

Note 8 – Subsequent Events On February 1, 2023, the Company entered into an agreement to cancel the 75,000 stock options that were previously issued to a third-party management consultant and agreed to pay such consultant monthly retainer of $16,750, and an incentive compensation bonus of $75,000. On February 6, 2023, non-qualified stock options exercisable for up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--ThreeBoardMember_zSSUkGSrN4A5" title="Stock options">375,000 shares of common stock were awarded to the three independent board members of the Company. These stock options have a ten-year term from the grant date, with <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--ThreeBoardMember_z1cMr1iYKEWe" title="Stock Vest">375,000 fully vest on the earlier of February 6, 2024, or a change in control. On February 6, 2023, non-qualified stock options exercisable for up to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--TwoBoardMember_zNDaAH7dvwI1">1,000,000 shares of common stock were awarded to two senior executives of the Company. These stock options have a ten-year term from the grant date, with <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--TwoBoardMember_zxmTm2Sg0rea">500,000 vest on date of issuance and 500,000 vest on the earlier of February 6, 2024, or a change in control. On February 6, 2023, non-qualified stock options exercisable for up to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--FiveBoardMember_zKhlTCFv5Kg8" title="Stock options">150,000 shares of common stock were awarded to five employees of the Company. These stock options have a ten-year term from the grant date, with <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--FiveBoardMember_zNwgSXpL84si" title="Stock Vest">150,000 fully vest on the earlier of February 6, 2024 or a change in control. On February 6, 2023, non-qualified stock options exercisable for up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--OneConsultantsMember_zGRB3VyGi99l" title="Stock options">200,000 shares of common stock were awarded to one consultant acting as a sales broker for the Company. These stock options have a ten-year term from the grant date, with <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionAxis__custom--OneConsultantsMember_zKgzIPROI0g8" title="Stock Vest">200,000 shall vest based on achievement of certain net sales targets up to $100,000,000. The term of the agreement is one year from the effective date with an automatic renewal of one year if net sales defined in the agreement are met. On March 3, 2023, the Company approved amending the Consulting Agreement for Mark Thoenes, the Company’s Interim Chief Financial Officer and extend it through June 30, 2023. In order to extend its term, on March 3, 2023, the Company also approved the grant of a stock option award to Mr. Thoenes to acquire up to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230301__20230303__us-gaap--PlanNameAxis__custom--IncentiveCompensationPlanMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znGTIo7lzeub" title="Option granted">50,000 shares of common stock under the Company’s Amended 2020 Stock and Incentive Compensation Plan. All of the option shares fully vest on the earlier of June 30, 2023, or upon meeting certain terms and conditions.

75000 16750 75000

375000

1000000

500000

150000

200000

50000

EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( != <58'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " 70'%6%K,E1^T K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)TE!(71S6?&D(+B@> O)[&ZP:4,RTN[;V\;=+J(/X#$S?[[Y M!J:U4=DAX7,:(B;RF&^FT/59V;AA1Z*H +(]8C"YGA/]W-P/*1B:G^D T=@/ MI:^$*6&"$*>3O KJ56*I_8DL'V#DY9;^FQG&LQZ;DYAT$O#T]OI1U*]]G M,KW%^5?VBDX1-^PR^;79WN\>F)9<-A5O*G&W$U)QKAKYOKC^\+L*A\'YO?_' MQA=!W<*ON]!?4$L#!!0 ( != <5:97)PC$ 8 )PG 3 >&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ M%T!Q5@?]GH$4!@ X!\ !@ !X;"]W;W)K_[*W9HI]/,&$M: 38I9@9C.Z%Q,#&..VFG%VMI 8TE+5VMP/[W M?5<"B7A6+U038G".+EH+)1:OK>LQ%OPB"6G M8LECN#,3,F(*3N7<2I:2,S\31:%%;;MC12R(&_U>=FTB^SV1JC"(^422)(TB M)E\O>2C6%PVGL;UP'\P72E^P^KTEF_,I5U^7$PEG5N'B!Q&/DT#$1/+916/@ MO!^ZKA9D3SP&?)WL'!.-\B3$LSX9^1<-6Y>(A]Q3VH+!GQ4?\C#43E".?S>F MC>(WM7#W>.M^D\$#S!-+^%"$?P:^6EPTSAO$YS.6ANI>K#_R#5!;^WDB3++_ MR3I_MFTWB)%&LB]=/@I@^RNLG40!/$NAFG2L+= '2J/Q0K+DF3) LF>=*S%'CJ M.Y:WT5_F>EJA=\EG$:M%0JYCG_O?ZRTH2U$@NBW0)44-_V#Q*7&=$T)MZAK* M,\3EGYD\)$ M:VQ+7%D7E):@%"W9=:P"]0J<(2?C-'KBTHB'F]BVW6QW;*=C!$2U=0'++..@ MZ6$+>,_G@8XST*9C%IG;$#?Z-!@]#F[)Y?U@?#4EH_'X[G'P,+H;3\F'^[NO MDQ.X-#PU5L QXHU3YAL'3RB;"AA"=Y;0E4>065_()_YJK +<"MK9.>M0ZG:- MG,?(/$X9>AP\M6PX']@+&?D &\P"CV7O4:1?XY;G;M-M=6G7/C/R'B,..64> M>MZR#_49M/.#6,=&;MSN@YX*FX\L?&8R8$;>8Z0HIXQ1#IY\WO(6'7LB MQ2J(/7-CXYXWMT;08\0I6L8IBB>@MZ 3D2B8I_\*EI5C=X^C2[LMXPR-Z^J2 MEJ&*[@E5&:?DK!H,-_CMW'7?&<&.$:)H&:(HGG]N19;T%R+&0M0>DU:;-EOG MM&WD.T:&HF6&HGCT>0@4Q$,Q(P[][>D=F7(OE="61DC<:2BB2,0_$?@W5<)[ M/B%+2-8K%J:<_&*?0KX@2R[SE3EC11PC2]$R2U$\ ,''N1_$ ME):VWW7YTDK6E/!>,7^Y[G'\9EPZ'N*JNIQE1*('1:11K+C,MPOT-RO;@ALY M<<(0[2, M0_2@.#2-6!B2RS2!VXFYU^(^56N?N*PFGEN&(/>@$'0=<3G7H_(#.*@%Y(1H MR6)CN^XQK.+$974YRPCDX@GF6F_E03<;"P7)G7Q-.%$+#M.NXGHO:7?U-U\X M-*+COU&Y_(OKZK*7*M=AFMG3U4/?*RK>6$ M>'KI(-].+:X6V]>#;-/6*A_/][X_,SUP$Q+R&4CMTS/X>9EO)^#C,E: P.\PR TO+K%:K_6 20Z-)XD[B\-A?OTY:DC9V#(PJ!#3I M]?4YL7W/L7/P(/(?Q9QS"1[3)"L.!W,I%WNC41'.>+YQ%=_-975C-#Y8L#L^Y?)Z<9FKJU&3)8I3GA6QR$#.;P\'1VAO0IRJ01WQ M/>8/Q=IG4%&Y$>)'=7$6'0Y@A8@G/)15"J;^W?,)3Y(JD\+QD;EA!9^(Y*\XDO/#@3\ $;]E92*OQ,-GOB+D5OE"D13U7_"PBH4# M$):%%.FJL4*0QMGR/WM16MLE4?ZF=3MU9LXJP:QJG,U;>Q:B?'$Y$5(HDC)GD$CEG"LI"#:96N !^O M,U9&L?KF-[ #KJDB=N Y32P'"NLHS 49:9F6,Y#'M^SFX0/0<:E">HR MD[L&P44^#E 'J2',6IBXFH0U8RFV'$[5/0XY)+ \7NXT(8+M7(YR^YY)D4>\\*$CFJ] M$H\B1WO0>AS")/"P:T;G->@\*[K+G"]8' '^J 2J,$/T=(B(4MQ%J([3SN/7 0,%T4&#&B6"K3-"*]%/\J%;8$F%O M>5CEV)@4A#H=C/:>7C4HFR36Y!5MLX(HED#<-L.S4/5$F1TC<:0/D.,3''A= M[GH@1M11/ST#U HILFK7N/9\%=RRX,MQV@'*7^9,QMD=2+AR5T;D6$>.7%4+ M81>Y*3#P ]HWM5I91'9=G%W,CLY7#L (D>@]$TBKB$2.\13P3T@6Y%$ MSJN,ROG9T?'9^=GL[-3L5I!5;-]J5[:5;9-T*[C(KKB--5BPI[X*BW2%]!&F M71TUA#FPMJ#&<6EU%-F%M MQ9W,M&Q'KJHF)"SU?FT[6KG^A4+7ZB^P"K%CE M);<+,-*EE7JNXY(N"ST.P2! ;H\&HU:$D5V%)_6.2%74B"]$$9NE"QFD$\.@ M:VX-88X3>'WSHQ589%?8!J/:D)99!*+2/(MUX224!FY77PUQT P1M]**[=)Z MPF^Y4IA(052FT(P/Z\J*E+JL^8_5_D:/4W,;>SWU#[?2B5^0SDTI >(FB>]8 MO?E_G>'&!HGT((7=Z6J*HQ2ZJ(?!VD[3+I";7BN)V4V%M9Q,2J..<7WWX'L].KK^N:8\1JE=OP8;K43V[5SZ6I>&CJ#*GJ!\HU!%Z=A MOTH)Q6[?PFX%%%/K-)O.+B9_?+XX/SF]FM8KV=L'IW]>G\W^-I_&_((F6B;; MEK)M3(>]6%=VEV*J#9Y7@K;?'RM_F.[_A]% M45RM0%56J^."G3@#(5O$JLP:P>H*3Z"O-AN>5E/U2!P0SUUW:)N06SN [79 M&:LR+9<&,>*W<1@;-[)8E_D=C"FFT-- M6TBT)#M:>PU5O0/\RO*[."N4K;I5F>&NIY9+OGRMMKR08E&_F;H14NV8ZH]S MSE31J0+4][="R.>+ZF57\W)S_#]02P,$% @ %T!Q5K92F\+O @ G0H M !@ !X;"]W;W)K5^>2X&JF17C"9:JR]>F2#G@,!E8 MEFLFF%##]_*Q.?<]ELF84)AS)+(DP?SW#<1L.S5L8S=P1]:1U .F[Z5X#0N0 M]^F=.=S.#4L300Q M!%);8'7;P SB6#LICE^EJ5$]4POK[9W[QSQYES! 8%3"IQ3 M!?U2T,\3+FURMLB%4O\:%Y&J6*)WT9XP*%I,0 M2PC1#8XQ#0 MM)U %_<49R%1,V_1Q1QSH#("20(&94I%H M/S,HGWI3/-4Y\-0OF/90W[Y$CN7T6^2S;OG70%9RIRDW5?Y5$9RJ"$[N-SC@ M-U=_'>!<54#5.WBX+/-".),1X^0/A&TI%I[#W%.OEHT_M/++,S?U7(['-:#[ M%72_$WK&DD2M@Y(XQ1QM<)Q!&VEA-*H16#W+LO ,RI/J.GA6 M+]O:77O()X4VN(<5]_!\;B)$ULX\?/Z.7=N=6)-]XA,"&[QNQ>N>SZNV;2$Q M#0E=MT&[IT*?$-B 'E70HT[H!7"B,*_1TP)3O!FI\R-P M':#F5XS)74>?4*H3J?\74$L#!!0 ( != <5;0>Q:,(@4 ((5 8 M>&PO=V]R:W-H965T&ULK5AM;]LV$/XKA#L4+=!$(O6>V@82 MM^LZK%N0+.MGVJ)MH9+HD;2=_/N1E"S9$L4Z@Q$@ULO=\7EX/#XGCO>4_>!K M0@1X+O*23T9K(38WCL,7:U)@?DTWI)1OEI056,A;MG+XAA&<:JMG]VPZIEN19R6Y9X!OBP*SESN2T_UD!$>'!P_9:BW4 V23B M:7//Y)W31$FS@I0\HR5@9#D9W<*;&0J4@[;X)R-[?G0-%)4YI3_4S==T,G(5 M(I*3A5 AL/S9D1G)'Z+]J\I+,'',RH_GW+!7KR2@> M@90L\387#W3_&ZD):8 +FG/]'^PKV\@;@<66"UK4SA)!D975+WZN)^+(0<8Q M.Z#: 74=_ $'KW;P--$*F:;U"0L\'3.Z!TQ9RVCJ0L^-]I9LLE*E\5$P^3:3 M?F(ZHR6G>99B05+P*.2/S)'@@"[!7QO"L)IK#MX]E7B;9M+F/;@"3X^?P+M? MWH\=(0&H,,ZB'NRN&@P-#.:!;[04:PX^ERE)3_T=";Q!CP[H[Y UX.^XO 8> M_ "0BSP#GMGY[L@"QVLFT]/QO(%X#V1'RBWAIIFI/'VSIRK6&[[!"S(9R6KD MA.W(:/KV#0S=CR9:%PIV0M)O2/JVZ W)#Z DPL2T<@^UN]I%=E/D>T'L!6-G M=TS"8!?[,$GUQO,1&9.2Q4K. +AN7$7:=\(>5$8 MF'&&#<[0CI.^X%R\2) :KPE%S!.(C\#@^#&?+B([HG,.,&9FR%^3<5.#_,\O"J MC?LY#E"0P+@#TF G5VT<>V:428,RL6X=,\J%VG0MJR&YY YRH6 G7*';BHYK MS4F';:=47XS*XO:+(8F#V'4["3(8>G[LAVA@7X%'4@E?A?KMFQA!^!%0L2;, MB-D:[ZS*K#G!'B<_AD.5 5'+")U1&XN?K[TZSAFSWS?T @]%R1#65ENA5=6F M7QCE7&TSRTR =[F\,7<@7@] X+NP5\<&NZLP<>7? -!6'Z%O+>6Z;RI7@#S+ M;IN;A0=:5?:UY7RI:*>46\F%=LV]37=$2BQ7I'&9JBP55+>.1NI]/0WB.(&] MM62P2U#@PH$,M0MY(+[9I;%2P];X7U]=0+_#")>G#[ALA-5*LQ +>57AC;2T'MC" K M%[0P;RM6Z7YU$5PHVBG95L&A532G7TM!9%QAXYOT%P9,@FY#9Q_H]1T=:H49 MV86Y6E\_2QLR:+&!AGVL_T&C56ID5^H_E%3,R9(R4M-0;2K1\K'+U!&$D59? M9:]0DOC'FE S,UE&,4S"@0I'K20CNR3?'Q "B?X$O!&R-=@K.HP+!#HEW.HZ MLNOZGT0 I>9&>E[O&W$H(R9+:T9:/4?V#]X#0"!W7=DK%87,#5]CIMK6.>;9 M0NM(FN5;T3W4J%E4\>-C;.ZUV_W*'# ;Z$=0*\[(+L[?]5&6[*VQ%&F\(J#< M%G-)179\QVPXH%O!A>2BA.5<:@:)#J'NH[KL3%_:R//]*.H0=(Y.LPK"5OJ0 MCTNLVU)41T/-T^8@\58?GW6>W\&;674_8;;*2@YRLI0AW>M(PF+5 M@5]U(^A&GYG-J1"TT)=K@E/"E(%\OZ14'&[4 ,VQZ_0_4$L#!!0 ( != M<589AWR]8P4 .(= 8 >&PO=V]R:W-H965T&ULK5E= M;Z,X%/TK5F8UVTIM@PT8Z"21IDG0[$JS6[7;W8?5/KC!:5 !9[#3=O[]FH^2 M (:2R"])@'N/[7-\;9\P>67I,]]0*L!;'"5\.MH(L;T>C_EJ0V/"K]B6)O+) MFJ4Q$?(R?1KS;4I)D"?%T1@9!A[')$Q<E^[S:=3=A.1&%";U/ =W%,TI\W M-&*OTQ$4_&PO4WEU;A""<*8)CQD"4CI>CKZ"J]] MZ&0)><3?(7WE![]!-I1'QIZSB]^"ZD0CNA(9!)%?+W1.HRA#DOWX48*. MJC:SQ,/?[^A^/G@YF$?"Z9Q%_X2!V$Q'[@@$=$UVD;ACK]]H.2 [PUNQB.>? MX+6,-49@M>."Q66R[$$<)L4W>2N).$A =D<"*A-0,P%U))AE@ME(,'%'@E4F M6,T6G(X$NTRP&PG0[$C 90+.N2_(RIE>$$%FDY2]@C2+EFC9CURN/%L2'";9 MS+H7J7P:RCPQF[.$LR@,B* !N!?R2TX;P0%;@_F&)$^4@S"1#]CJ><.B@*;\ M5[#\L0O%3W#VD)!=$,K$HHP>W@%>2+2C@ CPYTI< 1-> &0@J!*U@,8Y=+9\O.\>N"R'7AI(VRX%JP'^NU B$UDF="L FN,F15C9C]C M!4\908\5>6=R@O -22D_'\16*U9 :$!W6:I:.J1KVP. MV8:ZCNQ*&[NWCCIED!N)))U?'!:5BO!>^"-GZ=QNC1'#PR$6Q.MLVG: MCMDL&$U=\M7-'6QE-9J=BF9G$,UY1:AY_JAD>ALXMF2<]BBAYV+1DI[:0RQ(LHH9#97K#+L<(0(>B:&1G/#4$1>NH:% M7*/A;WQ%)#0]A&VK8R[# _<.AQH2F@1-*_(Q=7"@%U$&2O:PUR*PM\/'KOE: MT7Q=:'6Q]G8;ZO';:JEZL8]8>V#;'-L88J^I(VH7@FO\->DSKXF-0/?,-^]SWHT&0JE=%EP6';@RNWDW:8 M:;@0VH[5K F5J4'GZO4[)Y@+]7LMHUV MUT:BU6MK1?-UH15BC@_>=F5O/[^35&[X'$1T+>&-*T>RE18O%(L+P;;Y"[!' M)@2+\Y\;2@*:9@'R^9HQ\7Z1O5.K7NO._@=02P,$% @ %T!Q5D]U!E?9 M!@ WQX !@ !X;"]W;W)KQ\XPR4QZ2Y$?V912<=8P,$8^X+S,5##XV?,BC*-,$.'X62COEG-G W>=7 M[5>Y\6#, Q-\F$3?PT NSCIN!P5\SM:1G"9/7WEA4 [03R*1_T=/A:S10?Y: MR&19# 8$RS#>?K+GPA$[ T"/>@ I!I#Z +-E "T&T-S0+;+8!F$CX@1E*@9(Z&3"S0 M%<19H(_W,5L'(CRYG*:UNMIEIKMI!/Q(KY_*P# M*U7P=,,[_0]_8-OXHC+Y2,KV'&"6#C!UVOMCJ#M1(H3*R.U(.Q^9%9=-OTL\ MS_0,[[2WV35 )>BXV+/-4G /G%6"L[31&03_PGK*TAO)!$J0G\1^&'$4%Z"S MM]FSG^7]*DTV(20I>GA!']<"'L+X$X+JF3(9QH_;\A/*D(L3E;'6,2-Z)&5[ M3K-+I]G:B,YDXO_("V6 _&0)["%85G]51FLUJ7$BE;U;/=9. F!L$,M0A]\I M+7&TEEQPF-8/6]$[BEGM6FIJ9WB3A7O0W1*Z^X8@)*N<^/AS%@2N,L%MFF!2 MRW&=FAE-.6IXCM'B8*]$Z6E13B?W.PLDXI S.K!> X1I0SFH06U*47M': \H M-BK2,_2%>L'B1RY@30/'IFE6$I@0''B/Q0&*0O801NV+NU!^I-5]+&W[KMCA M?ZR-VL#WDW7&^+ X>+AA#Y$R6H66W4!8-L56+5P*,=MU/9>T1(Q4,(D6YD0N M>+J#$7WXPR48?X%74=Z[K%@J7Y3(27-5>*;E&77H6@#O7]RXZAJPEI/[MRE? ML3!X72Q*]BQ4[%D!:]:M5RB%'/$LD[;XOR)VK&?V4;R!59*D:A>;C4F[Q"+8 ML1OPFI+4=$V;M-0>7)$[UM(@ 1ZXDBRYU]ELM7TI&TXU"!UK ?PKC8A*L[% M>M(MU^2*O;2:T61)$Q.S8413K&L3%[VU.KA@5:RE55_PO M^)P#GM*+)J%T*7%3OW91RV&FSH>)+HN?+ M\?LW:4HSFE3I8=)H:11B78(IM7#+?I14I$K,=YT7C,;?+F>U\P)E!TJT9/W> M#O18VO:]4#$W.8!(\\.GO"N:)RGB/]?A*MNY;Z=M->6<-,F]"PU&O=<[!)&V M4%343@[8!9<)7>0P_&VXJ*7PKND:!RCX7N6 W]^K[SN@ZAN(\ZZ/I&W?"U7_07ZQH^=21A#KZ>P>B06#*=!3*!=Y%BB-UZI[Q]D* M4?0JU'*LEBTUJ5H5HM_]UW-XZZQY&+/8?T,M_OT&I+!/T?)H[*-5HT+UC4IN M7WYLD)\:9)9F9P6 1J:AGS6\;;&CS>[%=1Q:YQF%&/",[1&G9?-&J^Z$ZKN3 M<_X8QG$6A3;S M^^DEFERALAH"]U]-IC>#N]%DK"Q_]+B7!/_'+0&M&A_ZJ],$R;,8Y@ROM/: MED19#XZ@:-_&JJVA;SV0X*+=SM]O1 H[K<:M"39LZM:77F_GJA#V*X_Y#:I M^5Y^>^]6OBUO:0?YW63M_3D^&6[O6BLUVZO?&Y9"N1&P?YB#2N.S ]#2[6WJ M]HM,5OF%Y$,B8=.4/RXX"WB:"<#O\R21KU^R"E^;1, '8R 8 >&PO=V]R:W-H965T&ULI5MK M<]NVMOW.7X'QF=-Q9F3YE39-\YAQ[/;4YS:-3YRV'^[<#Q %2:@I@@5(*^JO MOVMM !0I.X\[]T,;B2*!_5Q[[0WZY<;YN[ RIE4?UU4=7AVLVK;YX?@XE"NS MUF'J&E/CEX7S:]WBJU\>A\8;/9>'UM7QVN#UR_EVHU__=)U;65K M<^-5Z-9K[;=O3.4VKPY.#_*%]W:Y:GGA^/7+1B_-K6E_:VX\OAWWJ\SMVM3! MNEIYLWAU<''ZPYNGO%]N^-V:31A\5M1DYMP=OUS/7QV<4"!3F;+E"AK_W)M+ M4U5<"&+\E=8\Z+?D@\//>?6?1'?H,M/!7+KJ#SMO5Z\.OC]0<[/07=6^=YN? M3=+G6ZY7NBK(_]4FWOL4.Y9=:-TZ/8SO:UO'?_7'9(?! ]^??.*!L_3 F<@= M-Q(IKW2K7[_T;J,\[\9J_""JRM,0SM9TRFWK\:O%<^WK=WZI:_NWCB:JY^K* MA-+;1KZ[A7K3!3P1PLOC%KOQF>,RK?PFKGSVB97/U5M7MZN@?JSG9CY^_AA2 M]J*>95'?G'UVP7_K>JK.3R?J[.3L_#/KG?>JG\MZYY]8[Z(L75>WMEZJ&U?9 MTIJ@_OMB%EJ/4/F?QQ2.ZSU]?#VFSP^AT:5Y=8#\",;?FX/7W_SC]+N3%Y^1 M]FDO[=//K?[_2BH?WG7-1-<*J?%8;LRLO;9R8M+MVYTO9W(5VPU^.F]65JZHV[[7],O M&[-_I0O]%>?S1=?Y=/')1!'!C*^VZJYVF[K00?VGL^6=NFVU;]7/KIHC%$*4 M<*(V^-W6I?.-\[HU/6447CZ_02WB,!8 _:"(:Y,I3?:F^DG M+71=J[?:ERN&\RL:V$%W%4:WP*:E<"@=[4M%?YSB'K<:BH\X;=%V ;HI0Z3 MU7[\]>HVFTV<[:$438 -&U>;N@UJZ,$;[^9=V8;^F;6NNP62J/-49:O>V+E5 MOVM86RWXC7>_\4NM^G@4/$&F*5=J5;98."T^)ROUJO_[SK4$34#>ZO MDA%7UBS4+=(8%A2Q$3X=%G1^J]XM%A:FD,L:-O*P1C30P/Y3]2[[YOGD$?= M<4.-;-VZ0M>/&5W28^F-@1_;D9&NAK=)E_'BJ#E$?I #>FVH[&>;6Q3=ZW;QX MKSXOUU3==#YTR$#5.CY>?/ZY2?3UDCD+P8?6&QD,I;J:H](9Y5DVN7AO0R./ MY:!BVJJ@*Y.M@(\%;I\Y&,P;!'>E*@/U4K4T/LB=M:N/'O]YJBX[[R%LMDB_ M58DT@Q1T-"($2)'B(X?K]=4U/I\^>_J"D7+1+;%DKDA[L2)@,T]P6/RB9SVP MZ!XC5$87FO!PA=BR0G2,9Y1!1X1 VCK!*M?9 9H PF8%#V]3+> MU%#RI2#Y;VC*C,0@"[M'X "*\ XO3& %GGXF 5!"+:T)(+1[7E8#A*""P MI67>5%;/(.H !+\0'F^NORXLBKVP4(^$A< <@X(XQ[2U0Z&3B?C[#N@$O6Y6 M$+D!Z_,>:-TGU>WT8MHC_LW;F]N+(>2/Y-1 ::@>*^EXN9'A)),&:U[OX"JE M=MZ>P"_*A'T@4U\ LF(80>@BJI !2#Y_KIZJ6$]#AG+;2@B*Z[A[+2I]S[QM=CFL MYV0SO78JK-W=?OX60FYPLC.DA>ZJI2 '\)PHBJW="$6;1"8.R/]![I+1"DPBOO/3 8J"E@, MUX-%4:/JU-'*ZK8-@X6X+"19NTP[A_9!=KS[_?KJZ/2YNL9ZRLRH@PBJ^^M[T*?U%G2O >RP2XM 4" 2?W1K70](>FKM6A- MT0 4=R&[<(Q:I-9=3435T45QNSC)2$)7E'+KL!B-VCBL0/'BSE,8J]@G[C"" M*BL4!+NPF>YD$[NNG6'QNXC'#8O?&FC!$8(T$R*P;BSY9(D; T7.YC,?D6Z= MM!&=SR0_18'T9,]>A&)A0XE[MP9$6-@>[8 OT(,,6E(NWO*P.L7V)A)AW&\E M'F)&A*YI<*EP).7/MY[$?JGLE4F=4#(2(Q6WC%*T+ MQ/E!'=HG:DGA:RE;IL8=92QA>"XI*.!$^PB6YY(\[PPC"X9R=&!P)?)56+FW MDHY(ZB@"S0'+56SV;'T$K,3F:HU:P99CN">,/9#&L4<1$*!)#BUD3> .4,?2 M# J@1&P0*['^P@$5D4=\4BV0]P,2#(')DWMC#$65'18(E;Y&1=&EN>D=,+ Z MH1S\?0'9!2.1T^Q+ ]+G7AC&) LJ;V=% M1#=6.%0E:N9/*# MD2:T("'Q/2A,."K8H*HPXG*+^DB23&"P#LBIY\P.TV?5HQIF2CG-4)RP^J>K MB^+F[8<+<,+2ACQMN06!,W]UC))+U\$%%\F/%Z)AQO#S3$2+M-0 F6,7W0KC M;O6=B0-1)TTC8U ]?_Y/ 6?H94N]"Q-1;DZJFVK,E:D9^N_\G&&6 ?OMU;O= M (")MT;,0@Z$S>GD]+MGDY.3$R$L+:Q:EBZQ :P\I \Q'A$]W)6;_6V\&]:W MKET!C__6.PH1.H1OTY>XV$/KRN%N*9!U1$0CV1Q[AG)73EG?10#@"%+';YG% MI0&/8SK('P^;+LB/RK32EH2$@(4VB,'0&5RII9ZZ+4'ILM6*?KP3.E] R MSZ7H088+#Y^5ZI!X >+\Y '#F3(B\I1HPK[*UG4JF;OI%8M%IBTD/I!I3>!J MV&5+$@="!X*[JDR]-%F#J?J)^3<9S\+2) +_#P9UAZ@@4,2'_H3L I0(*S"" M'.6T!O,&*L5>N]TF>= B.51S2ZG/TW?3PM.4)^]4*27 C!]F) M!E8D@ ^/ #RS! A!#Z FES&7XZ;SG%&$<3%K5.R+1L7=16^!ZS1^Z2LJ)4DY M IYLR!QM!)(^YRA:&.[U8 ?A"%^,,""13#9:%:$>3 MD=^13Y0QL9;?IK?3""T$ZPMQ5NB;PQ_976 7=6E]V=GQ8.OT=/=##P"MRQY) M)NJ!;Q[1(_F$F>C-B@WE/8@J@"_DA"L>-<<#R]$^R'>_[&(QB1:7Z9F?6=1& MOQ48*W4#DUD'TM>!BD7%+N;PE8R86]G?.T ENPO@:X]L%S?#CG57"I Q7I-' M$OJSJ1@-=!#3!TR2'9$TD!Q+MHS(;!>.A-/X4^PRML00A2>Q[LB,0@@:,>M# M,LREJ]&&5B.!/USN!);)6@I*CE6, &#[2'-$@_5.Q?[>P6"2S'E$X%V;.H_D MO::;0S9R>/**',6'H%-:'(YHE_IP"@.TG=Z5$,85# M"P0S?2I @OT\2\U /[MI59JUE MZVR/N*$-0YTDI=^52 I8]O3I**$3\NW;VINC&' 9P1*5EU$GTR"V.L'N $N6 MF]L(-!DH\SG"()#GNM49Q4>L(73"9$ULIP'!+L* I'<1/5J:.,-ZD!B"L)'= MBI.3!4PJ.UE[HF_4OAFT[GW54+NJ\7H=V:J9T?F M3_+^DW3JH8?Z?M(-O1NC55J[U)G^\@I:)BM#74^R M!BOH7"#G\]BKU[BEZN MM0&?4RM324-/6I#<<#8='!"3$V'\2=#-XY(V\';"J/$:B :-[#C83$;JCYJ?*;3VEA MVE@(!@5E7(^++];C?JK$A&+)B(;IP4UF+ 8V)3X85A$VLS,#)=%B %%&/'%D M%[U<(B59C(N$U(/R/!ZX27P=P06X_VC49C>5KDEY@EW64;1&NN16;=&BKC(K MEA,\>3S.3?8IE0C$@QJ:*CMG@<9N7G#\4>H'L)_AFU5?.<"M%/&^4X>80=%)]B!WD2N//>S<^]^_(P1U:)[(\!SRG# M*A^M/\9T^JY(#N!'^%$B1RS/94*#<)EQ I8I[7!*ESPM[LWNIY761G/" MAW5&I\=HNNK:5&EYF8\?+5S9$7EV8=?P'16>P?4O/<0Q3M*[!8(9(B8;WX]6 MM"OBK/V>Q_#]M![+^E&76:;SDWAS&L?WFPS8+P"@'^+EX5;B+\#U=4P,GE@? MN<41['+$B232T![)6S?&+XQM"_;SM$>9V)8>[6G7TU: MLS3W2KRJD.FTX0 /N2I.Y,G,X&L^AJKA@KK,P7"H,ZHD36,K/])F(MK^25%X MQ_G1G]U\:=)^Z<6.6,X (;V,T8Y1U5_=_6C, &6?GT1E]:)-&#_2+AAS-^BR M1JU_DE2*\&W7D%;'6C;%1KU!%GOZT_7"B2;IU8*^?8Z'6&H#@,QOVUB'R+#R MC,!H\O'>;M>96# EUF8\G.>UTC:((N!98C&(NG0DW.:!6#J,KZK_ Q-@3LS^ M3..I?48XG$T#E$KDMR!F9B(/2.7C?@!G(0-5&W;Z]O;]4'4ZYJ5[GE%BZ= MJE\^7$WR7#V36RF0B9&*&7.7_5#K(DWVWO-T2\C(;W5JQUJVIA$:XG'.@ I8 M>6D*T.18O?_F1@/_Y-EAX]_MU5VV(7EV77NL5"VK8L MP-AOZT&-B&(WRM-=R%LFP0SS8S0]YPLDGZ/.A(-EQ,5C) MXC;C([@!I,C#&PO86 -;&7@;4K!X5ITD+O8;88E1>0^;382,I.*YVZ[0";*] M0(^V8:CLO=G(@XBV'^6(1 !^S["0D[Q\[F[7J?X +_@6P53Q-5W//.%)S"=0 M\FM4>M#;?ZU*4[Z#8MP#G<:GFB,?#L8ADH3@/K8$O)")CSJ)7% V>=#".%^3 M@KLTJ(OOI$()W.C6C&I$J'':#V-6@CX[8T*9-@V V@ MM=1'&X9-0&X!X\R-PR"V)>/I_22_!%?%%>/A7JV]=QN>[9'#0N1V%RA]9/E. M0"X>4$?VN)-'2/DH$'MF6NPS4_6PFYPDQHA_U&.OE1\/_A9 7KZXE#=]A'3' M/POHK_9_5'$1_Y9@=WO\BXRWZ"* *JHR"SS*\Y>#^+IF_M*Z1OZR8.;:UJWE M(R@3U.4-^)W'T_D+-^C_U.3U_P)02P,$% @ %T!Q5ILU] ?I&0 T< M !@ !X;"]W;W)K9L9WDUJ=-XXG3W@]W[@>(A"0V%*D2I!V=7W^?W05 4):=GID[M7KVRV-"MM1_7:5'@RKYN5 M;O&U6;RRZ\;HG">MRE?3\?CDU4H7U=[;-_S;;?/V3=VU95&9VT;9;K72S>;* ME/7#SWN3/?_#YV*Q;.F'5V_?K/7"W)GVC_5M@V^O I6\6)G*%G6E&C/_>>]R M\OKJB,;S@#\+\V"CSXIV,JOKK_3E)O]Y;TP,F=)D+5'0^.?>7)NR)$)@XV]' M;O\>>]L3^5FKKNR_5P__&+*L\&_O3#Y.3\<4SW!X%;H^>H_[_ M>W+/+K5[([_7K5%3]=,/9]/)Y$+M9"?Y!^Q@0E%EQ;HT//VZKBR>Y+*=+TNC MLO"+R=6\J#1&ZU)9+&$ #ZU-,+_L:@?JA V78S6^2%;L!3JG[5Q3UH_*9GEF7ZZ]7-2-U4K6DR(:*@%975C"TV MT8U1IBQ@H,3E*$@C&1P.[49GC@#)H*MTEQ>8@2V =+'Z_F:W]J*6^MZHF3&5 MPM&LP4>NBHI7:7),-L"3=LG?G=S7O;@7IC*-A@CHN5D+'TS]CXJX4G>T+"]Y MN0)[F5;[)+SI^.*_+B]O^>/DXB4+B&8UG3M$^G)GLJXI6CIA>O[^6[;4U8(9 M7Q660=T3NWM_/:!EEW57YLD,%.%G:#\0RU]=)4#.&Z(5G.QVBXGH5#5QCZ&- M:6NBT<)+B8!VJ<.JMBU6S##_,>TDHMU3(EZ>H'9951U8^FS6==,J\$U>1$W& M![^FH%JZR2*J]]:Z:-0Z5FJ0Z ]@7=LBX!"KA+'PCZP4""0:+>9"M.BIUWH\*>KJV& MDR8/3K_A& L@_I>GR*HGR))Q0A7"7@HH?%'E4&>*"!*GKYXD- 6*9[ZM955/ M<]Z5)39J,^QR8W0S4K^+=M7\^+MVFP)MBFR)( 6JS6#3 A +MKZ\6Y?$C4F( M5(Y%RMIV8.BQSCZK\Y[76)$=RUX4%K^3\O04(\5RRIHFO?CK5=$RHOUA#4G[ M/?1FQ:! QR"0LT,/!N!,NZ#PL6@WHO,$'N#C[ZZ@/?:Z2L))VJ6&<\SD.QYV:VXU>$<"Q1F"\<0A0%GI6E(Q"[(MZV=) DBXTGNU] MYQRE914Z5H]K3Z+-4^PTYMY4G6. ]*JRH)QW;&S]),9F/J5_8-"QD48V"ED# M]DT3!#E@.(8PL@? < E\I87[ W>^%$Q<9FW'P"!VD;'BY@5DWZAY4Z] O+;1 M68W4M;9+%@5_>(_SA0_EY;Y$'HOA!TQ:WL@283-,H"PPFMS/O?';$L=%.RH6 MV$*)';7D439R$HTA1>> $FH/QT/^G-Q@U\#36)R!6')&O)B>%P80G/^#85A0 MA^GIZ6%Z,CW#IY.SX_3L_)!&)!^4R&40V' KTAEYICQ. MQ^,Q'5V2R\BZ2>FK^O#NYOJ@H%E@9J:KK_(SA1N-719K12:_J)O-:""?)5Q> M5_EYF9?I]CY("B_ ,S%PS H]8CRV0_M$2,4%/05\*ZH!J,F* /4P"$6@?.;@>D M S)A(YB]ADO#$"@\N2%(@ETE_LVCG7D+*,R6T F\;.)WAY5F=2=0+!P@U:? MBXP>7.5FAH4CV=?5HJ;-.W8-3*9S,0(K:ET5/(%5#I(QV#D\78:@WE2Y\S(K M2NA5 8:RE@7RA!2<'YUW0">75.N(L\2#XBD!S.*%;PU M%Q%+$GWV(3DXROI"0-"\H7$%\5KA.YB-Z&UC6WBM-)%/9'<^3_MP\^%32-16 M!OX?POY]QXY)OD3,QP8(>$U9NNPS,]YD$*M MQL"GJZ1^'+663%K^0JT5=YP(P;-E\ M%#[.IFC%GXU]O3O]1*"O'J!DR'ZM2:+I'TJLG6O9[$,=+*H?S;4,2)!J,R1@ MO<""#CHIUH6@A.E%Q:8WX_I$2$ =*URW\-8?Y3J2(_36$T7L,*W,Y)2KI)1< M/!@*$:P+#;\S@YP#Y04F3Z)HF-7.K_XWC@C*J@R5#'B_CU()'68P(Q=* M2S6B6)GO@DP"D/DLD3I%$O6B*D+-QD_3>4U%$G5Y=ZU.QB=IF, ( DB$S&3)?OB )E=>+*,.9] .VFDG"0?S5LA3L ZG-*^"(\ M)-VC;7$,RD%Q[A=V*4BJJ 94/A*%0#1&P50HU#2"1/4O"Q7!@L1\7 M24JVI>>DHW0*F,)9E!-6VHN6N%_K@@L**;(_L[UQ52.P!FEO!T*:A+JJ&Q-\ M&.LJELIT); +X,NXBF#9]F0$BYEC$88C"K 1+T&P&9R*'4KMH6";_3KD!MPU M!A&-0^I[%V*T["&%EU'RB1SR8(M(6Z1PLF,-1/_8-CE:DGRH5OB=R7)/P?,S MYY_$F5/80./.ET3MBR MHP#CU=OT9].7,WK42H9K[@R(7+RI(Z.<4?W-/K%!\90!RH21HBT%X3I LU=N M M.F@)'A >4-_?X>2>,7!)4PM[3?5TA%J:YIMUQY@C44B@'Q5LM M,\G!29*;LB"H<;4GP)WM*U9<46U$P.$4P2)YE!Q8TQ2SCG4J8V;8B NV!M9F ML@';!SI#$. QD&4H@"0A(6*.XB6#H]JPMO4CG+BT+T[)L@@RC!A;O8;_Z\=M M!UFQY+R07HZ2+SN&LNKX1&:)_W *^$E\01G.0>L"2GZ52"*C]TC#8W+2F1- MA9B*^/F0,9"6D,0&Z@BIS.EX7)8I(M5-0[1R$U:V,=E6LCE)P?EWM#@0RZ2K5G5Q2N M0N5!0J515%&G3I2M1 ZQ"=@!P7[QD0E,W_+D+C[!Z?P M3H8P=1/X M"9[56_( AUES1!?%I.(#E!467:D;1&7=FN^$TI"INH(2QX^;01W?L^8"YJ% MV):V!D,4V#0AB_A0KN%IKKM^!7#*48E+%U2R;" >TQ %83K?C7C(WSZ].&@/ MX2X53TJ=A8C/B=ZY7<#TAFYPF_: EJ:+#G$&B.R<+($_I9N=^P@J:&,BR09= MFO)\B*&BPK\HS6- C>I.EGCI,R@:VU6A" (MX!H+)? L6%!!T.0S1*].5&1S MB"BBBTNK,S/G8#Q>(J<*SR"[W1)7R !_E/E?I7!QXF MASZP_O7J1@(.YD#<:7+[\4;]!HBM8/.7P\#C]N/MW66J#-_-D25JAMN/>A.( M#BZTB13U ACLBZF\@S3Z.^U;Y"FDG]Z11RLG867ADL5,P0-Q0&H*!U)VEG@H M((5[1".D':7C&P0[*DZ0 9ML6=5EO=@@):NS;N5OM5.GVJUA\^X$06"*+164 M$BHHI7T\9)SG)T^ 'Q& $)5D=7D3)4YR!!K U1;;G=Q(WC^YXETOQ7CM01B(F':Q M;,,M>-@;Q)$.;B.Y?LNGA2\N-!VOO?QF!?_"L/#=;"Q+PNP+ZE2B;4WEH9C&W$2&F]PZPTT5Y,]+N5WI)E3] M5=0&P*$+9;%2"=M>DC^8!:*L#W0!7H*NL,VE*6*=E6N-\^=6DD3NH"#W>U/6 MDI.ZBK K]A)+3RA>J%UYM?7(X\R'Y[N;XL&J[N8KZ)?804&NB:HLNS6HQW"R MBCD9Q/[Q2W:!KNFC0SB@?6T+H:=YL$X?X V#1Z>9!URC=G%25W$K0"^GN>9F M*[H&H"9GCJ-8=(E<4P:*P9XQ&2FXQ?M+ MI/Y 728NXC)5B(&])(/_PEB.]X;1L#=A"3ID;N+FY.X0TUCM17?T)H @DC$ M"D)]3$?WMYX=^4<7[=F(/!;A>=9DV' M(+P2> $,7'-_M22/^5I;;]C%(Q\6B3JJA53O=:9$ODK)/IB\/ MN'W%*^Z\)ACBNF:+64 ."]*OE?[& M6XUV[W<= M5:T&H5.0<1]YK[U&CC3VUCY.1!E] N:DY6=<[]O]ZQ>&!91_4E M +^MRSPJ1?:V0S+IK4<&"TV7W^L(S!Y%CLD3A 98.L/BY#$I1V_D9I%+WIQ" MI7UG2QKT<0;IY3Z30D;W52Z]U[(W/L9:IB>/ 7?KKLR(>3I/YEO;"&E);@.D M#AB#L4X[J+$&5EKP%6QP5:&FF3Q023-<'VS6+D45.;KP0>HN=,:RU: _81=; M'3Y( %TSA9;6P7!Q*T\(,[UQ<"7$'SH\GY97.K*FH+X'[=%H9J!4\#\^C'=- MUSY3\7D/L+[RE_9/8^S@[BEYG$K+GK:JN3%*N:L2<6:[UW#-F=;EKG1;U9BX M-Y8NZ+APUW)/>0:50NS@"X7P,&95]9;!E2[NC[I02U\#A@A"0=(W)FYV6DG$ M&17 ,LUU;^=.?*Y9SU^K_>*E^@(Y?X0;HG7? 7C(Z^Z_H%!V/)9^ML/^(TF MP,VOTU>4*45'_1/!9V6X!$ M\N(;-HF%Y]RIZ6[0_J+[$#A0IT-2G64_$ =!\G/HJ&! 0UPOL:,WLV$&L?)1 M([V0X.\$G[M%3GRKRF#/?/O^(+Z6):)WWF[Q,N1H^_#;9>9B9+MZXCXXAS]H MA=Q]49XF=.C3XQ_)E;Q0Q^?GZ70\Z3N?=]QDR:L< M I8;/I^QZHG<_-O;IY M=X/,D+]\E&P?JR8.VX7;-6?6'RS_OU)7#D[3O/L'//F,5"]HO M"FP+BM[4W]A%@\6)V^3AZ30]GIRI?[S'Y-$>5;S'.X1J7\F>'['[R^C+2/T" M#U AA+RN1VJ23L].T\D9C.@83!P?J4-(YOC\F'>6]HVM74M-X.Q%9KIT604U M<8XGZ0D,;S(]22?'9SBO]&@,*J='^'>LIF?3]&ARI.Z6T*X#:=D@G836A?=, MPIVH*]W["P!WZ>"3@B?+[A0S +LX""6[Y6($\I%.:E/[EM>6.*DWT\;T5WS2 MKI] 7OXMCZO^C9%!@,41ZP'W6//K!=)"Y+&!N" 4=GV<6UT%[*4C;'>-).(C MJ;:;%>O"06*HXG$TR,@5&F:V]T\DP; LSP@\O?#W90#IMI_I%MZGQN6^AQMI M+=EG(&'C@"S.,T)YTJI4DG5_BH44$2,WUG=O[*3 A=FFGC$ZT#U>)D7[S-4G MGY0S'Z:J78L]52E"R-N%)M*K$BI^<)?Q3=/!1[CSNDIDSH&O*B,J,R4OE@Q7 MX-!"!H?\8_"-.F42[HIR'Z;)>W?#E>0%*3M$MBD,@NRQ^I'^ MWS]W)\.Y^C[GX"\1"^!__9#[FM(:CCZFI\>CDS/0F)X?C8Y/$2I,1L>'H/>Y ML%\/YCA#>9W-T%LH)/RCT62*X9/1Y!S_.>'^^N@"$*LF_"*/R-'K1XBE[/;% M$%7KV=MN3_%MY='%8@2RH^&ZT8Y(;_A0$@=)T3.?MS7RIL03KQ)2$,X5&QRB MK,.J8?)P[2>B>)" /W$O#JO&BPQBJ*20,90=@=$?HSO0;!C)-WQ[,KPQ#CT? MO+RW,U]C"F\P14;VG7!!,NQ=SZ;2VXA0,3TZ/$Y/STXYNG\!): ^J[%*D_AM M @48)"#XTP/!A] 6?1.YDUW7[]XCRKOI_A8V\7E$WU\=^2612H:8FU^OC%[" M\=>7T7L^_J?!^SY]+$$R ^<1CLU,IJDS,X04I7:[E.NJ+0WU^0R-=>^P1*55 M;H_L)=!W,@;]=$VUTK]++8=GTW$:B_.CN'9YS8H(O.O?'$M^^N'\Y/3\0OU& M87 R">_I_E&%:/OOKI9N+@X%"O^*?,C[I1>FX1YO*CMP:[?D$ZM^:<%7[@/A MZTCH&/49D@:#,$&'DSF]I=.+>K3%8?\F\4VU[FBXN^%&)++-J+RAY%^^Y/EJ MTK-;S\@W:U] ;L48Z>V/G@.$\J[0GB,DR"B%H!U4_EOTYLK6\GP_7ZR*DFJZ MNW;V6)(7.T@$86%V\EUZCXZ$(@-9Y +/GQ?8,X))'@M&[9O18I0.8JRG02:H^D)C?15,TR4C4#% MJD=: M"X0L#B\/!"]WPF,,;_DC?+-Q5VIT@2^W[\DNV/+M'[M7\Z_ETYMKZ:X71=*^ M0SQZ[FNK7%S*LJ8ST6N3H^0_>ILE*\DRW+O3W%<_XBQ]\-<.J!!>X7-F'CF\OEU@9LH"6NXTNZ)J4B:MR-PY MFT=WZ^L!.;[W&_[DI] ]%-'>0"?"=,A][IO94_=&LDB%WK&DFESI!OMX:/!7 M"W:] 3M2N_ZDQ:OH#Y.L3+/@/[_"KY)6K?R-DO!K^ LOE_*'3?KA\N=A/NIF M0;6VTLPQ=3PZ/=Z3JJG_TM9K_C,G@(.V7O''I=$ *!J Y_,:F.B^T +A[]Z\ M_3]02P,$% @ %T!Q5CM*HW2S!0 A@T !@ !X;"]W;W)K?C@=\4[?S>LV!/$FN_\N)C=CJ<,B#2E ;6(/&SI=>D-2L" MC&^MSF%OD@7WGSOM[Z+O\"61GEY;_;O*0G$Z?#D4&>6RUN&+W7V@UI\CUI=: M[>-_L6O/3H<3>&(LHW,LBS$V=WPO%I M:..'Z&J4!CAE."GKX+"K(!?.WEME-N*U-2DY(+\0G M:T+AQ5N3479;?@(H/9YYA^=\_J#"GZ49B\5L).;3^>(!?8O>OT74M[A'WR]N M(XWZ6S(%1NRGMUIELF&$R<2%(T\F-"]L+MXI(TVJI!9KO"30+WCQQRKQP8% M?QZ*4 -@>1@ %]4K7\F43H<5VW);&IX]?C1[/CU^P+UE[][R(>W?3]^#XH?! M?;:!Q$(\?O1R/IL=BULFQ*\%X;FLI+F.!UX<>Y'W,?-]S ;2D8#."K^94%Q^ MJ749SA$8'@IQ.5Z/Q?O5ZD+(JM(JE8DF$:R08A,-IHW!D=@5*BUX"D"5.9P \CPV?RUCU VQK)1.E55"0!! ^8KB@-936SA.K2&J/ MT'@?L>&0-22N23HA\T NRH T%!_2GD3P[)#O@GU7WM>4C<7'?[O>C05,$,1[^WH"$ M [7Y8P&*- 4S*G@0JS#ZEM@MW8;,E8:_;*# DIO$]]90G\@O5['6M%5];"/* M\7[SB-Y7UBN^E./-'>'(2@5XA3UP$W=!C4&AOPY&_/(G\7QT-%V,7BYGT'U+ M94):@5B^LV![YH,J8?JV^U2KCR!LBU"?&IZ;ST%40L[DH MX[4Y^"]$O-56SBF5==.[^EP);GK6W:'9[:B@#OQ-=GS3,&_X-&CX!':#&::= MG&+3^C_D^F!W0.!&;3M0?F L0Z:->!'(JM[RL=BY$8&Z+9$ MITMUS&=7[I=&L;W8*IL+9Z-M@G!>-S%']ZKUS7!1U0EN-@$^I51U'??MYS=K MAI#5Z=ZEM95.V1I88]MTRG_UG,Z&F'NQ:8KH^U=09G')<2)376>('1=O]A?F MR68[V &F7QZ-HW(4HE<9>' M@V<'^U=RS'XIK[G_8)06N;-E5(&6AN;:49RY[FZ%!\N:"1;PZ<&:QN+00#79 MFXU+!%O$*;,;E_VW]DK)K9^N9X\X7R2;J- B$UY1"=CE\<#0$E3OW- M K=CG+03&S"WQ\<"'TKD^ #V&PO=V]R:W-H965TS@M(LKKU]=[A>]BM;:T,#H_K=F*WW'[H[[5.!MU6@I1\LH(58'FR[/!17QRF=%^M^$O MP3>F-P:R9*'4 TV^%&>#B !QR7-+&AC^>^177$I2A##^;G4.NB-)L#_>:?_L M;$=;%LSP*R7_(PJ[/AO,!E#P)6ND_:XV?_#6GC'IRY4T[B]L_-XX'4#>&*O* M5A@1E*+R_]E3RT-/8!;]BT#2"B0.MS_(H?S(+#L_U6H#FG:C-AHX4YTT@A,5 M.>7.:OPJ4,Z>7W,TR9R.+.JBE5'>REUZN>1?Y%+XIBJ[-O"I*GBQ+S]"#!V0 M9 ?D,GE3X5=6#2&-0TBB)'U#7]H9ECI]Z?]LF)?+#LM1$IR8FN7\;(!1;KA^ MY(/SWWZ))]&'-U!E':KL+>UOH'I3[C"J/Y7ED,%OO\R2./X 7C?_O52UR MF&7)$=S#S7(I<@ZL*N#.*HT9"W>$"&XJ^%,]\G+!-7C_X5_;0\$KRS4O E'A M00Q*"IQCJX[=P&,"MM*<8[);C']<_,ZJ%:K[1)*U%H@&45U?A2!5SBR:("JX MX]M2-3J$+U4A6,7P4 68,)I#K571Y!9W/:)*I;? T,JU,&!06DJ!Q#E-6!B& M>XR5K$!QMB4H!K!L."F/453.+(:G(DZUA'?Q/)R/YUZ#W[-A!A S9NH.YM>F MXD1*,MQGZN>I@K>Y^OSY$]PIV9 Q!G[7JJGW>6+2PC5[P%.$W<(/R]8]JEA1 M"))D\C5K ;/P_V$MCF:DH=OTFK8+=+L,.MX2Z ,)^PUN(?YPY"G\BH46;D7^ -CF@-7(Q),HR>AM@"Y*TP0;4&79 M0G+L&PU#WI;4,7-5+C!3BYV1RN?(HA&R$-7*)$/[!T;M@W1>YB/QW\Q^<"TP(C^+)46!0O29)[-]TRYU;RDO-@90BY= M<=R@O4F4[J)$0QZY]PI]XJ\<1X:CXWH,4(]SU@)'2R5%RCN(I^%T.H'A9!K4 M>(*/QJ+19"2!6@J-\EO.-'F85KP;[M&G+1[<\\B/W1;O* M)3K3YX0[1&Y[@#8"C5IPS(Y"U# 0?Q+)Q,QC <1T'K*<-S MA)0T=5_NEJ L- K9NJH)R M#)V?NZ2*H^A7!P^OAQHK L8!?\*;HJO4HC(-!C)F0JZ,-=X^RYZPIR#L@+-\ MC:U)\JK 8' 1T0LE'SA4#(: %R]8*&<=A^\W/WSG4*"B^4QLY.D- XRFO(AF/X=1CTDV?- M"O1L-@DI-Q%3\ [2<()C407/M'A4+3F=V]!=O UQ@Q4,[U" -R"L+-ON$N1I M>[&*M0_[?\W=959NAW#%S!J6>+?&4_T=W5^7I2LUZ&)WO@F(!T;\2]QK3H([ MO-X7C72VY3^IXR7"5^""&U> O N_/.L*',J:B<(76-<+##$NF^*Y?)8HUW@? M$"S/W,[)@B/JFX[6#C/:I%4)+P@WZ)GWK6N.:.P]<^2JGR?!!9POZ>Y%XFY) M71P=M^8'[66)?-&#@NSD2O>P4XPIB;6:*%LPZ<+?WY%;1?6!' M8<\S-TL,-0R-BBK=9:ORCE0&GN%;97PFOW+,2ZT]XOSEKK?0I@T]7X[5\I@Z M56LSUL4P'B=AA)7-C>>S<#Z9!^[I1B8U/?]L7[H GR_:E:I::8>2VD@43J*4 M1I-)&(WCGU4E%3F+FDDMYRZ*?3,$IG;IS$ MDW"63 ]& _5,K!:FK;P62Q/I" Y%)/7REOQ@1_Y^;EUSY!)]N<\_7'>F?O,G M;)\]$K0NZKXX-7TI.OF VP/G>R(W"^-T3M,,.],,)QE-QMB&9N$LBF@R@62, M21&[+]/ E>BN T.&U,Y1RE$;+!M$P@&;@# YY2X&I.>BN_01JVDZ#B=)')#- M)\$7=R\SU"S&LW \2^$HN*7'"[XX'IEL^,$5@D,OLU'O M45QRO7)/?^H%"-^_C[O5[M>%"_^H?M[N?YKXQO0*>QJ"7:)H-)R.!SY?=A.K M:O?$QEZ%#W8W7'.\$VO:@-^7"I]J[80.Z'YS.?\O4$L#!!0 ( != <5;) MI=PTY@0 %H, 9 >&PO=V]R:W-H965T$N5#,[*;7C.)/5;;/'3Z ),K"0U), !HV?WU78 4)<>R MDQX/% $"^^V!_1:KLZU4G_0&T>&$JG(N-L1_&\[.&KW&)YM?F6M%L/* 4HL):"UF#PM7Y:!&>7"1VO]OPF\"M M/AB#]>16RD]V\E-Q/@JL05AB;BP"I]<=7F)96B RXW./.1I46L'#\0[]>^<[ M^7++-5[*\J,HS.9\E(V@P!5O2W,CMS]B[T]J\7)9:O<+VVYO1!KS5AM9]<(T MKT3=O?E]'X<#@2QX1B#J!2)G=Z?(6?D=-WQ^IN06E-U-:';@7'729)RH[:$L MC:)507)FOC0R_[2198%*OWF51>'T%-Y];H5Y.!L;PK>[QGF/==%A1<]@Q?!> MUF:CX5U=8/%8?DQV#<9%.^,NHA' V=GCQ,WB=8_#[ MXE8;1?GPQS$?.XCD.(3ER(EN>([G(R*!1G6'H_F;5^$D.'W!P&0P,'D)_1^> MQHM8QRW]( U""@X[/(4C^KP^2)>RJH@U;@=\URI1K\%LD!Z%"%5WT&@/&NB8 M6B*TMSNI$_@@X9K8A4K1<@=Q*>L[5(;FOQ *;\U&*O$739MAHW8;Y\;(IA6%N(7AK6Y1?;EZP^OUER+>56NTX75!><3@*C?2"O89$Y'[]&+1)(6, MS:*0)>$,0C^@0&3^)(/(G\Z\'Q2O;?[0WG07M"B8LB1*(?!G,_?C[=0679)' MI\^]O4M>YW0;8,$H/&J%PMBA5(#WC5#? /#(I9X$0[F""4O2SJ77$$8LC#*6 M)0E-G*W6KYE=\;-L9S.G%&+>$R"234-&W*3M$Q9D*4O3=(?S=D"*_"Q^CJC> M(Z(.T S(>G< '3]VG%.8RW7MV$D6LB1.V32;0AS,V-2%/2E6PK+K48+BWF$;>V@;(.+LCC5*)FR:3*V#&;D6 M35.; V$ B1]&_Y>R/>'"+!C&$9M- GJR9Y1_Y,IFH=X-#JEF>=;7BX;JA2RT M)R@YTM-[0L^(Q6%&SQ02E@0)RX*(,G<6N)^!F%_CR[^AIO??J7F,43MW7A\X M]+ISJ7M]E9-?17#WW+8_->#=D1"U;*=,9GET;[@FA+(6*&_1IA<5YT_>)^>]=UO^=J+8@D):Y(-/"GZ0A4 MU\EV$R,;USW>2D.]J!MNJ/E'93?0^DI22]%/K(+A[\3\;U!+ P04 " 7 M0'%6O*,'EW(% "8# &0 'AL+W=O-QOV1"=4^.PMJE.3G2M9-"\4M#MBY+9C:G M7.KU<3?I;A>NQ*IP?J%_D8>+]/2AM^T;O8.L#FK MK=-E:PP&I5#-7W;7QF'/8!H_8Y"V!FG@W3@*+,^88R='1J_)^-U \X,@-5B# MG%#^4.;.X*N G3NYXI(YGK^]9,9MZ-HP95F(ESWJ.^#[7?VLQ3IML-)GL ;T M22M76/J@PPZ=A?=V\LQ7+^'$7A6&YN>7=D]>ODG%\^ +IX8[T\"7T M'SRA%[&>9OI9.TYC>OUJFB;)(3WOC\X5?6(F*_QYQ!&Y@M-[759,;2C3)4HU M0W 7M857:PF-P[!@V&&6&$K8HE1(+VG!L5VH54#@=YF$R2VG7. (Q*)VVOA= M&3<.784^?#Z;$U,Y )KC@W&E%5?.TB\>P3-/X\-+H_,ZS3NL.@GZB M-#I(A]%X-,(H&0RC83( _=%P@)\1)?$TF@X3FEF_&^5X-+H,%!MB(! ?@$2*T20>@ER*8",(=7-@LZW8O1,X MJ\TV*UV!(%/9]#/N^]D^?<]T\) I6.F5$O]RGZ>-FY9'/!W]&'+Z?'2V!Q3A ..?MYF[32'!PVENRRU"!>&. MMLX#6RVYW&PM3L_/SM$')\-#FCN1W42TYH93U7+,[\_L45EV .J,EO*Y,D1C M\"Y8Z05N0ST^F$1I$B,7!Z,XFDPG_O#'230\2&@PG& <_Z^CR$5.2KN=@ET0 M7E#RJ,$\VUMZC^ODR9+('U=J6YU-' ZB)#V()J,#2A)??AC&= V(/T[/Z2,: MA@+ST$70LB'&Z%N1XU #0;_'%DS*#K ;4-F:+#DV\6\UJD5Z0S@=W:<'R[^B M=T$99\8+-'K#).0#QKM!GK"E"VW1Y\?2Z\@"=9EFHK#:^H?MNY_-^XQ%LQ3.!MHO/\*%"+3")&\#(\^\I#KS;5 O>W*]?YERBKAF$3)X^J4DF2#P&P(&I+/UJR)_VS^!5Z2\=L861(CL^IC/^P._2US9G6=@3^9:W_/BA^2B$S(@S#%VK$'0WQ)O,,]9$<%X M:'1V6I,LN/N\T?[!^TZ^S(7%&YW_(1.7772F'4@P%57NONC5]]CX,V%]L&[T" MPZ=)&S]X5[TT@9.*DW+G#.U*DG.7-[HHI*,H.PM")7"CE9-J@2J6:,^'CDSP MP6'&CZ0@L_!>)9CLRP\)6HLOVN"[C@XJ_%&H 8Q'?8C":'Q MW[CU=^SUC?^/O_!.VCC7MC((?U[-K3-$FK^>BT)MY/AY(UQ(9[84,5YTJ%(L MFB5V+M^\&KT-9P=<.&Y=.#ZD_;^G[*"ZY\%^T@[A!-Z\FD:CT0P.1^W7#/E$ M*=0:4IU3G5NXNKN!XTEX%(5]^%G;?8E^\$LE[U.9YU\>X8XLRACA:F$0V01< MT6_BG]ZG*?JR!6%!I_!)+[&8HX%33XBH#V['-DF@P220RFF0!#47#JT#T>JC M]RSPM6UZ7Q=[Y9&:K/596O;'*$HG'G(F'RMV>^/9KU!P%%Z MBO]?02/78U%R#R,#M-@Q^T%7AJ"U 6NL@[EI$87VQB/FAAW=P+6$BJ@;HF;Y$!%Y,SA<^PT"S;M9M)OV$R\A54F MXVSKJLU$GH.HJ#T+)V-:K.F*4G0)T3U)-UP;<3T(N10X?A;E'+L)-Z-KSS&^IR#MIW!JZX[ 'B5C;'??9\?W8$=*XM^%7 M:?12N([I5%J$JZM95VX&E"FFE%GC+" MTPW"NBA71CIB%1]FA0UK-*,(/ H"F^R%E4$O#%&,2XJ3=.1HU.@':<697%+7 MP(0*'-613YS2ZNBA$KE,)0GHLAXH5L+XS!!=*3D>,2^C2=@/PY Y0OV4:;MI M4#&U41*D2SV^KYL*^82/:&))TN1+C $=?QT.3J=O3YDNM9*:PGPS<2[\N4TU M-*I]HSZ9V7T3]/"TX_3:AM1O.-UXXZ/A*[3 0AM)SO[]I!0%:5/;,'RN!=OT M]2DE',^OF_0%8UKPB$*4D'1FKE5%/>BAXA)IVF(X MB$Z^VP18E&5.!3[/D4*DK0TH (8(332Q)%'?AZ2*=(DFB"0Y9F/>H-H-69,6 M'SB[1YV7R.)3Y;M.P.STDV@"?JS-)"YQXVB,QM$H#E0G'#14%7J$5*$I%2L- MW@NN=/I#NB!KPKX>3<,6+^]J1^UB1P/A6E+<1-/ F*-CW]'V[WX1QZ8B5*\A MFO;'HRF,Q_WIR0B>FWF&.R-K@82&!W.F+[7B>GIMW[:S_U4]\FZ/UQ\.'[U/ M=-MC2J+AX&32 5,/X_7"Z=(/P'/MJ%_[QXR^7]#P =I/-4T[S8(-M%]$E_\ M4$L#!!0 ( != <5;IL[/9\ , -8) 9 >&PO=V]R:W-H965T98LQTF6V :2K,5:(&O0[,?#L =: M.EE$*%(A*3OY[W='VHJSN5Z!]L&F2-Y]]]WQ[LC9QM@'5R-Z>&J4=O.D]KZ] M2%-7U-@(-S(M:MJIC&V$IZE=I:ZU*,J@U*@TS[+3M!%2)XM96+NSBYGIO)(: M[RRXKFF$?;Y&93;S9)SL%C[+5>UY(5W,6K'">_2_MW>69FF/4LH&M9-&@\5J MGER-+ZY/6#X(_"%QX_:^@3U9&O/ DP_E/,F8$"HL/",(&M9X@THQ$-%XW&(F MO4E6W/_>H;\/OI,O2^'PQJ@_9>GK>7*>0(F5Z)3_;#:_X-:?*>,51KGP#YLH MF_^40-$Y;YJM,C%HI(ZC>-K&84_A//N"0KY5R /O:"BP_%EXL9A9LP'+TH3& M'\'5H$WDI.9#N?>6=B7I^<5]MW3XV*'V\&Y-_VZ6>H+ES;380EQ'B/P+$!.X M-=K7#M[I$LO7^BG1Z3GE.T[7^5' CT*/8#(>0I[EDR-XD]['2<";?*V/\-?5 MTGE+&?'W(7* N<)E8%#N\9D\?;-^#2[/,+UI.=Z<@S]Z\[C M.,2OQB.XM!T5(6RC/ 1?(]R8IA7Z&4@*+98#J;T! M0:6SLH@-(]"\$+I %>3/IL,LRV!\.CR;9KO9/OKI#ET;_>-C)Y2L))9 65T\ M@&FY+MT G] 6THFE0J N UW+9B81;K ;J8+9) JK)%HPU;^MG R!E 44M= K M!*FAH+2T1HV^%Z4Q$PEDIMMQC<[#-S ;?"]FT\AG-_X/GV\.U&!+!P[3R6-X M0&R$I9; 2T8CFW'4+ 7E$3=CO0+AB(<3"ATLK7D@M@RRGXH[*%<+I6*\N0F7 M$#IZ+7$=$Y.\+-!ZNH5 TU46,;VP*Z2$CZQ^&$FU9[9&AJX(* MM>1XO[8G+$*#/D3_5MBBALFAHA1M:\V: 1IE1P]YG438\K3JQZ1@TA(#^2D M(5KN%5#H"V>7#CYPE4,R]>\<[*BGB4XE76QSSB([RU MHYU//!7%8RO%\#^?^*[ZA$+N6(!NZ,#EHNZ1APBZX3%E:RI#=HT/]/-V[ M:QND_.(7A2.M3OMX[?:K_:/E*M[5+^+QQ4.Q64DJ(H45J6:CLVD"-KXBXL2; M-MS<2^,IS<)G30\OM"Q ^Y6A5K^=L('^*;?X!U!+ P04 " 70'%6)EV9 M41@; "63P &0 'AL+W=OOF%*\6W(51)/4/4Y<)OGS=TX/OGLKJ:[TVIE%_;/*B_OYHW33;;]^\J9.UV>AZ M4FY-@5^69;71#?ZL5F_J;65TRH,V^9OY='KQ9J.SXNC==_S=??7NN[)M\JPP M]Y6JV\U&5[OW)B^?OC^:';DOOF2K=4-?O'GWW5:OS(-I?MG>5_CKC:>29AM3 MU%E9J,HLOS^ZF7W[?G9% _B)7S/S5'<^*UK*HBR_TA]WZ?='4^+(Y"9IB(3& M/X_FUN0Y40(?OUNB1WY.&MC][*A_XL5C,0M=F]LR_Y\L;=;?'UT=J=0L=9LW M7\JG'XQ=T#G12\J\YO^J)WGVXOI()6W=E!L[&!QLLD+^U7]8070&7$T/#)C; M 7/F6R9B+C_H1K_[KBJ?5$5/@QI]X*7R:#"7%;0K#TV%7S.,:]Z]UW56JW*I M[BM3FZ+1(JLB50_9JLB66:*+1MTD2=D635:LU'V99TEF:G7L/KW^[DT#3HC> MF\3.^EYFG1^8]51]+HMF7:N/16K2_O@W6(%?QMPMX_U\E. _=3%1I[-8S:?S MTQ%ZIUXLITSO] "]H07_[\VB;BJHT?\-+5CHG0W3(]OZMM[JQ'Q_M"5!5X_F MZ-W?OYE=3-^.<'OFN3T;H_[NOLJ*)-OFAG?RMBQJ\)SR5@ZQ.DILF-61&=3/ M:Z,2_XU)U3(K-)[6N:JA3P8VW-01QN=M:E2#IX<>(+KTVVVYV>IB]_=OKN:S MR[>U>EJ7>;X[*9\*4*[;19VEF:ZP'['Z46>/H/$OO:A98W]\?S=1=T5CJD2( M*&Q746NV_SK2E5$FSV!$Q.5$C0C^W O^?%3P@]8S)/)1,L,B5XYXU#--DK9. M[ ))/]M"MVF&%4'$6'JV>7DS]F2MUOK1J(4QA<+T6\@I55G!LU0I!AOXI&;- M?UN;V 9U6)G"5!I;1+^;K?#!U'\IB"OU0-/RE#<;L)=H=4R;.Y^^_,?R5H7*V9\D]4<&1RQAX^W/5KUNFSS M-%J (H(5K0=B^:TM)!CP@F@&*[MA,1&=HB3N\6AEFI)H- AU(J A==V4=8,9 M$XQ_3COJT Z4B)<#U&Z*H@5+7\RVK!H%OBD2J=GTY,<85',[6$3U\98>@"-L M$5W5Z51\H3JF'ZV,\,7]9PN(HZZ)*Z (I=529Y7:=I4:),(&;,LZ M\U&(5<+4B+&L%$ CE19S)EKTJ]-Z_)*5J:,+T02M1J G%$#?81LSA(J?#Y%5 M!\B2\X J^+5D4/BL2*'.A"HBJZ^.)#0%BF?^V,JLCN:RS7,LM$ZPRIW1U43] M6[2KY)]?M-L8WC!+U@ Z4&UVA@VB<\;6E[;;G+@Q$9%*,4E>UBT8>JZSHSKO M>.TJLF79B:+&]Z0\@6)'L:RRQE$0?[G)FI<\[H7WN!>C'O>7VM"&?83J;V%-9(OH>.LV8DUDEN#A'YO,Y)^L"+:YHW^"KWP MLY"&ZQJ(>"O*UZPUW,9R";6Q^F3EK#?D>EE7\;RQOBG/]"++V3]&]'?8=7J0 M]AVVR)YH<(S2,@LIG/.X!_W@(78J\VB*UC) &E_4H)RV[ ;"((X:K#]_PM5T MW4?'>T#6"$BF\H+L,=QUKF2I"! Y/#]-'%31HA P<9,T+;LLL=B$32K-(/M* M+:MR ^)EW=FK4>V]]-I[.:J]M[I>LS3YPT>H" ,<3RDQJ.DAM7X('W69Q?N MV7=#CC7+>HV\!?XCS_ TQ>Y'XR0O49^$GJT@Y1Q";R@<[T19*D->@F$\? :B M-H$UPA!MA3!=0TW$#2;$BPF\L/>%BCX9]JGJ-+Z\/(TOYE?X='%U'E]=G](3 MT2=E4H(6ZH/AD "]@6H3'HENRPI*)98Y/Y_&T^F4M"M*YG#W>U) M1J/ S$(77^5KPI)5O'&)4ZF^^L@*;P"S\3 Q?F, MGHE>J7E\/9O'EUB#;B(?C6UF$C.AGY*F7( /^^T\)BVD4(%(DN]&%>W**]K5 MJ*+=I(\&1E=S+,:4]]#H\A X'24UK&@'Z:L;-E__*R3N?Z('D?I_->P-G*^( MK5'BNRCQN Y?,UZ7AU+1+#P(?/%")+GV(KH>%Y' V1H!*S'8TT5NF$,LH'QB MU$NA\$/9+AK$;9<"#UKJZ$0'!/C79N\\7K. V.FEY,D3!&S"6@T'B8)L6R@Q M4DH=)8OBZ[[*P^9!,ZO7')3"6#4XENL@*<'-X+@]9J584]<<\&Q,29#!0;LE M[NP(*WE"E5\./+)W3"(-CC%$X[K M7%,RPJQN]4YS;B3I >UA(^P[W@+\5&;;;ES38X?H!?<4N.^?'.\:E.FB5 MI>*X=_H2[R7#:SW^_(C -&8*REL:Z<'1D =[.+H_=9FA%0#*3ZSHXU MM7RB8+YDSR>YNJ&41>?9?WB'R""@J[?TLP5^ GEH *N+8X-'EY3DRV^1BS2D MGPN"LL[+9!V6)&T+N2PX2D+]U%M$W^C]MM?"MS=GL:>J;H!8XD@^D3]P!8Y/ M=Y]^\A6.C0$\A1+\>V#%)%\BYJ K,D63Y[9LDQAGRH#2L+F*'&);2?JS:&MQ M-P3FHCX-+S,J/>6FEZ#O/Q4@>Q>IUYJ]_']AI]&^Q,LBW[G2 TF-DS**6JE: ME64JCH\]#F^%2U )J;J]J;\=KML@0U9/4+)UV=8FZ@S_E&/N5,MBGTIOZ>%I M+E)"@F0 )&"]PH36I5,J!D$)TZN"7<*""WN^[A:)$IT=R+Y'MRY\3[>_8*[WUNRRN6YGXS6I0<2)>BUKIQ*^(>L/4=)5L@ P M\",9+ND$)V^<3:9N8EM>B!55GO-G>B3QF,((E=9XB91Z]).]#*H(A7+ZQ.QF'?2?1;G7& M-=98I:W9WQ55(A<%:>?AA#3M^*:LC$PCO$RBGP@"]I:8 M%;74D@?F0,*,91.$(LG[ JY;F4QW*/".*&?4K8?X!51V?TG4KIYLJX'88K@! MK/"5.KVXB*_/+Z+IJ-:&\\W92P>ULK)%I5IM^ZQJNO2 M':9Q28(G=LS.;,G1#3G=HWE-0BG*X@1[H>'%O!OL0T/O0Y >8=H:+=SIDZ<60SD(YC?, M)&/B*#5Y1G[05N3AB^M0Q^<3L$H$['<1+%(L3N$(JVS1LDXES Q[F(RM@;69 M;* .^+KOH?@9R-+77"-?'V".NE/Z$+]C;0M/6'%I5[*7:8%MC1A;N05R",_M M8_NNY)R07D^BGP<>9=5Q>?T:_^&\2;(:X@DP8PF?*Z3H6_&?O.W.#=)S2:[K M.A-3$83D$U72$I)83QTAE25MCRVZB$AU5=%IMX"JO@=Y M\8UF-QK,=B92%=),& *5GIT?A-5MC+:%\YVXB=!+(8FDQ7!4E?#>KMXKQ?F* M'@_S!Z)R,. C7$8_V:-]4BX8T&/&)S>2U37EOLM\Q@QQ(5C"GK>&0S:P\;6 M_A&N]!P\ZBJ3XER70P]+7;7 13L2JP32NIMIX3EL#M:@9/_X$,P7O*&K=")G MC\H*7X@3D#GIG#82P[+G?I(J>/J8!$H'[5R@H)+@BO5NK]0:2IF15/BHLBY] M>R0FCED= ,X%3#"?9%M.==W,KA+#0A>&K3K2 05TB'>@[AUC5J9307:GPI$] M+[8*;V4(4S<^O%D $1X,=8)?!S>HR]V^\-6^\/%Y5>F-=/Y0<*U2T5$M?#!! M!F3"C8^LSI)[?I@U1W113*J[@3+#JLUU!T-9^C?(7CE*V2D"Y>J68#<3X-$ W#^<38N?S] MW>NF.QZ+4\TN!WIR<-2*WH9=N.D===Q4S0E-3<>_$@P .ZTLX7]R.SIU",IK M8R1I&C6Y\'B(H:"S1E&:YPZU4X:MB9>0>]*S;>%K;] "+NU1W8@%"RH 3:XP MX=2):L[6(XKHNB<-"[/D3*$[14J%Q1Z<*(T<.T/CJ,YB,U%;(*?<@^DB;NN& MC9@D6QAI XGN'>VN2]3IHZ V?\CN-$6*;WM*_3QEULR1 Z'C%>/0\38;;WG[ M4NYTCD RAL3_0K?;'EGU4Z'^V4(^LU.7D?SX_D[ $$M'0GUT__E._0ONOX _ MNNF#HOO/]P\WL3+<34%>0G,H^*QWGFBO.8I(45^9@"1[;C M0$9GYLC/+%RR"A"P(0[(A!#<\K8F'C+LT".0$FEN;OD&P9;J=>1<3+(NRKQ< M[9#+EDF[<1U2L36[QK#K:<6[P4TT5&.-J,8:!ZQF+"JA*(4O 8YXPB)+2@KT MRIPDR /@\,EU>?C5JT0/3T7=+OA M5+NCRJT&%DDQ[IP.::A8-:LG2<;WJ!] MN7^6X4':_>-X6\\.4NS.W8.HP-NK=>,[JOS:((ZXUS_"1RV\6_C#HCK>@FZ. M].=6$S.'G"RP\-/(]X\-\J@LCRY1[PB F"&>]-[<6MWJ;=: T*V;AL_: PO2 M-"8F,XTCTFZ18MTNG*(YO<0DHIKPP6#2!*57D)J M&<<_*IN0NKGC?A-'T.F82WE>*Y4)(NHIX/,U3M1[*I7S=A?>61 ;1('N,N#?E6'AV]&8EH09SICHU*(Q MA0L3],Q=QW"C>VNXL8+\>2J[*EWY@S#5:=QB6$49MM0W]Z?D#V8%!/B)^H%R MT!6VN:9'K+-R;;'_W)88R7$QY/YH\E+R97M(8L\_B*4#BN>+?DYMG>>QYL/C M;>-,;U9[2.WU2^P@H[!)Y:EA#0H^G*QB209Q?/Z:P[-MTVL!5;0K"@(6FZ?: MZ@,BM4<;-/*$CVTLAFL+[HP*)TAO#AB,E(I;*[ODAJ(]07:-&@*3P^=Y+T\0O/,A;M(W5G MP@*(9&QDQZ1V$^.NVHONZ)UW@DA,!13XPJ+NM%HX=BALV9--W\-(AUB<<[AT MMP7/TDHOI1G(M%U2/:&R.-IM8>S@'I\P:T#)=9]L.,X&-Q+VQ()H&ET47&8A M-^"J04+$KC3BE;*?!_8YZ:UVU6K6= C"*8$30"\TA]-6^9D[4/2.0SQR=9&H MI9K9C,EF.M3&[4*UU9T&N2PI^VS^^H2[^9SB+DL*D?V#02>02I:+]9'38W#5 M7_G^D)CBT&^&>DQ*MI@5Y+ B_=KH/WBIG=6[57L078JWVG2"@XA[RSW/M/!# MRYA8>5"_B$7TT:9,^6*3"RS.L6P[M2\X_KK,TTZ9--@.R218CSPL-&WM07>< MV3/D&!T@U/.E"TQ.$9/J!Y4BBB[T^+B"]U&5Y0-=?I3]E*VOC M;2QE>/3X='QLQ3QO)7#,R>5J26\]3>Q^#9ZUV4!,?K#3CK@0?JGR]-7JB MR5*\_?A5[W81(3FW?DY8V=-_+(+^0SW3&P54: MM^F(?%KN&"951BU*VGFCA8%2(?XX&&\O&+E,Q>5D\/6%ZV,Y[&-[)XK1\S1? MUK17:>YZ*7O&),%L> [;Z%_;O)K.("O3O6=!QZY<5&SX_E0"E0)V<$5,1!BS M*8)ES'?JK6K3T,$OECJ6LEW@U;2X8R*7M*J\^G??/.@*R3:O=US2"0O/IH4++SDWGI[]/@;G=4@@%H= MDLHQQX$N")*O?9,1.S3@>L&.SLSZ&<3&H4:Z?.<.4\<:*R+75=9;,S>D/$FL M98GHP6-!GH8";8#?-C,7(QMJ7_UD WZO,WRX=R2.:-/GYW^C4/)*G5]?Q_/I M+-RB&3AEDUMVXJ!C\LTFM )1Z[ =^_[NPQTRR]GEV5MU=CHG?7F1;!>H1T^Z M]B=_UJH_W?SZH-Y;?Q*'ABQ\[3)6L:#C+,.RH.A5^0>':+ XLXL\O9S'Y[,K M]:?7&#U;H^JN\0%0[2O9\S-V?YC\/%$_( (4@)"WY43-XOG593R[@A&=@XGS M,W4*R9Q?G_/*XM#GWS9TH8BCR$+G-JN@GO;I++Z X7R M#/].U?QJ'I_-QAL4POV>V?@%GXVKC,I>#YQ8$;.!@&2F3<^&*"9*F5HI[QS7/+6 N^)+*A#-2N9\6 M85/=M<;WX8ID#P4RK#[AJSM\GTY:_YP#(RXH5-B^\+V&%H82G0!D&\ DD%-Q M/,FVF?7;O@S*D)7=JV]TVU\_D03#,CV'B?E;=^"(2-*$D7;B8[IL$JX&(?HE.)Q>>N;TM_GL,.3AX2/ZDX^ W.4121C3EQ9'M#1Y#Q9U)^! M\8\\[)/@7J\>=^FQN^U#]P-.EWW4WK=S<2&!=_#'A1=[)TRRM_$%J:$%A1:" M)WXS L5^J!TE;MT;;ZZO/"0;M!'?1IC!I*ULR4/';&RE7-V0?L3P@F7R5?VT MM>CF5]_^G]1DU;$W8SVPSSZ:(\(HS0C98?(=IE!)C!5?Z/_ MA]_MSG!!X9@+!:\!6/"_\,AC2;D70Z3YY?GDX@HTYM=GD_-+X)G9Y/P4]+YD M]=>3)?90[F\;NG9)PC^;S.9X?#:97>,_%WPGJG."BEDCOKDJV9DKA/DKNQTC>P'32!E@Z+>Y]"0#S\9GI^?QY=4EIR"OH 34XC=5<=2] M :;&CVK"9Y)._JW$78M)@5/T+%P__Q%1#LO'W'W3NHKKSZLYU5_=5[]IK &BTQ^"\XW<7)M'4 >YQ M6J[MKLCYY)Y%N221GK7W)#OU:F[##A(('=/>GFSSOMP3H-;AJ_DT5AUQ?A8H M(K>-B<"'<+4[^OLWUQ>7UV_5ORBWB&8,&F:SM^J7PJE]!8R=,G<>W!\ M,46:GRJ^XT*U'+[:(DG:)DPM\8 ;?_C\&39!+;ED<2!,KL[*G&Z"!E%/]CB< M>P[OBFU+C]N6!B"G?4;EHJY[.P*/5[/ ;KD@U=.N*M^(\Z#;;X$#Y$?V]"(% MA$DH+Z,5%.ZOSM7#O>FY(2/;9#D5RH=6]ER2;P=(>&%A=/0BO6=;0DA&)GF+ MW\<%-B*8Z+E@U+&9K"9QWVW6K]_:0@!/Y2DBMV>X:]_ZP05PSC1*NBY3 3R5 MDGXL=MW993D1-$?3+_2D*T5BH"P$*E8\TY)3=>+TP_/ UPKJSBN)[ E?QW*[ MZDK+:(O S$1,2A[TC2L1A9FV)EPAP+O3=L/%>.>'7)VW URXS$:W7 LN[W0: M;?2CQCYS4;+LWKTXE&D3\ ON/S@VCP,=%X!8UE^>B+\<=(]=]Y8^\V]UMT>Z MT[$A[1;1D-MR_3[#L[GW^M#MZ'CHHEP<;J)T?G<%:Z[8)4G5FL[; R;1?W6; MKP,ML*/\RA9I2Z%4+G ];'>^S4W:DUP_1=-#^X5D1?;E)GQ_9SQ&AWO:L_&+ MVE_D#1O=]TU598'/TH0P'*#_PH7M9_-$_7F&FUD6)L]@DM8,"ZHG)M+%STWG M::>[8MLCQR>__:_<$#J))-H[*+ ?#B59NALTL7V_B6PAO72 JK*Y?=B!S=X[ MD(;>6C&\06\ZKTK;F&K%+X3CUS\4C;PUS7_K7SIW(Z]:"X_+&^L^ZVI%U=;< M+#%T.KD\/Y*ZN?NC*;?\XC7XKJ;<\,>UT?"F] !^7Y9PX/8/FL"_BN_=_P-0 M2P,$% @ %T!Q5K/*JS'% @ (08 !D !X;"]W;W)K&ULK57;;MLP#'W/5Q >-K1 ZVLN;9<82+H.VX!B0;-U#\,>%)N. MAC["1-@31/ Q*;E,C#0U&DAVNEGTR):.&Y$M*,O-+:^B8(3%9B MQ8RO:I2T4RA=,4NJ7@2FULCRQJD201R&_:!B7'KIL%F;ZG2HEE9PB5,-9EE5 M3&\F*-1ZY$7>;N&!+TKK%H)T6+,%SM#^K*>:M&"/DO,*I>%*@L9BY(VCFTG7 MV3<&CQS7YD &E\EG?,U'7N@(H<#,.@1&KQ7>HA .B&C\W6)Z^Y#.\5#> MH7]N&[+D7?E08X%6PK[H-9?<)M/S^%E2ICF">O6=M#W(%L: MJZJM,S&HN&S?['E[#@<.5^$;#O'6(6YXMX$:EI^89>E0JS5H9TUH3FA2;;R) M')>N*#.K:9>3GTTGS' #JH"I1H/2LO:L9 XSOI"\X!F3%L99II;2;"S3GP\ 2#X<69-N8DS9F_$;,!.Z5M*6!.YEC_MH_(/[[).)=$I/X M). W)GU(H@N(PS@Y@9?L#R5I\)(W\(ZE^WL\-U;3)?IS+.$6KWLL5^BE']Y%_?#C";;=/=ON*?1T1HV:+P6Z*LY*IO'27=,NP.8"'IE8ML4>&^K(=OE8:B>#'T_M/S+JC$V'4*C"2YH9 M\$KK4,D[KN2P%>+.W7--[8YY)^I^_HW;MG\Q;X?G/=,+ M+@T(+,@U] <]#W0[D%K%JKH9 G-E::0T8DDS'+4SH/U"*;M37(#]5R']!U!+ M P04 " 70'%6"'Y3", # "N"0 &0 'AL+W=O7 MQO!8?D;_S>:.N:R)HM>"_=U4>COWQSY4M"8]TY_$[G>ZSR*5@RO["SIW- M,Q_*7FG1[HTQ@K;A[I]\W=?AR& T>FD?8C!#1,ES1,OD+. ?A%]!&@>01$EZ!B\=,DPM7GHVPU.).;OL MM)V9AJGJ2$GG/K:[HO*1^HN?W\5%],N9J+(AJNP<^N(!IZOJ&0510TG4%FH< M#VBX&S/7\8QH6H$6P%Y-X7]WXF'Y>YS.@0'X9B'Q[O662K!EA9L#EG=M/'2D MJ0#7@+2BYUJAMY+UV!DH !I"BW:]I#C7VH1EO0)KR+IAC6ZHFGKW'96(R#>' MF!744K0@AAT7+/P$%UD13+()7!HY#0HCGJ$G'^C)WU:Y^QJN!78V5YC"DC#" M2PH/9MQ.T7$6]'1'O<&3YVJ]$JJQI'U'T7VIQ1HY.5 T%,IU_]&"*[@TE]5[ M4;_O42%*46V*&0=QG@11$CEY,@XFQ<2S%[7AJC]BZNE;,O"RDM*0V@EIHT2( M410446JDH@BB/'XK%!,H:BI;C (_+D&6YD;*HV T*KS/0A/VOF;'']T*-A$*&'$[0RG+HU3U&0J'G5:-*\G<$;EIN,(@:C2-KD9X+4CW.G"*%IW](J^% MQN^[%;?XH*+2',#]6@C]K!@'PQ-M\2]02P,$% @ %T!Q5NP2NT8F! MT@P !D !X;"]W;W)K&UL[5?;;N,V$'W75PR\ MP:(%&%NB)$M.; -.-ML+L)L@:9N'H@^T1-O$2J)"4G'2K^^0LK7)QG:VMZ?V M0>)USLRAYI#4>"W5)[WBW,!#651ZTEL94Y\,!CI;\9+IOJQYA2,+J4IFL*F6 M UTKSG)G5!8#ZOO#0"'7DU[0VW9< MB^7*V([!=%RS);_AYN?Z2F%KT*'DHN25%K("Q1>3WBPX.8OM?#?A%\'7^DD= M+).YE)]LXX=\TO-M0+S@F;$(#(M[?LZ+P@)A&'<;S%[GTAH^K6_1WSONR&7. M-#^7Q:W(S6K22WN0\P5K"G,MU]_S#1\78"8+[=ZP;N?&?@^R1AM9;HPQ@E)4 M;-NOPQ"#=9T W!M3%W3IR4;YCADW'2JY!V=F(9BN.JK/&X$1E/\J-43@J MT,Y,;XS,/JUDD7.EW[Y):9"&'1DIP^R#>A9"TKW M@(;P059FI>&BRGG^W'Z 791TFV49_0@X(^LZD,8$* ^#0_@A1WKT.&%>_ V M#'^=S;51F!B_[>+80D2[(:Q83G3-,C[IH1HT5_>\-WW[)ACZIP<"C+H HT/H MTYL54_S8IEL.5^P156!@IA2KEMS6"5S6-JD)S&Q6(Y==! ZZV$W@!D6?-P4' MN0!M4P.D6Q1>=WF5CM&%5+JHEDLN,M(:;+TXA)%@0.HPA)2,:D"@80=#W0Z!I?Y@" M[2WE;MSFX;*>G^TKOG%49;A8\)X![ MWX(+8ZM2 7^HA?H*@&>4,(,;W/2Z)(8AB>*6TA$$E 0T)6D48'B]"'QTYC$<;S%.>Z0:#\-X5VC,!HP*XZ/XAQ*IU./ M6YV^B)$ 1N\^ '$FY[*L6?6(>W$FEY7X'4TP0A*%,4G2!$)_1!*W[%&:DB2, M8=0/4_#ALH*/\IZ[7!B1#6 EJ^.[AA5B(3"IGN4:KG!'V*X]-#48"=O/2J,A M2:+$$DR1&DUBFP.!#U$_H/^4L]"ZWS&K4Z&T%1-6> MF^X TE95=B%KKH3,M2 MW@MY4A(&*3X)1"3R(Y+Z%#-WY+M7)\S7]/)7I.G]?6GN4M26SM$30DH-N&D;6[M&PO=V]R:W-H965T,=+:)4*1*TG;\[4=2BOQ0F8T#]8TE4KP_[W?BR7?C MC9#/:@F@T4O!N)H$2ZW+ZS!4V1(*HBY%"=P\F0M9$&V&+QVPIF'D@2JOQVSC4QC^[2YC5ODPK7^(3OB3H7G"]5.B.YY ?VH>&JX&+ M7^&FL5?P3\(O48(_HCB*DQ9_;M]N'GO<29I8)TXO.:$WDR;[I-Y^1#-FHVJC M?/=M14N3%AI]_GKW4IH-=_FW?5,48:9($^;(%(U7JD_6HX0LZT[1V\Q_( := @#=Z&M!;, MY#>C>MM&4HG@:"^6\>6P/[@Z"KEWLW>>G6&#,O2B/%#U?#&7 (AR\V9 :22) MAC:RB>0+;FO5?AW+SO2.P M=M3 CG[BYV_491@Z$CL( XYV?[E1%_GH5SD7N58[2N]1KS]L_U[BO0H"=Y63 M?J6SD7!KBF,\.H$4[Y!B?UZ2EQ_FI5_B;):.U Z!=Y4)_IFE">ZT-NE*[3 4 MN^H$O[$\^4%V>E7.9NY]?Y03S3>-XX]JEH_FI;2A=5[23J;K1>R(7E"O$8&XD(U/5 M!$A6#5XUT*)T/=*3T*;C < 8X 9 >&PO=V]R:W-H965TBR,DJ3(?:\T3"E/!O,3JMSUV)VFAS@3]X/O&%WZY5>6(X.]W06W;#U-?-M=!'PQW*DJ(AHHK.3D7^@$1YM48KOU1D5M8Z?)Z5]_U&"?TKUW9J M=D$EERA?H6O!),L4K>]&MD0W_#;C*Q[33*'S.,Z+3/'L%EWG"8\YD^A-Q!3E MB42?J!"TO'L_HU_0UYL(O?GQY].ATHTK70SC;4,NZH;@ PTAZ"K/U%JB]]F2 M+6W[H0YJ%QE^CNP".P'_H-E;1/P3A#U,.MHS?[DY[C"/W.:?8W7(W(J&[.X3 MJ?#( ;QKD2^+6*'+K,[U\B[]\U%?A"X52^6_7837B$$W8CF@O),;&K.SP::\ M]^*>#68__>"/O%^[V(($BX# +":#'9.!"WTVIW*-V+>"W]-$=WC9Q5R-,*H0 MRI'S?N:=#N_WZ7#ZZ$N'RYT58[B+,3P>8YG$\0N"K:'"/>]D/"8C/&F$['39 M-^0.IZ-).)F2[L!'N\!'1P,_01^BR[G.%%D(MD3G:3ET=04^:K4!AY[^-.)V M>NP;-Q"811\S?A19L;MNZ.I&85^@QJGO[[4M)WBJ8_'A[K$9!?U MQ!GU>:)K&YK%#.F1$RWS8J%61:(+CNJ1UID1DU9+FGW"Z;)OX"YW5LC37]TUS?^L;;X163$(^# Q'OE6Z^.Y^W-Q9]8:M" M#_8?.5WPA*NG$S0O-!7=N;T%M8?>T30<-4EP.N]-@O_29YR/3?S8&?\7=L^R M@J%/N:I[^EQ7D$(K"5U#JS5ZIN<$?59K)CJY<#KH6R)MT496]YJ,_4EC](B@ MW-J\F5+2=]97.]XJSJ0N##JI(>TT);C]='3[ZMU-7J,R]$UIZ+MKPQN5QW?H M4LJ"+4_07S0IV FJ3W[>E#6WEB>/3,1O'_4 MBERR;@$4M(>?@(3CR;C):?M"XNEQJM6/@*I0FRU39/KN*O-F305#6D'J07>> MIV7@6V%RQ=(%$YVBQ(W9.^5 BU(H-)M/4[OZ(W"-YT-6IW-0M @*S:;35+N^ MN]Q]Y61NEZL'DKFCF.Y,9J!BVF;+5,G^D3)Y6P_K8B)F6BXN$K;+8_0?^@U= MHRMW8D/6Q'-0M @*S>;6E./^%#ZQ(6ON.2A:!(5FS^N92A^[*_W/A9**9LMR M.G)!DU+;=3&(.^IN3S>B6<&XO?7E!@K-YL9H NS6!$?2^ .]E\XL=L/W[7:@ M:!$4FDVMD1L8@V;@^G@1P&Z-VO0"?DH=!L\HPB MP1/X- 45(:!H$12:3:<1(=B]*/#]LZ6X/7,?3J>X-7WN;DAOVEY#;! C-HA; M;'RD=W*=>0?5)U!H-IU&GQ ??A\#J"8!18N@ MT&PZC28AK[T$XG;0FUS;MKW--&[M\3N-[S+VY$YBV.TS ML/MG7D.>$"-/2 "?Q*!Z!!0M@D*SZ31ZA+C740"2&%2=D([-.02'T["9Q*^A M.XC1'<2M.X[.9;GM>[,"*DR@T&SNC# A8_@,!I4JH&@1%)I-IY$JQ+UX I#! MH,*%M+<4D7$0M-:W@K&49>XY:C=D;Z) 5T>@T&PZC4()X/?[!Z"*!10M M@D*SZ=S;\^]>4'G>&LE9]W[_CIU97OUI[OL'%1Y0:#8K1G@$1X1'_D03]80V M]"D]L%MTB[ _^I #S("N:4"AU&UL?511;YLP$/XKEC=- MG50% DU698#4).K62=NB1ET?ICUM(UHB'/#1+H_LM_ZVFTM.]"XDOR1%:9.Z34E!9:PY^9>=I]Q MJ&?F^'+)M?^2;H@-*6B+9O;^%(]VHICPCW*UBA[RBS.9)\D$Q5929&C$N1BC088U^0;* 7N MOMXG@;%I7'"0#Y3+GC)Z@?(+B F)IY>- M7^#]KBH0["^XU[QTDK7DK(#^<45!-@HU"M,[9$ENF0"1,^!D:YUH.\EH\O-F MIXVRO?#K7&&]@*OS MQ\+'0+.::T=;G4 6GV[LUT'GY\I;QX+"]^C3U[M-WK MWB*'EAG@Y^3U!'-/X*;MD,UG87Q]-4V"PVGFX*0?W&A]!54QH0G'TB+#R8<9 M):IOU]XPLO4MLI/&-IS?UG;"4;D >UY*:8Z&Z[KQGY'] U!+ P04 " 7 M0'%6X[ #)#L" "(!0 &0 'AL+W=OA;NX%?)150 :/;&:JP176C=SSU-9!8RHB6B FYM"2$:T"67I MJ48"R1V(U5[@^S./$B'9BU-Y TL.67 %14<22@2?#.=+R-;[PI^4&C5T1E9)ULA'FWP M)4^P;P5!#9FV#,0\]K"$NK9$1L:OGA,/K[3 X_.!_=9Y-UZV1,%2U#]IKJL$ M?\ HAX+L:GTOVL_0^WEG^3)1*_>+VJXV"C'*=DH+UH.- D9Y]R1/?1^. (9G M'!#T@. E(#H!"'M Z(QVRIRM%=$DC:5HD;35ALT>7&\"ZTJA3SR' M_#G>,[H&<<%!W"(X2_B5\ D*IV]1X ?AB)[EO\.#,W+"H5>AXPO/]FJL+QTN M&L?909RKAF208#-I"N0>P.2:,I+E!%5 MH<(,N4*%% R)X:8^V8:.>^:X[?K8IU?1[#JZCKW]L<&1LG!V5-4I]XX^:@:R M=+.N4"9V7'>?T) =ULF-FZ(7^859,]U6^$O3[:@[(DO*E7%4&$I_\MX,J>SF MO@NT:-SH;(4V@^B.E5F5(&V!N2^$T(? OF!8OND?4$L#!!0 ( != <5:E M!E7;BP( "H' 9 >&PO=V]R:W-H965T:AYHV;>&K$]]WU5KJ&FZE2TT.@GE9 U13V5*U^U M$NC2BFKN1T&0^C5EC5?D]MZU+'*Q0J:RL<+X&(W\T+OZ<8-6ZW1 MW/"+O*4KN 6\:Z^EGOF#RY+5T"@F&B*AFGF?P_-Y:NIMP6\&.S4:$T.R$.+> M3+XN9UY@ @&'$HT#U9&51C@>/[E_L>R:94$5S 7_PY:X MGGE3CRRAHAN.-V)W!3U/8OQ*P97]);NN-DD\4FX4BKH7ZP0U:[HK?>C7820( M)Z\(HEX0_:\@[@6Q!>V26:Q+BK3(I=@1::JUFQG8M;%J3<,:\R_>HM1/F=9A M\1WT&BAR= E(&5'Y3]+'.31<[FON0:X:("+K%_\FE\+DB)K5J3#= %U#A.W@]E#YZJE M)_R#WMV,T5]W9]"P]&^J>I9X,J2<'4]NV041%3$K.Z()Q MAH]$[,&4&RFA0=(*:7:_"Z1[3S(.F 5I$.]Q.,K2-$A"-T8R8"1O@<&%'B+( MV@60O$RF6_$D3O8(7'5)D&6I&R$=$-*#"+\$4OXR<<_"W+LG=7P561;$T[W, MCKHH3*=1MI?9'W4R0" !""@ &0 M 'AL+W=O4^6 M(*VIIG7JM*A=M\\.7!*K!F>V2=I_/QLH2Q-*IFA?@@WW')_'Q-B3+1*48+6$ND*R*@HBG2V!\.[6P]7SCEBY7RMRPD\F:+.$.U/UZ+G3/ M[EPR6D I*2^1@'QJ?<+C&7:,H*[X26$K=]K(H"PX?S"=ZVQJ.281,$B5L2#Z MLH$9,&:<=([?K:G5C6F$N^UG]\\UO(99$ DSSG[13*VF5FRA#')2,77+MU^@ M!0J,7\J9K'_1MJGU]8AI)14O6K'N%[1LKN2QG8@= ?9?$;BMP/U7@=<*O!JT M259C71%%DHG@6R1,M78SC7IN:K6FH:5YC7=*Z*=4ZU1R WH.)#J[ D4HD\A] MC\[1_=T5.GO[?F(K/8*IL]/6[;)QAUB-Z0>_+*1%\VJK!6F:6\27#H8V\TL3>[T0?-3XSN=]']8]']ONB-*MB) M[KHQ]OR]Z(/F)T8/NNC!L>A!7_3@,+H7QXZS%WW0_,3H81<]/!8][(L>'D8/ MO!#OS_J@^8G1HRYZ="QZA$B9(;4"O67E"D0?271 X@?.Z.#_,SC6B21Q1Q(/ MDOS@BC"45ZH2@*HRHS+E5:D@0\Q\LM":/.FM4O5^NN(#/.QY0>CB/;[!!"?R MC3J^T2#?#4@Y1M>:2'NK/HK1 <4Y#N(@]O8H!L1LF",JIH_^;2FK[X^.(HGJ&Q%+ M6DH=)]=*YR+2$RF: TO347Q=[_D+KO0)HFZN]"$/A"G0SW/.U7/''".Z8V/R M!U!+ P04 " 70'%6F!)PKCX& !9+@ &0 'AL+W=OLOX-[&D5*+O29R* MF]92RM55MRMF2YH0T6$KFJK?S!E/B%2[?-$5*TY)F!4E<==SG$$W(5':FEQG MQY[XY)JM91RE](DCL4X2PG?O:,RV-RVW]7K@.5HLI3[0G5ROR().J?RR>N)J MKUM2PBBAJ8A8BCB=W[1NW:O &^F";,0?$=V*VC;2I_+"V#>]\Q#>M!R](AK3 MF=0(HGYLZ!V-8TU2Z_BG@+;*.75A??N5?I^=O#J9%R+H'8O_C$*YO&F-6BBD M<[*.Y3/;_DZ+$^IKWHS%(OL?;?.Q_KB%9FLA65(4JQ4D49K_)-\+(6H%(^= M@5<4>,<6](J"WEZ!6FES@5\4^/L%_H&"?E&0G7HW/_=,.$PDF5QSMD5 VD,?6"J7 @5I2$.SOJM66"[3>UWF.\\*_,@V'>2Z M;>0YGMNPGKLCRAWO8#FVE[\G:0?U\ME[#>7!\>6>18Q>V;->QNL=[)D0E+91 MUKLVPE3,>+3*[KNOCVHL>I T$7\W+/1=#O:;P=J4KL2*S.A-2[F.H'Q#6Y.? M?W('SJ]-FD/","0L ((9W?'+[O@V>G%'M95;E6UIZH0=(I<4W;%D1=(=HJFD MG(8742H9(BC1=]8EDNPRVT*QG@^1!:=4&;A4_J$.WM\':,KBM9Y=H-\X6Z_: M*&8S(FF(HA1-22S1(_FF9HGD#GV19-E62*3\ABM8&$:ZDL1HQ5FXGDE5LU%P MQG<71"*YC 02BA7'D:0Y5PWOH,^U92ZZML5C^(+?1=UFJ['_RFI7=%GDBXH5X:F M*M4RLA8_/MZ9JM*=.B/>1@]I&)&4U"3]CXZ(R(OSZ#CNCW/"(1G?KY5''%(1 M6U4\]48$@ADW8K^\$?L_N!%SF_RTHOI/6KHH#3,2LTRP9Z5(T[UIY9[JDI P MG,-<)Z/IA\#-Q.DX?O^ZNZG+#C2G(?N@E'U@E?TAG?'LPE//%/G66WW1[74! M/4;D)5*7_:ZI =893FT ) SGL$%-_\O>>#@:[S6@:9@[=,I1AK+#4MFA5=G; MRI:S6ULT26=%G"H=) SGL'[]TMU3#6@Z0]Q1*>[(*NZG^3R:472;AFBJ_%F% M)#35DZ&O'VCR0GGCXY05>:K8D# ,"0N 8$9?QF5?QN=ZV!U#=@<2AB%A 1#, MZ([K5/G1.;O=VZ5)"A>@1)PZ"T (IF]JCZ;,2UAOO) MTVM2FC..GM568S= /P&"5C<<=S@<#O8-YQR?<;C5AQRN/4UGQO1YR^S& M!)DE[T!I&)060-',;E1)U^V?S9A PRXH#8/2 BB:V:,J%KOV7'R<,8$F7U : M+FB&,8T&@_W/'J F-66N,K)K#\FY,2TY_<$S$VA.!J5A4%H 13/[4<5J=W0V M:P*-UZ T#$H+H&AFCZJ([5HSXI'6!!JG06FXH!G6-.[W_7UK.D=4]JJH[-FC M^ZYG,D#3=R@- Q*"Z!H9H^JQ.U9 MT^)QSF1GG-P-T&Q=T.K.Y#F^W]MS)JA)39FKT.S90W/N3-'&_LQDAYRL,VAJ M!J4%4#2S'56X]ORS.1-HY :E85!: $4S>U1%;L_^[?)QS@0:KD%IN* 9SJ3^ M[7\G!S6I*7.5FCU[:LZ<:1I]MQL3:&H&I6%06@!%,[M1A6MO>#9C @WHW\\9DZ\[>H+R;?+)OU!+ P04 " 7 M0'%6*.0$OV8$ A%P &0 'AL+W=OVW8E=M&@[7ZH^L$DEQ!-$K.V@9E_7SO) M)#R"@71'G0]#G/@>GW/MFQQ[L&7\22P!)'J.HT0,K:64JQO;%MX28BJ:; 6) M>K)@/*92-7E@BQ4'ZJ=!<603Q^G:,0T3:S1([TWY:,#6,@H3F'(DUG%,^N,Q#)92W[!'@Q4-8 ;RZVK*5U!!4_6S@#J)((RD>WW-0JQA3!^Y> MOZ)_3,4K,7,JX(Y%WT)?+H>6:R$?%G0=R4>V_0-R01V-Y[%(I/_1-N_K6,A; M"\GB/%@QB,,D^Z7/>2)V A1.=0#) \AA0/M$0"L/2#-G9\Q26?=4TM& LRWB MNK="TQ=I;M)HI29,]#3.)%=/0Q4G1S/)O*V5*/I&-O+D6\S9'("N84F+)%+@1X2'_S]>%NQ+*B25ZJW MQ CXB29-U,(-1!S2JN!S9P[_XLDBG!CHM(K,M5*\]@F\S^MX#ARQ!1)+RD$@ M521"TL0/DZ"!(/VMREJ&VDE1=9%M1MUVAY!N9V!O=M4<]VMIYCO]]FBW"]IM M(^UQ$' (J 0$S\"]4 !:\="#2^EGZ-T=6IA@XKKM]@'_XXYNG^ V[E?S[Q3\ M.T;^W]+"!!_1#7#UHJDI(QO$W971=-T#"<>=2+-W@G^WX-\U\O^=TT0>UD/& MJ5LQXQU'_1W0,@Z@W_LW8D4]&%KJQ2Z ;\ :_?(3[CJ_&59]KZ#?J[5\&B@X M+:QWM!344NZUR>&2-PY=4YA;"'.-PA[VEY$2$YA%N4>+PVGV^P>*C&/65-0O M%/7_2Z48Q?4O$6<B":OD;XZMYH:JOBEU@,Z+W/DZXYKE!D;Y M1M1KY-< .B^?E/))C:(T2S0V@\\I+FX/-/N=TY7O7 MY\0XU#4YJ0%T/B>E=<)F[U3].JB1CQH.JCH?;V'%<.G%L-F,G7U'U$A-#0]6 MG9JW,'.X='/8;.P)ZF_9/I=8?Y,YRP6_A]7!I]K#9[575QJ6; MH1P:8[/?J^J&FTZK>D-$2B='S$YNIO?/'VZI^I:A*7V)(9%HS%,%^KJ!OJST MD4\#%1JGJ<;'K/[SNW0>J491$N.\)/9CJM3G[/9D$;?9/91O5E%S@DEI!8G9 M"D["Y.R*-D-O-WZ4K.H<^/Z?D>(NONKDGEG3IWHC9O?W? M2[IUR?[-K.':^;5W#B%CX$%Z-BN0Q]:)S,XCB[O%^>\X/?6TR^[9X?&$\B!, M!(I@H4*=9D_9#IZ=QV8-R5;ID>:<2N.ZCG"\;D:T,/4)R*C_X% M4$L#!!0 ( != <5:7ZP?OC@4 /PF 9 >&PO=V]R:W-H965TYQ@*:AV"#[KGW7$ORT95Z2R[>DBEC$KU'89ST&U,I M9]>6E?A3%M&DR6@H,XI""]MVVXIH$#<&O>R[)S'H M\;D,@Y@]"93,HXB*'[NG1ID+?X)V#)9NT8IE5?.W]*;AU&_8:<1L9#Y,H6@ MZF/!ABP,4R05Q_<5:*/PF1JN7W^@_YZ15V1>:<*&/'P)1G+:;W@--&)C.@_E M%[[\DZT(M5(\GX=)]A\M\[9MMX'\>2)YM#)6$41!G'_2]U4BU@P43KD!7AG@ M;8-]'LC*@&1$\\@R6G=4TD%/\"42:6N%EEYDN)96WU,;R5\BW.3+> M@TS0(X_E-$'W\8B--NTM%641*OX(]1:#@'_1N(F(30/J60C]%E.5?Z&/%)#:9KV\05##['/(X8N/O$DN43? M/BES]"!9E/Q;ELOY[I;\>\V]+K8<9UN>?SM(OXV&/]+-E^IKD@73*CYUY!&[L1;I]'T MO"T*NXUPL[,G_DX1?P>,_P]!8[D]3>0Q=4J>>,M6?UMA@0X,>[U7A.\9=9\K M--E/S-OI"JHK=UR\W>5!UX;$N@6Q+DCL?K,;*3(3F%1WIW/8S6YWBQ'HTY"1 M8^M7GGW,6 'IK: K^,$!F!)<>Z<[!SVT<@:@;7ELJ.PM8P)431)KDMAPR#&0 M/HA:A[X!4#5]K3X<\"V^9V#"U UT03GU,7S@((7B<+!D#5 M6=""Q8$5RY#&OEK]J#2HQ=R8!6E"N%#<9X'8PQP$K,/< *B:N98Z#JQU]H]\ MOWY.0%=U7Y.(<<<[0>5 MI^8<@L[1BLZ!)=T+%:F^0=\>6;I4*UV.PA!UUZ.G0MLL&VB]A^W_<:6.3Z3M M5C6+67ZYK MNYZ-MRE4-]RDH#4$Z!J MXEKVX"-E#Y2#4^D;$Z#J'&A]@P\K6963-) BY23/H6F(UC0$KF$95C]@U!KT M38"JZ6O=0@ZK<-6H?L"(=:B?H^Y%M.XAL.XYKOH!@]?)PCG*7V1M\PV63O6K M'S!@'>;GJ'X1K;X(K+Y.6?V 7=7)R3EJ843K.0+KN5-5/V W=?)Q#O%'M/@C M1^T&&J7F5-+0!*@Z-5H:DH.D(7T-62G-W=W&\H4M[,:4AA9ZQ'3#D540W-UU M+%_VP@&8$M0JCIAL/%:1V]U]W%U2PHY-CT=HY>8>N?M8P='=W8'C MM7:^*&)BDAV[2I#/Y[',CQH5WQ9'NVZR TV6;IZ?"WND8A+$"0K96)G:S8X: M:2(_:I7?2#[+3BN](2L* "4; &0 'AL+W=OA:QYH"I8XX:(F M*3F>ZA_?X&)!D"A(S)QQ4I5HN]\E=8\ \! $+Q_2[&N^Y+P@W^(HR:]ZRZ)8 MO>[W\V#)8S^_2%<\$>_EE]=I- M-KU,UT44)OPF(_DZCOWL\0V/TH>KGME[>N%3N%@6Y0O]Z>7*7_!;7GQ>W63B M67]+F8125);,>?#;2WS5D&[CY^HM-JY\7.W/DYGZ71EW!>+*]Z MXQZ9\WM_'16?TH=?>+-#@Y(7I%%>_4L>ZL\.1ST2K/,BC9M@L05QF-3_^]^: M+V(GP'2.!%A-@+4?,#@28#8\RW_\86R9HY^)]^96+?K;9PI13V5H5VQ;./\8)@':\CO^!S\K%8\HS,TE@TK],? M?S"'QL]M(D#"7"3,0\(H$L9 ,$5*SE9*CHX^%<*)11>7E^T:R9>^R/"*A'F^ M;FUSWFAA7;6"A+DU;%#!R@'%9FI<]C>[ D"FHT@8 \$4 0RV AAH!7 CQC(\ MRT1+4FG@52,"XJ^+99J%_VW7@9;950=(F#LXT,' J/[LJ0&9E)Z9E(&2*H4> M;@L]U!;Z$]^(00M_^JFOHK 0@] \R,)5.A>)WB3C M"]M^^IT)6M,&5]$7;5T7\JNC2!@#P11!C[:"'FFK_&$=WXFAC_@"FZ^R^=;; M6RPMJZN6D3!W=-!XV*TM%C(I1<(8"*:H8+Q5P?A$LQ:DBZ3LIPC_MA(#8-Y6 M?2VC:_61,+>>J;SKV8#0>[57_\'.V,1GMBX0BMXV!8$I=)]NZ3K1U_9QD M!Y7-1:->'_6()C6MNJV\K=I: MV/,)>>1^EA.'Q+6O8X[(W']LT[\'W3 *I3$43170CG]G:K_&Z\4BXXMRH"?& M95F8Y&% -GZT;I>+EM59+DB:V]!VFY+] 0,T(872&(JFRL"2,K"T,O@]%?U( M&)6^;3GJ;RV^EM"Y^$B:V]#*W]*V^M;%:# <[TL F99":0Q%4R4@/513ZZM- MWR8%%]SBN "@QBB4YC8T10#&A>&8UKX H+8GE,90-%4 TODTS[(^ZX/V/][S M\FBRU2#7E$:A-(:BJ6J1-JDY>,9S+B;40(727"C-@](HE,90 M-%52TI U3SFRYU@7>DAGJ4!MV.^AD5:5@$ 4NG\,15,%(@U.4^]PODD3T=A4 M/H>^@X*:FU":"Z5Y4!J%TAB*IHI%^J#F^#D[**AC"J6Y4)H'I5$HC:%HJJ2D M!6OJ/=@S.RBHW0JEN>:AX=INK[=\L-5?AVX>0]'4"5W23;7TGN)O#ZEH))+R M/*F?%/FVCR%_D;,/CO0INE8?2G.A- ]*HU :0]%4(4E7U3*?L>^QH+8KE.9" M:1Z41J$TAJ*IDI(.K:5W:.N6ISG))[H?G@5A[M]%K5U0P]H]AVX-#D^AS_0Y M.VL!2?.@- JE,11-U8*T:BV]54O#C-=G:<@B$SU5^PR/!K+;A5O.<.2,]D4 M=6*A- ]*HU :0]%4$4B[UM+;M;?5Y*M5%@;M34 =;5J*(SX9#R?[Y8?ZKU": M!Z51*(VA:&KYI?]JZ>>IGG'&KB&Q:T"T,>;1CV'HG64"/5%H30/2J-0&D/15$E(A]32.Z0G3^(V M\2=/E,[TB3H+ .IZ0FD42F,HFBH Z7I:^NF?'\61Y/]L84"]3BC-A=(\*(U" M:0Q%4X4DO4YK\IP6!M03A=)<*,V#TBB4QE T]2)-::_:>GNUDX6A9W55#)3F M0FD>E$:A--;0=!=CJ&*0%JFMGWAZGH=A'\[JM"9#8W)P"*//UKG 4%<32J-0 M&D/15!5(5],^X6KJ38PF^K2)H4_3N?Q0(Q-*HU :0]'4\N]R6 MF9VM)H8^56<)8*^UQUYLC[W:_O]A8]K2QK3U-N9)$^-$O,[$T(=VE@34VH32 M*)3&4#15$M+:M/76YDD3PVXQ-EM-#'VBS@* &IM0&H72&(JF"D :F[;>F/PM M+?R()%PH@&]XLN:M5S4V$&4NR]AHNU1XIL_760=0-Q-*HU :0]%4'4@WT]:[ MF;?'EA30N5=Z9N<#1Z@-"J5Y4!J%TAB*IBI'VJ#VE$:A M-(:BJ9*2AJBMG_QY\UT+ ^FAG:4#-3X;VNF5-J!I*93&4#1UM3#I:3IZ3W,F ME\LYZF+H$5TU *6Y#6V\HX%R-9[]I<*@%B64QE T50#2QW3T/N:Q9D&S9AQT M.B>4YC8T[;)Q4#<32F,HFJH%Z68Z)]S,4^-5\A?YEQ]NQ,'-+VDT#Y-%3MZ) MOS/M@%:?M+->H$XIE.9!:11*8RB:*BWIE#K/N<2I [V4'TISH30/2J-0&D/1 M5$GMK'2J=TZ[K1>GAW66C'/>T-.%IO6@- JE,11-58,T71V]Z7KV[" ]I[,0 MH XME.9!:11*8RB:JA;IT#K#Y^R.H)?T0VDNE.9!:11*8RB:*BEI]CK(Y4OU ML,Z2.5QSU&I=L=B%YO6@- JE,11-E8-TR/%/%M4M[TJ MQR;KI*CO%;1]=7MKK>OJAE)[K[OF:Z^^09;$U/?K>N]GBS#)2<3O!=*X&(EA M2%;? JM^4J2KZ@Y,=VE1I''U<,G].<_*#XCW[].T>'I2)MC>B&SZ-U!+ P04 M " 70'%6T6[F['T$ #!%P &0 'AL+W=OR+F$M@'FQ=>'YD^='\O#HS Z$/K(MQAP\96G.YL:6\]VE:;)H MBS/$+L@.Y^+-FM ,<7%+-R;;48SBTBA+3=NR)F:&DMQ8S,IG2[J8D8*G28Z7 M%+ BRQ!]OL8I.)+@@_LY!I(5U:$/,J;VWAN6')$.,41EQ)(_.WQ#4Y3J23& M\>TH:M1]2L/3ZQ?UCZ7SPID58OB&I'\G,=_.C:D!8KQ&1$W?'3(DWH1 M25GY"PY56\\W0%0P3K*CL1A!EN35/WHZ@C@Q@.XK!O;1P.X:>*\8.$<#Y]P> MW*.!6Y*I7"DYA(BCQ8R2 Z"RM5"3%R7,TEJXG^1RWA\X%6\38<<7]SA%',;VPIOG'HBG%+/44\$Z$T$^/J': IN.<[8/P/CO*YTW6%= M&3&Z(P, PW6-C\=,/<&+],L1,IUBH2:S%TZUYNBIUP3,BFSSY3R"E M>(_S @^Q4VJ,95>)34HQ&6_W"\>:>C-S?\JDW\AV_$G3JN6L5SOK*9V]S86' MG-!G\*U :2(64"3V&A71!#^)$X)A-N2\4G.L\Y68=^K\)/!M:'7\U]1I"].D MQC118KJ*(EJ(!;&FY7$PQ$0I,);)I,_$]?U)%XFF/EM(_!J)KT3R)]]B"L1F MPK5(,OM[A;(7I8*112HV%HU,LU"360CBM$4[?*')/=?+4*19J$FOQ#&J> MP?=V*2ERSL ./SCQ@4W:#)59Y.)30M&_CX7X:!4!F.-4>8"IM<9& M7*UJH2ZU-LT(56]$K7FV5K50EUJ;8).00_^M-J+6_%RK6JA+ MK0VU2=&A,F,]*Z=42XS&-QW88)[E3_WN3NPW#* =^%[PREYL\FBH3J0?D#CE MR1HL*8F+B _6 -02HYWNY^4BJ$ W@%VG^PTA%/F%[UD=K\V3VF:&Z::L$3-0 M3F=5*ZR?UG7HJ[+ZVGE^(^O39(;I*<@12OA:1UX8NYH%6]N+KA M9%=64%>$&ULK5;;;MLX M$'W/5PS4["(!LI8L.8F1V@(2>XMM@19!@VP?BGV@J;%%A"(5DK+KO^^0LE4G M=8QVD1>+ESEGKI[A:*7-@RT1'7RKI++CJ'2NOHICRTNLF.WI&A7=S+6IF*.M M6<2V-LB* *IDG";)15PQH:)\%,YN33[2C9-"X:T!VU05,^L;E'HUCOK1]N"S M6)3.'\3YJ&8+O$-W7]\:VL4=2R$J5%9H!0;GX^BZ?S4]]_)!X%^!*[NS!N_) M3.L'OWE?C*/$&X02N?,,C#Y+G*"4GHC,>-QP1IU*#]Q=;]G?!=_)EQFS.-'R MBRA<.8Z&$10X9XUTG_7J']SX$PSD6MKP"ZM6]B*)@#?6Z6H#)@LJH=HO^[:) MPPY@^!(@W0#29P!2O!^0;0#9<\#@!'D^'04.S+ T\1\HVS2*DM?4);!1Z(O+?RM"BR>XF,RO+,^W5I_ MDQXD?(>S'B3],TB3--MGSV'X!Z9ZD+T,G_XZ/#W@3=;E(@M\V?_*Q518+K5M M#,+7ZYEUAOXR_^TQ^J95,MBOQ+>1*ULSCN.(^H1%L\0H__--_R)YNR^ KTDV M?26R)\$==,$='&+/[XA/<(3KA4'T,:;N8+D1M6\_^\)XF.Y$G$+-UH%(S^&X MGYZ?)4D"-1JH?)&_A1-!,C.M&@OXV(@EDU[8:4AZZ>4?'N5*!%;74G VDP@+ MHZT]>FR8<6CD&BPAVDH@*N)B),%:?9E7%A0JK0@AQ5Q@ =0N^ /HX)/UJNK& M\)+:(MB244P]E*JL9FH-G*J-&F\+696"EUY(RJ,E6A=Z:0&A,9<"E[AUE*.A MCJ! T40R=*X:#!;61L^%H\YD%G3KZ(-4Q4WMC3CN#Y/.7G^K'9.[#&37DN+& M?/2$+HZ\@[!&9NR^DCR8F-\MR5U*2YUU)GA\N2&ULK9I=;]LV%(;_"J$- M0PMLD41_Y&.V@<9DL S+&B1K=S'L@K896Z@DNB0=M\!^_$A)D/1:'&V%_*16G&OT)4MS-0Y66J^OPE#-5SQCZDRL>6Z^>1(R8]IL MRF6HUI*S11&4I2&.HF&8L20/)J-BW[VRDR(3W;C=C$.(CLBGO*YM@AFWI[YE*>I)9EQ?*Z@09W3!NY^?J'? M%"=O3F;&%)^*].]DH5?CX") "_[$-JE^$-O?>'5" \N;BU05KVA;'CL2VPOE44OS;6+B].1Q,U/\\X;G&M%G M\ZK0&\(U2U*%_F12,EO&M^@7].&1H#<_OAV%VB2UH>&\2D#*!/A @AZZ$[E> M*43S!5^X\:$9;#UB_#+B:^P%WC%YAJ+>SPA'N-\SSI(<'D?D;A<^[^@(E=?0=U/H.O/KN7_-W/)MQ MV7J]>U%=I8:$$4@8!8(Y]1C6]1C"SD%#R)I P@@DC +!G)J;V KO*6L.&.O/'0"/Q*7LB4% CFR'M9RWMYPK5K[_X7:"XR8XD4L]=QF\Y> M4E>=+_=T;KN,(5-2()BC=FC[G[1].=&J#[E.7>ANM/ MV;4DH#0"2J-0-+=X.\8MAFV[%0^J,I T DJC4#2W,KBI#/Y. U !=CMFRUWV MU)^GL\:0- I%J>NOE>0<70LF%_ZI"M0,@]((*(U"T=QB-88X M[@-/5: .&91&0&D4BN96IK'2\1$O?XF]\ M5&S:P?O<_K2=JTVJF5WWXNT'H"X8E$9 :12*YA:L\\?D,LD52OF3"8W. MSDUR62XR+3>T6!>K*&=":Y$5'U><+;BT!YCOGX30+QLV0;W4=_(_4$L#!!0 M ( != <59.R5%Z/ , /(3 - >&PO.Z6"_?KYQ"!_U1:P/&RRH MQ+['Y]QC^Z9Q.ZC,4K"'&6,F6!1"5D,R,Z;\$(;5=,8*6EVIDDF+9$H7U-BN MSL.JU(RF%9 *$?8ZG3@L*)=D-)#SXJXP53!5D&[\G@9,; MJY0-R=/%VQ]S96[?!.Y^]N[LK/-T>;L;OZB!2Q)Z1:\/$+WJ='!A #'Q^##Q M?=J8],VV=#W\W HYXCE&ZWMH-LN:"1V,G!RX5OL7RTTI;/9\-,B47&]]1%S MYJ<%"YZI&)(Q%7RB.; R6G"Q=.$>!*9**!T86W/64!W4@^O@"RAHVH_+TCK,-5UV M>]=D3:AO-LE$Z93I-DV7K$*C@6 9V-$\G\'=J#($T!A5V$;*::XDK3VL&$W# MRDZ9$ _PK'[/MK07V<;.=F!?9=NTAIJFDW$=T-]4<]J;LM&K=(.2/ROS:6ZG M(^L^E N[URSCB[J_R%H#F'H75Z=E*98?!<]EP=SD#TXX&M 5+Y@IS7_9;% J M4QM@F@3/3!L^W8S\U+1\9 NS*J=%AGONG:#GO[O..9-,4[%IVM;^,:_RJQU' M-__*PUV/S CYVD]>G8#(^!9,G49/]XS<9)/SL=AF+>^%^FCG#[*<2P?,JX_ M6!X_)[&7?Z9)$D5QC*WH>.QU,,;6+8[AQZ^&>0,&E@_/]A3$D5)XD< \SN((@R!IQ%', ?@ 4.BJ'X/[KR/ MPM5[*ES_EV_T&U!+ P04 " 70'%6EXJ[', 3 @ "P %]R96QS M+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0 M"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-# ML%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H M5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( != <5;@&82Z%0, !<5 / M >&PO=V]R:V)O;VLN>&ULQ9C+4MLP%$!_1>--TT6;6'GP&,("0BDS#&0( M92KZ]L-R"G]$XW:E:.'I&/I>M[9)V\*/VT5.J)_"R$--,H MM[8\[O=-DD/!S%=5@G0MF=(%LZZH5WU3:F"IR0%L(?IT,)CT"\9E='JR'6NN M^WY!64@L5])5UA4/'%[,>WM=)&MN^)(+;E^G4?-;0$0*+GG!-Y!.HT%$3*Y> MOBO--TI:)A:)5D),H[AM> !M>?)']:*&O&=+T]18MKQC#F0:309NP(QK8YL> MS?C,,:[!=6Y+E57?N+"@9\S"I595R>6J'L8]1=][C&8>MM=V$H_UOTRCRC*> MP$PE50'2MO.H0=2 TN2\-!&1K(!I=*[6H.OG<3>X2MMGLP[*FRE]S%V#ODH; MO) HTBC!4W?WE)PQP60"I)E"0WH_I =)$4BZ1\A'ZD$.$X,\SYF_W&,$Y(PXNCZ+@MLT@=>2[0+,NX$ FO+O$F#OBP/)85$L# MSY7K1"[6-:H/AODB#BP,-(-TU!MCQH@#*P/''/J8F#/BP-)H\PKIN3VI //9 MQ\(L$0?6Q$<)YD-(S!)Q8$W@2SSR,3%SQ('5@6.._0TUYA0:V"D=Z9+>#"SC MPI ;IK7KO/8Q,;W0P'K9OC"_^?Q@I.@'26"I['"1N$.&F80&-LDN&>V082JA M@56R2[:-->@08A:A@2WBY\%/;WGPH]C#)$(#2\2CW&7Q\3 MLPH-;)6_[U\;6!\3LPH-;!5T$TMZ_@D(9I5AZ"^5W6UL]VWW,3&K#-LSN>U! M7 H9EY#>N%L85Y\PDK1A70$ "03 : >&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'/-V,V.@C 4AN%;(;T RSE5U(FXFHW;B3= L("1O]!.1N]^""[P M([.8C>E9D99P^H;%$\+AR]:9OW:MJZZ]B^Y-W;I45=[W'UJ[O+)-YE9=;]OQ M3M$-3>;'Y5#J/LMO66DUQW&BA]<9ZGAXG1F='[W]S\2N**ZY_>SR[\:V_H_! M^J<;;JZRUJOHG VE]:G2]WK>=GJZT&JIM!.AM4&_S3KV=?]36S3W/-9[_3JK]^*R=CY^6S\W%2YAPUO!3[/@+4$L# M!!0 ( != <5;O6\H)A@$ -43 3 6T-O;G1E;G1?5'EP97-=+GAM M;,V8S4[#,!"$7R7*%36N72@_:GL!KM #+V"231/5L2W;+>W;XZ0_$JA$5$5B M+K$2[\Z,O=)WR.1M:\DGFT9I/TVK$.P#8SZOJ)$^,Y9TW"F-:V2(KV[!K,R7 M2)2KE2(7G>Q,^^-GJ:.E(^31YWA:W7-)76JCJ7 M(>ZSM2Z^N0SV#EGL[&I\55M_%0M2=M*AW?G98-_WNB;GZH*2N73A13:QBFT4 M\V&KR&?]$BY &UL4$L! A0#% @ %T!Q5A:S)4?M *P( !$ ( ! MKP &1O8U!R;W!S+V-O&UL4$L! A0#% @ %T!Q5IE@10& #@'P & @($," >&PO M=V]R:W-H965T&UL4$L! A0#% @ %T!Q5OW@XS'-!@ MZ!P !@ ("!5@X 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ %T!Q5AF'?+UC!0 XAT !@ M ("!UAT 'AL+W=O 8 " @6\C !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% M @ %T!Q5ILU] ?I&0 T< !@ ("!(3X 'AL+W=O&PO M=V]R:W-H965T5E !X;"]W;W)K&UL4$L! A0#% @ %T!Q5KRC!Y=R!0 F P !D ("! M FL 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ %T!Q5B9=F5$8&P ED\ !D ("!H7H 'AL+W=O&PO=V]R:W-H965TR8 !X M;"]W;W)K&UL4$L! A0#% @ %T!Q5NP2NT8F M! T@P !D ("!XYP 'AL+W=O&PO=V]R:W-H965T < 8X 9 " @0:E !X;"]W;W)K&UL4$L! A0#% @ %T!Q5N* .V@= @ /P0 !D M ("!M:P 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ %T!Q5EQT$6GD @ 0@H !D ("!/;0 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M%T!Q5I?K!^^.!0 _"8 !D ("!:L( 'AL+W=O(2L* "4; &0 M @($OR >&PO=V]R:W-H965T&UL4$L! A0#% @ %T!Q5IZ'^Y1T P M6 D !D ("!1=< 'AL+W=O&PO=V]R:W-H965TK1A M70$ "03 : " =CG !X;"]?7!E&UL4$L%!@ G "< B H "3K $ $! end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 92 223 1 false 42 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://kaivalbrands.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://kaivalbrands.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://kaivalbrands.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://kaivalbrands.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://kaivalbrands.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Description of Business Sheet http://kaivalbrands.com/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://kaivalbrands.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Leases Sheet http://kaivalbrands.com/role/Leases Leases Notes 10 false false R11.htm 00000011 - Disclosure - Stockholders??? Equity Sheet http://kaivalbrands.com/role/StockholdersEquity Stockholders??? Equity Notes 11 false false R12.htm 00000012 - Disclosure - Related-Party Transactions Sheet http://kaivalbrands.com/role/Related-partyTransactions Related-Party Transactions Notes 12 false false R13.htm 00000013 - Disclosure - Commitments and Contingencies Sheet http://kaivalbrands.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 00000014 - Disclosure - Subsequent Events Sheet http://kaivalbrands.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 00000015 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables) Sheet http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables Basis of Presentation and Significant Accounting Policies (Tables) Tables http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Leases (Tables) Sheet http://kaivalbrands.com/role/LeasesTables Leases (Tables) Tables http://kaivalbrands.com/role/Leases 17 false false R18.htm 00000018 - Disclosure - Stockholders??? Equity (Tables) Sheet http://kaivalbrands.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://kaivalbrands.com/role/StockholdersEquity 18 false false R19.htm 00000019 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option) Sheet http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option) Details http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables 19 false false R20.htm 00000020 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details Narrative) Sheet http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative Basis of Presentation and Significant Accounting Policies (Details Narrative) Details http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Going Concern (Details Narrative) Sheet http://kaivalbrands.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://kaivalbrands.com/role/GoingConcern 21 false false R22.htm 00000022 - Disclosure - Leases (Details) Sheet http://kaivalbrands.com/role/LeasesDetails Leases (Details) Details http://kaivalbrands.com/role/LeasesTables 22 false false R23.htm 00000023 - Disclosure - Leases (Details 1) Sheet http://kaivalbrands.com/role/LeasesDetails1 Leases (Details 1) Details http://kaivalbrands.com/role/LeasesTables 23 false false R24.htm 00000024 - Disclosure - Leases (Details 2) Sheet http://kaivalbrands.com/role/LeasesDetails2 Leases (Details 2) Details http://kaivalbrands.com/role/LeasesTables 24 false false R25.htm 00000025 - Disclosure - Leases (Details Narrative) Sheet http://kaivalbrands.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://kaivalbrands.com/role/LeasesTables 25 false false R26.htm 00000026 - Disclosure - Stockholders' Equity (Details) Sheet http://kaivalbrands.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details 26 false false R27.htm 00000027 - Disclosure - Stockholder Equity (Details 1) Sheet http://kaivalbrands.com/role/StockholderEquityDetails1 Stockholder Equity (Details 1) Details 27 false false R28.htm 00000028 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://kaivalbrands.com/role/StockholdersEquityTables 28 false false R29.htm 00000029 - Disclosure - Related-Party Transactions (Details Narrative) Sheet http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative Related-Party Transactions (Details Narrative) Details http://kaivalbrands.com/role/Related-partyTransactions 29 false false R30.htm 00000030 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://kaivalbrands.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://kaivalbrands.com/role/CommitmentsAndContingencies 30 false false R31.htm 00000031 - Disclosure - Subsequent Events (Details Narrative) Sheet http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://kaivalbrands.com/role/SubsequentEvents 31 false false All Reports Book All Reports e4478_10q.htm e4478_ex31-1.htm e4478_ex31-2.htm e4478_ex32-1.htm e4478_ex32-2.htm e4478_ex33-1.htm kavl-20230131.xsd kavl-20230131_cal.xml kavl-20230131_def.xml kavl-20230131_lab.xml kavl-20230131_pre.xml http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 50 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "e4478_10q.htm": { "axisCustom": 0, "axisStandard": 12, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 362, "http://xbrl.sec.gov/dei/2022": 30 }, "contextCount": 92, "dts": { "calculationLink": { "local": [ "kavl-20230131_cal.xml" ] }, "definitionLink": { "local": [ "kavl-20230131_def.xml" ] }, "inline": { "local": [ "e4478_10q.htm" ] }, "labelLink": { "local": [ "kavl-20230131_lab.xml" ] }, "presentationLink": { "local": [ "kavl-20230131_pre.xml" ] }, "schema": { "local": [ "kavl-20230131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 356, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 49, "http://kaivalbrands.com/20230131": 15, "http://xbrl.sec.gov/dei/2022": 7, "total": 71 }, "keyCustom": 39, "keyStandard": 184, "memberCustom": 26, "memberStandard": 11, "nsprefix": "kavl", "nsuri": "http://kaivalbrands.com/20230131", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://kaivalbrands.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Leases", "menuCat": "Notes", "order": "10", "role": "http://kaivalbrands.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "11", "role": "http://kaivalbrands.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Related-Party Transactions", "menuCat": "Notes", "order": "12", "role": "http://kaivalbrands.com/role/Related-partyTransactions", "shortName": "Related-Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "13", "role": "http://kaivalbrands.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "14", "role": "http://kaivalbrands.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "15", "role": "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "16", "role": "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "17", "role": "http://kaivalbrands.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Stockholders\u2019 Equity (Tables)", "menuCat": "Tables", "order": "18", "role": "http://kaivalbrands.com/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)", "menuCat": "Details", "order": "19", "role": "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "shortName": "Basis of Presentation and Significant Accounting Policies (Details - Black-Scholes option)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://kaivalbrands.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative", "shortName": "Basis of Presentation and Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "kavl:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Going Concern (Details Narrative)", "menuCat": "Details", "order": "21", "role": "http://kaivalbrands.com/role/GoingConcernDetailsNarrative", "shortName": "Going Concern (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "kavl:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Leases (Details)", "menuCat": "Details", "order": "22", "role": "http://kaivalbrands.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Leases (Details 1)", "menuCat": "Details", "order": "23", "role": "http://kaivalbrands.com/role/LeasesDetails1", "shortName": "Leases (Details 1)", "subGroupType": "details", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Leases (Details 2)", "menuCat": "Details", "order": "24", "role": "http://kaivalbrands.com/role/LeasesDetails2", "shortName": "Leases (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2021-10-282021-11-11", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Leases (Details Narrative)", "menuCat": "Details", "order": "25", "role": "http://kaivalbrands.com/role/LeasesDetailsNarrative", "shortName": "Leases (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2021-10-282021-11-11", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DescriptionOfLesseeLeasingArrangementsOperatingLeases", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Stockholders' Equity (Details)", "menuCat": "Details", "order": "26", "role": "http://kaivalbrands.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31_srt_MaximumMember", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Stockholder Equity (Details 1)", "menuCat": "Details", "order": "27", "role": "http://kaivalbrands.com/role/StockholderEquityDetails1", "shortName": "Stockholder Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31_us-gaap_WarrantMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "kavl:CommonStockShareIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "28", "role": "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "kavl:CommonStockShareIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Related-Party Transactions (Details Narrative)", "menuCat": "Details", "order": "29", "role": "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative", "shortName": "Related-Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "lang": null, "name": "kavl:InventoryQualityControlExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://kaivalbrands.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2023-01-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2023-01-252023-02-01", "decimals": null, "first": true, "lang": "en-US", "name": "kavl:ServiceAgreementDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Commitments and Contingencies (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://kaivalbrands.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2023-01-252023-02-01", "decimals": null, "first": true, "lang": "en-US", "name": "kavl:ServiceAgreementDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2023-01-252023-02-01_us-gaap_SubsequentEventMember", "decimals": "INF", "lang": null, "name": "kavl:StockOption", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "kavl:Revenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://kaivalbrands.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "kavl:Revenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2021-10-31_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "AsOf2021-10-31_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://kaivalbrands.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Organization and Description of Business", "menuCat": "Notes", "order": "7", "role": "http://kaivalbrands.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Basis of Presentation and Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPolicies", "shortName": "Basis of Presentation and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Going Concern", "menuCat": "Notes", "order": "9", "role": "http://kaivalbrands.com/role/GoingConcern", "shortName": "Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4478_10q.htm", "contextRef": "From2022-11-01to2023-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 42, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r398", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kaivalbrands.com/role/Cover" ], "xbrltype": "booleanItemType" }, "kavl_AdditionalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional amount" } } }, "localname": "AdditionalAmount", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_AdditionalLeases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional leases" } } }, "localname": "AdditionalLeases", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_AggregateExercisePriceCancelledForfeitedOrExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate exercise price, cancelled forfeited or expired" } } }, "localname": "AggregateExercisePriceCancelledForfeitedOrExpired", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "kavl_AggregateExercisePriceExercisable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate exercise price, exercisable" } } }, "localname": "AggregateExercisePriceExercisable", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1" ], "xbrltype": "monetaryItemType" }, "kavl_AggregateExercisePriceExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate exercise price, exercised" } } }, "localname": "AggregateExercisePriceExercised", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "kavl_AggregateExercisePriceGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate exercise price, granted" } } }, "localname": "AggregateExercisePriceGranted", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "kavl_AggregateExercisePriceOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Aggregate exercise price outstanding, ending" } } }, "localname": "AggregateExercisePriceOutstanding", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "kavl_BidiVaporMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bidi Vapor [Member]" } } }, "localname": "BidiVaporMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_CStoreMasterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "C Store Master [Member]" } } }, "localname": "CStoreMasterMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "kavl_CommonSharesSettledAndCancelled": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock settled and cancelled" } } }, "localname": "CommonSharesSettledAndCancelled", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "kavl_CommonSharesSettledAndCancelledInShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common shares settled and cancelled (in shares)" } } }, "localname": "CommonSharesSettledAndCancelledInShare", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "kavl_CommonStockShareIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares, issued" } } }, "localname": "CommonStockShareIssued", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "kavl_CostOfRevenueRelatedParty": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of revenue - related party" } } }, "localname": "CostOfRevenueRelatedParty", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kavl_DeferredRevenuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Revenue" } } }, "localname": "DeferredRevenuePolicyTextBlock", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kavl_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://kaivalbrands.com/20230131", "xbrltype": "stringItemType" }, "kavl_ExciseTaxOnProducts": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ExciseTaxOnProducts", "negatedLabel": "Excise tax on products" } } }, "localname": "ExciseTaxOnProducts", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kavl_FairValuedOfOptionsGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fire value granted" } } }, "localname": "FairValuedOfOptionsGranted", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_FavsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Favs [Member]" } } }, "localname": "FavsMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_FiveBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Five Employees [Member]" } } }, "localname": "FiveBoardMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_GPMMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G P M [Member]" } } }, "localname": "GPMMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_HackneyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Hackney [Member]" } } }, "localname": "HackneyMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_IncentiveCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Compensation Plan [Member]" } } }, "localname": "IncentiveCompensationPlanMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_IncreaseDecreaseInCustomerDeposit": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInCustomerDeposit", "verboseLabel": "Customer deposits" } } }, "localname": "IncreaseDecreaseInCustomerDeposit", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kavl_IncreaseDecreaseInCustomerRefundDue": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInCustomerRefundDue", "negatedLabel": "Customer refund due" } } }, "localname": "IncreaseDecreaseInCustomerRefundDue", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kavl_InventoryQualityControlExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Inventory quality control expenses" } } }, "localname": "InventoryQualityControlExpenses", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_KaivalHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Kaival Holdings L L C [Member]" } } }, "localname": "KaivalHoldingsLLCMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_LakshmiDistributorIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lakshmi Distributor Inc [Member]" } } }, "localname": "LakshmiDistributorIncMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_NetLossPerCommonShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per common share - basic and diluted" } } }, "localname": "NetLossPerCommonShareBasicAndDiluted", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "kavl_NirajkumarPatelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nirajkumar Patel [Member]" } } }, "localname": "NirajkumarPatelMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_OfficeAndStorageSpaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Office And Storage Space [Member]" } } }, "localname": "OfficeAndStorageSpaceMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_OneConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Consultants [Member]" } } }, "localname": "OneConsultantsMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative", "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_OtherReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Receivable [Member]" } } }, "localname": "OtherReceivableMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_OutstandingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Outstanding balance" } } }, "localname": "OutstandingBalance", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_PMILicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "P M I License Agreement [Member]" } } }, "localname": "PMILicenseAgreementMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_ProductsRevenuePoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Products Revenue" } } }, "localname": "ProductsRevenuePoliciesTextBlock", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kavl_RetainerAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Retainer amount" } } }, "localname": "RetainerAmount", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_Revenue": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Revenues, net" } } }, "localname": "Revenue", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kavl_RevenueFromSale": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Revenue from sale" } } }, "localname": "RevenueFromSale", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_ReverseStockSplitDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reverse stock split description" } } }, "localname": "ReverseStockSplitDescription", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "kavl_RouOperatingLeaseExpense": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ROU operating lease expense" } } }, "localname": "RouOperatingLeaseExpense", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kavl_RoyaltyRevenue": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Royalty revenue" } } }, "localname": "RoyaltyRevenue", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kavl_RoyaltyRevenuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Revenue" } } }, "localname": "RoyaltyRevenuePolicyTextBlock", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kavl_ServiceAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Service Agreement description" } } }, "localname": "ServiceAgreementDescription", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "kavl_SettledRsusWithCash": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "SettledRsusWithCash", "negatedLabel": "Settled RSU shares with cash" } } }, "localname": "SettledRsusWithCash", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kavl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1" ], "xbrltype": "sharesItemType" }, "kavl_ShareBasedCompensationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation [Member]" } } }, "localname": "ShareBasedCompensationMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price range, cancelled forfeited or expired" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "kavl_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price range, exercised" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "kavl_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price range, granted" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "kavl_StewartMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stewart [Member]" } } }, "localname": "StewartMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_StockBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "StockBasedCompensation", "verboseLabel": "Stock based compensation" } } }, "localname": "StockBasedCompensation", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_StockOption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock options" } } }, "localname": "StockOption", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "kavl_StockOptionPlanExpenses": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock options expense", "verboseLabel": "Stock option expense" } } }, "localname": "StockOptionPlanExpenses", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kavl_StockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Warrants [Member]" } } }, "localname": "StockWarrantsMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_ThreeBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Board [Member]" } } }, "localname": "ThreeBoardMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_TwoBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Board [Member]" } } }, "localname": "TwoBoardMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_TwoConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Consultants [Member]" } } }, "localname": "TwoConsultantsMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_UnrecognizedExpensesRelatedToOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized expenses related to options" } } }, "localname": "UnrecognizedExpensesRelatedToOptions", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding - basic and diluted" } } }, "localname": "WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "kavl_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "kavl_YearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Five [Member]" } } }, "localname": "YearFiveMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_YearFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Four [Member]" } } }, "localname": "YearFourMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_YearOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year One [Member]" } } }, "localname": "YearOneMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_YearSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Six [Member]" } } }, "localname": "YearSixMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_YearThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Three [Member]" } } }, "localname": "YearThreeMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "kavl_YearTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Year Two [Member]" } } }, "localname": "YearTwoMember", "nsuri": "http://kaivalbrands.com/20230131", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r191", "r192", "r193", "r194", "r229", "r337", "r354", "r365", "r366", "r380", "r381", "r386", "r436", "r472", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r191", "r192", "r193", "r194", "r229", "r337", "r354", "r365", "r366", "r380", "r381", "r386", "r436", "r472", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r191", "r192", "r193", "r194", "r227", "r229", "r255", "r256", "r257", "r313", "r337", "r354", "r365", "r366", "r380", "r381", "r386", "r432", "r436", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r191", "r192", "r193", "r194", "r227", "r229", "r255", "r256", "r257", "r313", "r337", "r354", "r365", "r366", "r380", "r381", "r386", "r432", "r436", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r419", "r485" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Schedule Of Condensed Balance Sheet" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r9", "r385" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r9", "r66", "r67", "r418" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable- related party" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r167", "r168" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivablePurchase": { "auth_ref": [ "r175" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase from purchase of accounts receivable.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivablePurchase", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r65", "r67", "r79", "r102", "r418" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Related-party receivable balance" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r110", "r111", "r283", "r284", "r285", "r286", "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r4", "r385" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r260", "r261", "r262", "r420", "r421", "r422", "r464" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustment to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising and Promotion" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r259" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r103", "r169", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r69", "r76", "r97", "r122", "r155", "r158", "r162", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r272", "r276", "r282", "r385", "r434", "r435", "r470" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r92", "r107", "r122", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r272", "r276", "r282", "r385", "r434", "r435", "r470" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r230", "r231", "r232", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r254", "r255", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BondOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option contract in which the underlying asset is a bond.", "label": "Bond Option [Member]" } } }, "localname": "BondOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net effect on income before taxes of the amortization and accretion of premiums, discounts and intangible assets in the year of acquisition, when the assets of the acquired institution exceed 10 percent of the consolidated assets at the end of the most recent period.", "label": "Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income", "verboseLabel": "Sale of Products" } } }, "localname": "BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r1", "r38", "r44" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Organization and Description of Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r361", "r362", "r385", "r408" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r31", "r95", "r368" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r25", "r31", "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Ending cash and restricted cash balance", "periodStartLabel": "Beginning cash and restricted cash balance" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r25", "r64" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash, Uninsured Amount" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r98", "r99", "r100", "r122", "r138", "r139", "r142", "r143", "r146", "r147", "r172", "r195", "r198", "r199", "r200", "r204", "r205", "r207", "r208", "r211", "r215", "r222", "r282", "r367", "r407", "r416", "r423" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r48", "r189", "r190", "r364", "r433" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r420", "r421", "r464" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r49" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r3", "r385" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock ($0.001 par value, 1,000,000,000 shares authorized, 56,169,090 and 56,169,090 issued and outstanding as of January 31, 2023 and October 31, 2022, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r39", "r40", "r62", "r63", "r166", "r363" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r39", "r40", "r62", "r63", "r166", "r360", "r363" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r59", "r373" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r224", "r225", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deposits from customers" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r34", "r35", "r36" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r18", "r122", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r282", "r434" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "totalLabel": "Total cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of revenue" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRefundLiabilityCurrent": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.", "label": "Customer refund due", "verboseLabel": "Customer Refund Liability, Current" } } }, "localname": "CustomerRefundLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r410" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred income" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositLiabilityCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits.", "label": "Customer deposits" } } }, "localname": "DepositLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r29", "r46" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DescriptionOfLesseeLeasingArrangementsOperatingLeases": { "auth_ref": [ "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "A general description of the nature of the existing leasing arrangements of a lessee for all operating leases including, but not limited to: (1) rental escalation clauses; (2) renewal or purchase options; (3) guarantees or indemnities, if any, (4) restrictions imposed by lease arrangements; (5) unusual provisions or conditions; (6) contingent rentals, if any; and (7) lease expiration dates.", "label": "Leases, description" } } }, "localname": "DescriptionOfLesseeLeasingArrangementsOperatingLeases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r71", "r80", "r197", "r198", "r199", "r203", "r204", "r205", "r301", "r418" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "verboseLabel": "Accounts payable" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r49", "r90", "r110", "r111", "r112", "r124", "r125", "r126", "r128", "r133", "r135", "r145", "r173", "r223", "r260", "r261", "r262", "r267", "r268", "r280", "r283", "r284", "r285", "r286", "r287", "r288", "r297", "r355", "r356", "r357" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r170", "r171", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r206", "r220", "r278", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r379", "r428", "r429", "r430", "r478", "r479", "r480", "r481", "r482", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r19" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r17", "r122", "r155", "r157", "r161", "r163", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r282", "r378", "r434" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit (loss)" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r14", "r68", "r73", "r82", "r155", "r157", "r161", "r163", "r352", "r378" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes provision" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r123", "r134", "r135", "r154", "r266", "r269", "r270", "r353" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReceivable": { "auth_ref": [ "r75", "r413" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.", "label": "Income tax receivable" } } }, "localname": "IncomeTaxReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Accounts payable \u2013 related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r372" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.", "label": "Increase (Decrease) in Income Taxes Receivable", "negatedLabel": "Income tax receivable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in current assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r415", "r467" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Right of use liabilities \u2013 operating lease", "verboseLabel": "Increase (Decrease) in Operating Lease Liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative", "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "auth_ref": [ "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Increase (Decrease) in Other Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivable \u2013 related party" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r28" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r115", "r118", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r105", "r369", "r385" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r94", "r104", "r144", "r184", "r185", "r186", "r338", "r374" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r20", "r22" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Interest income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement." } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Leases" } } }, "localname": "LeasesOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Lessee, Operating Lease, Discount Rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Lessee Operating Lease Liability Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r293" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r10", "r122", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r273", "r276", "r277", "r282", "r377", "r434", "r470", "r471" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities [Default Label]", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r8", "r70", "r78", "r385", "r417", "r431", "r465" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES & STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r12", "r93", "r122", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r273", "r276", "r277", "r282", "r385", "r434", "r470", "r471" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG TERM LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r19" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Advertising and promotions" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r117" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in\u00a0financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r117" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r25", "r27", "r30" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r15", "r30", "r74", "r81", "r91", "r108", "r109", "r112", "r122", "r127", "r129", "r130", "r131", "r132", "r134", "r135", "r140", "r155", "r157", "r161", "r163", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r281", "r282", "r378", "r434" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r129", "r130", "r131", "r132", "r136", "r137", "r141", "r143", "r155", "r157", "r161", "r163", "r378" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r21" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Total operating lease liabilities", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails1", "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r291" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease obligation \u2013 short term", "verboseLabel": "Right of use liability operating lease current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r291" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease obligation, net of current portion", "verboseLabel": "Right of use liability operating lease long term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r290" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use asset- operating lease", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Total future undiscounted lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2026" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2025" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r88", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2027 and thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r11" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Accrued freight" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r96" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Fixed assets, net" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostOfOperatingRevenue": { "auth_ref": [ "r18" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.", "label": "Cost of revenue \u2013 other" } } }, "localname": "OtherCostOfOperatingRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r101" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other receivable \u2013 related party \u2013 net of current portion" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other receivable \u2013 related party \u2013 short term" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRoyalties": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for royalties during the current period.", "label": "Royalty payment" } } }, "localname": "PaymentsForRoyalties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r24" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Cash paid for equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Conversion price" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r2", "r207" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r2", "r207" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r2", "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r106", "r187", "r188", "r370" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLeasePayments": { "auth_ref": [ "r295", "r296" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from lease payment, classified as operating activity.", "label": "Operating cash flows from operating leases" } } }, "localname": "ProceedsFromLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r23" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Sale of Products" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r91", "r108", "r109", "r116", "r122", "r127", "r134", "r135", "r155", "r157", "r161", "r163", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r271", "r274", "r275", "r281", "r282", "r352", "r378", "r382", "r383", "r414", "r434" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption" ], "xbrltype": "stringItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r424", "r425", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r228", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative", "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r85", "r300", "r301", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative", "http://kaivalbrands.com/role/LeasesDetailsNarrative", "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative", "http://kaivalbrands.com/role/LeasesDetailsNarrative", "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r228", "r300", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative", "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r298", "r299", "r301", "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related-Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r5", "r50", "r77", "r358", "r359", "r385" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r90", "r124", "r125", "r126", "r128", "r133", "r135", "r173", "r260", "r261", "r262", "r267", "r268", "r280", "r355", "r357" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r16", "r83", "r197", "r198", "r199", "r203", "r204", "r205" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenues - related parties", "verboseLabel": "Recognized revenue" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative", "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueNotFromContractWithCustomerOther": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue that is not accounted for under Topic 606, classified as other.", "label": "Revenue Not from Contract with Customer, Other" } } }, "localname": "RevenueNotFromContractWithCustomerOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r375", "r376" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r114", "r122", "r152", "r153", "r156", "r159", "r160", "r164", "r165", "r166", "r172", "r195", "r196", "r198", "r199", "r200", "r201", "r202", "r204", "r205", "r282", "r352", "r434" ], "calculation": { "http://kaivalbrands.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues [Default Label]", "totalLabel": "Total revenues, net" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesNetOfInterestExpense": { "auth_ref": [ "r152", "r153", "r156", "r159", "r160", "r164", "r165", "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Total net revenues" } } }, "localname": "RevenuesNetOfInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of cash flow information related to leases" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r66", "r67" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/Related-partyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r52", "r55", "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "verboseLabel": "Share-based Payment Arrangement, Option, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Share-based Payment Arrangement, Option, Activity" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r411", "r412", "r437" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/BalanceSheetsParenthetical", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility", "verboseLabel": "Volatility rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate", "verboseLabel": "Interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Stock options exercisable", "verboseLabel": "Stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative", "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted average exercise price, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Cancelled forfeited or expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Weighted average exercise price, cancelled forfeited or expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r445" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Granted", "verboseLabel": "Option granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails", "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r234", "r235" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number of shares outstanding, ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r234", "r235" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Weighted average exercise price outstanding, ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Stock Vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r250" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r230", "r231", "r232", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r254", "r255", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted average exercise price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r233", "r252", "r253", "r254", "r255", "r258", "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Expected option term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails-Black-scholesOption" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Weighted average remaining contractual life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercise price range, exercisable" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Exercise price range outstanding, ending" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at end (in shares)", "periodStartLabel": "Balance at beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r38", "r120" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r98", "r99", "r100", "r122", "r138", "r139", "r142", "r143", "r146", "r147", "r172", "r195", "r198", "r199", "r200", "r204", "r205", "r207", "r208", "r211", "r215", "r222", "r282", "r367", "r407", "r416", "r423" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/BalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r13", "r49", "r90", "r110", "r111", "r112", "r124", "r125", "r126", "r128", "r133", "r135", "r145", "r173", "r223", "r260", "r261", "r262", "r267", "r268", "r280", "r283", "r284", "r285", "r286", "r287", "r288", "r297", "r355", "r356", "r357" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/BalanceSheetsParenthetical", "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r124", "r125", "r126", "r145", "r339" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/BalanceSheetsParenthetical", "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued for services - RSUs, (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r2", "r3", "r49", "r50", "r239" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1", "http://kaivalbrands.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock issued for services\u00a0\u00a0 \u2013 RSU" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options, after deduction of related income tax (expense) benefit.", "label": "Stock option expense", "terseLabel": "Recognized expense", "verboseLabel": "Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense)" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative", "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity", "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r3", "r6", "r7", "r45", "r385", "r417", "r431", "r465" ], "calculation": { "http://kaivalbrands.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets", "http://kaivalbrands.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r51", "r121", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r221", "r223", "r279" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r289", "r305" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r289", "r305" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r289", "r305" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r289", "r305" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r304", "r306" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r170", "r171", "r206", "r220", "r278", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r428", "r429", "r430", "r478", "r479", "r480", "r481", "r482", "r483", "r484" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r41", "r42", "r43", "r148", "r149", "r150", "r151" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_UtilityRevenueAndExpenseRecognitionPolicy": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policies and anticipated effects of regulatory rulings and on rate-setting regarding revenues and expenses incurred and recovered, including billed and unbilled revenues, revenues collected subject to refund, taxes collected from customers and remitted to governmental authorities, and postretirement benefits.", "label": "Customer Refunds" } } }, "localname": "UtilityRevenueAndExpenseRecognitionPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kaivalbrands.com/role/StockholderEquityDetails1" ], "xbrltype": "domainItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1)(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919320-209978", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919327-209978", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r38": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r388": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r389": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r391": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r392": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r393": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r394": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r395": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r396": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r397": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r398": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r399": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r401": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r402": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r403": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r404": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r405": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r406": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "980", "URI": "https://asc.fasb.org/extlink&oid=126950214&loc=d3e40187-110364", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 1)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 51 0001731122-23-000408-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-23-000408-xbrl.zip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

Cover - shares	3 Months Ended
Cover - shares	Jan. 31, 2023	Mar. 17, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jan. 31, 2023
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--10-31
Entity File Number	000-56016
Entity Registrant Name	KAIVAL BRANDS INNOVATIONS GROUP, INC.
Entity Central Index Key	0001762239
Entity Tax Identification Number	83-3492907
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	4460 Old Dixie Highway
Entity Address, City or Town	Grant-Valkaria
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32949
City Area Code	(833)
Local Phone Number	452-4825
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	KAVL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		56,169,090